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SUMMARY 
 
SUMMARY 
The aim of this thesis has been the development of new organocatalytic methods for 
achieving the enantioselective α-functionalization of amides. 
The study is focused on two types of amide subsets: barbituric acid derivatives and 
α-iminoamides, both structures bear considerable practical interest, as they are the core 
structure of biologically relevant compounds. 
On the one hand, to achieve the desymmetrization of barbituric acids we propose 
two different approaches. First, a direct route using (thio)barbiturates as nucleophiles, aryl 
vinyl ketone as electrophile and a Brønsted base as catalyst in CH2Cl2 was raised. The 
adducts in this case, were obtained in good yields (between 63 and 69%), but basically as 
racemic compounds. Secondly, using the SBn derivatives 13 to break the symmetry of the 
initial barbituric acid, in this way, a 61-65% yield and 81-99% ee was obtained (Scheme 
1).  
 
Scheme 1.  
We chose different Brønsted bases and, at the same time, new ones were synthetized (C10 
and C11), in addition, several electrophiles were used for this purpose (Scheme 2), aryl 
vinyl ketones, oxy enones and Morita-Baylis-Hillmann type (pseudo)halogenides. In this 
SUMMARY 
way, a wide family of derivatives of barbituric acid was obtained with good yield and good 
enantiomeric excesses. 
 
Scheme 2.  
Furthermore, some selected transformations of adducts were tested to show the versatility 
of the approach. For example, aduct 32Aa was transformed into the carboxylic acid 42 
through oxidative treatment with NaIO4. On the other hand, applying a reduction /1,2-diol 
cleavage sequence, aldehyde 30 was produced in 88% overall yield (Scheme 3, path a).  
 
Scheme 3.  
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Adduct 41Fa was transformed into a spiranic compound through metathesis reaction with 
Grubbs 2nd generation catalyst in good yield. Subsequent, acid hydrolysis afforded spiranic 
barbituric acid 47 in 61% (Scheme 3, path b). 
On the other hand, a new α-iminoamide with preactivation elements have been 
designed. As shown in Figure 1, in this design it is expected that the intramolecular 
hydrogen bonds could facilitate the deprotonation of the amide α-carbon and rigidify the 
TS of the subsequent reactions. 
 
Figure 1.  
With the newly designed iminoamide 56, their aldol reaction has been studied using this 
new nucleophile design (Scheme 4), setting the base for further developments, and after 
optimization, we obtained, after 48 hours, 95% of conversion, > 98:2 dr ratio and 80% ee 
using an ureidopeptide type catalyst C17 (Scheme 4). This work is currently being 
developed in the laboratory. 
 
Scheme 4.  
 
RESUMEN 
RESUMEN 
Las amidas pueden catalogarse entre los compuestos carbonílicos menos reactivos. Esta 
estabilidad ha contribuido a su utilidad como productos funcionales finales, constituyendo 
por ejemplo la estructura base de las proteínas y otras moléculas bioactivas de menor peso 
molecular. A su vez, esta estabilidad cinética las convierte en sustratos recalcitrantes para 
llevar a cabo procesos de C-funcionalización catalítica. En concreto, la formación directa 
de nuevos enlaces C-C en α de una amida de forma enantioselectiva sigue siendo un reto.  
En esta tesis doctoral se han investigado nuevos procedimientos para la α-
funcionalización enantioselectiva de amidas mediante el uso de organocatalizadores, y, más 
concretamente, bases de Brønsted. 
El estudio se ha centrado en dos tipos de amidas: los derivados del ácido barbitúrico 
y las α-iminoamidas, debido a que ambos tipos de amidas son la estructura base de 
compuestos de interés farmacológico. 
Inicialmente, se ha estudiado la viabilidad de la reacción de adición conjugada de 
diversas amidas y tioamidas activadas derivadas de ácido malónico a nitroestireno en 
presencia de un catalizador bifuncional tipo base de Brønsted/enlace de H. Se ha 
comprobado que la citada reacción es inviable, también para el caso de amidas β,γ-
insaturadas, recuperándose los productos de partida inalterados (Scheme 1). 
 
Scheme 1. Listado de amidas y tioamidas. 
  
RESUMEN 
Una vez realizado este estudio, se pensó en el uso de derivados del ácido barbitúrico, cuyo 
esqueleto es una pseudo diamida. De esta manera, se ha estudiado la α-funcionalización 
enantioselectiva de ácidos barbitúricos y derivados. En un primer intento se ensayó la 
reacción directa de (thio)barbituratos con aril vinil cetonas en presencia de diversas bases 
de Brønsted bifuncionales obteniéndose rendimientos buenos, 63-69%, pero 
principalmente racémicos. A la vista de estos resultados insatisfactorios, se decidió la 
modificación de los sustratos y su conversión en los SBn derivados 13 que resultaron ser 
mucho más eficaces. La idea subyacente es que el enolato intermedio que se genera mejora 
la disimetría estructural en comparación con los (thio)barbituratos facilitando de esta 
manera el enantiocontrol de la reacción (Scheme 2). 
 
Scheme 2.  
Se probaron distintos derivados bencilados 13, con la aril metil cetona 14a y los 
catalizadores C1 y C2 (10 mol%) obteniendose rendimientos de 71% y 67% y excesos de 
36% y 66% respectivamente (Scheme 3). 
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Scheme 3.  
A partir de estos resultados preliminares, se hizo un estudio con distintos catalizadores y 
temperaturas para poder optimizar la reacción. Los mejores resultados se obtuvieron con 
C10, un nuevo catalizador derivado de esquaramida y con un alto impedimento estérico, y 
bajando la temperatura a 0 °C. De esta manera, se consiguió un rendimiento del 72% y un 
ee del 96%.  
Una vez encontradas las mejores condiciones para la reacción, se utilizaron 
diferentes (thio)barbitúricos derivados y electrófilos para estudiar su alcance: aril vinil 
cetonas, α-sililoxienona, vinil sulfona y diazocarboxilato (Figure 1). La reacción funciona 
muy bien con distintas aril vinil cetonas, obteniéndose rendimientos del 61-75% y excesos 
enantioméricos de 90-97%. Utilizando la α-sililoxienona también se obtienen muy buenos 
resultados, rendimientos de entre 61-72% y 83-94% de ee. No obstante, con la vinil sulfona 
y con el diazocarboxilato se obtuvieron rendimientos moderados pero excesos 
enantioméricos que no son suficientemente buenos (Figure 1). 
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Figure 1.  
Por otro lado, se estudió la alquilación de los derivados bencilados utilizando 
(pseudo)halogenuros del tipo Morita-Baylis-Hillmann (Scheme 4). Tras un estudio con 
diferentes bases, se concluyó que el uso de K2CO3 era la mejor opción. De esta manera, se 
obtuvo un gran abanico de compuestos derivados del ácido barbitúrico con muy buenos 
rendimientos (61-77%) y muy buenos excesos enantiómericos (86-99%). 
 
Scheme 4.  
El estudio de las reacciones de adición enantioselectiva se completó abordando la posterior 
elaboración de los aductos en estructuras de interés. Por ejemplo, se transformó el derivado 
32Aa en el ácido 42 y en el aldehído 30. Este último, se sometió a distintas reacciones de 
Wittig dando como resultado los aductos 43, 44 y 45 (Scheme 5, a). 
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Scheme 5.  
Por otro lado, sobre el compuesto 41Fa se realizó una metátesis con el catalizador de 
Grubbs II, y tras una hidrólisis ácida, se obtuvo el compuesto derivado espirocíclico 47 con 
un 61% de rendimiento (Scheme 5, b). 
Por último, se han desarrollado distintas N alquilaciones sobre el compuesto 
derivatizado 43 dando como resultado los compuestos N disustituídos 48 y 49 con muy 
buenos rendimientos. Además, se consiguió la arilación de este sustrato 43 obteniéndose el 
compuesto 50 con un 68% de rendimiento (Scheme 6). 
 
Scheme 6.  
RESUMEN 
En la segunda parte de la tesis se pensó en la síntesis de un nucleófilo derivado de amida 
con elementos activantes para aumentar su reactividad en la posición α. Con estas 
propiedades, se sintetizó la acetamida 56 pensando que la formación de enlaces de 
hidrógeno intramoleculares podrían facilitar la reactividad del nucleófilo (Figure 2). 
 
Figure 2. Estructura de la acetamida 14. 
La reacción aldólica de 56 con hidrocinamaldehído transcurrió de manera deseada con el 
catalizador C17, obteniéndose el correspondiente aducto syn (60) con un 95% de 
conversión, dr >98:2 y un 80% de ee (Scheme 7). Actualmente se está llevando a cabo el 
scope de esta reacción en el laboratorio. 
 
Scheme 7.  
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M Metal 
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min Minutes 
MS Mass spectrometry 
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n. d. Not determined 
n. r. No reaction 
NMR Nuclear magnetic resonance 
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o.n. Overnight 
PG Protecting group 
Ph Phenyl 
nPr n-Propyl 
iPr Isopropyl 
pyr Pyridine 
quant Quantitative 
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Ref. Reference 
rt Room temperature 
t Time 
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T Temperature 
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 Asymmetric α-Functionalization of Barbituric Acids via Brønsted Base Catalysis  
1. Introduction 
1.1. Catalytic enantioselective synthesis 
Many important molecules required for life exist in two forms that are non-superimposable 
mirror images one another. The two forms are called enantiomers (from the Greek word 
for opposite) or optical isomers, because they rotate plane-polarised light either to the right 
or to the left. This tridimensional structure is very important when an exogenous molecule 
interacts with any bio-system, particularly, with the human body. Thus, a single-enantiomer 
drug can be pharmacologically interesting whereas its mirror image can be inactive or 
display a different desirable or non-desirable activity. One representative example about 
the different effect of the two enantiomers of a given molecule is Thalidomide (Figure 1). 
Since the tragedy of Thalidomide,1 the demand of enantiomerically pure compounds 
(EPC)2 has growth sharply in the pharmaceutical industry and also in other areas including 
agrochemicals, flavors, fragances and new materials. 
 
Figure 1. Both enantiomers of Thalidomide and their biological properties. 
The administration of enantiopure drugs brings benefits in terms of improved efficacy, 
more predictable pharmacokinetics and reduced toxicity. These advantages forced 
pharmaceutical companies and health authorities to place stereochemically pure substances 
in a privileged position. Around 95% of the most-selling drugs worldwide are 
commercialized in enantiopure form. For example, this is the case of Nexium 
(esomeprazole), Lipitor (atorvastatin) and Plavix (clopidogrel) to mention some 
blockbuster drugs (Figure 2). 
                                                 
1 Stephens, T.; Brynner, R. Dark Remedy: The impact of thalidomide and its revival as a vital medicine, 2001, 
Perseus, Cambridge, MA. 
2 Seebach, D.; Hungerbühler, E. Synthesis of enantiomerically pure compounds (EPC-Synthesis) in modern 
synthetic methods, Scheffold, R., Ed., 1980, p 94, Salle + Sauerländer, Frankfurt. 
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Figure 2. Commercial enantiopure drugs. 
The great demand of enantiopure compounds incentivized the development of asymmetric 
synthesis. Traditionally, enantiomerically pure compounds were isolated from natural 
sources. However, this approach depends on natural products availability, which is limited. 
Owing to the importance of the chiral molecules in life, synthetic chemists have made great 
efforts in developing protocols to obtain enantiomerically enriched compounds. In general, 
there are three strategies for this purpose (Scheme 1): (i) resolution of mixtures of 
enantiomers,3 (ii) the “chiral pool” approach,4 and (iii) asymmetric synthesis. 
 
Scheme 1. Strategies for the synthesis of Enantiomerically Pure Compounds (EPC). 
                                                 
3 For general reviews on resolution methods, see: a) Synoradzki, L.; Bernás, U.; Ruśkowski, P. Org. Prep 
Proced. Inc. 2008, 40, 163–200. b) Anderson, N. G. Org. Proc. Res. Dep. 2005, 9, 800–813. For general 
reviews on kinetic dynamic resolution, see: a) Pellissier, H. Chirality from Dynamic Kinetic Resolution, 2011, 
RSC, Cambridge. b) Matute, B. M. An. Quim. 2006, 102, 46–52. 
4 For general reviews on “chiral pool” methods, see: a) Nicolau, K. C.; Snyder, S. A. Classics in Total 
Synthesis II, 2003, Wiley.-VCH. b) Nicolau, K. C.; Sorensen, E. J. Classics in Total Synthesis, 1996, Wiley-
VCH. c) Hanessian, S. P. Appl. Chem. 1993, 65, 1189–1204. Hanessian, S.; Giroux, S.; Merner, B. L. “Design 
and Strategies in Organic Chemistry”, 2013, Wiley-VCH. 
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In asymmetric synthesis, an achiral substance is transformed into a chiral one with 
concomitant generation of new chemical bonds stereoselectively. The asymmetric 
induction during the new bond forming process can come from a chiral reagent,5 a 
chiral auxiliary,6 or a chiral catalyst.7 While the utilization of chiral reagents and chiral 
auxiliaries require the use of stoichiometric amounts of the inductor, asymmetric 
catalysis is based on the use of substoichiometric quantities of a chiral enantiopure 
substance that accelerates the reaction and controls the stereochemistry of the 
reaction.  
 
Scheme 2. The three pillars of asymmetric catalysis. 
In the field of asymmetric catalysis, three different groups can be distinguished: 
biocatalysis, metal catalysis and organocatalysis (Scheme 2).8 
The present work is centered on organocatalytic methods. Organocatalysis is 
defined as the acceleration of chemical reactions by small organic molecules in the absence 
of metals and among its features are:  
                                                 
5 For more information about chiral ligands, see: a) Privileged Chiral Ligands and Catalyst, Ed. Zhou, Q.L. 
2011, Wiley-VCH, Weinheim. b) Schütz, T. Synlett, 2003, 6, 901–902.  
6 For more information about chiral auxiliaries, see: a) Roos, G. Key Chiral Auxiliary Applications, 2014, 
Academic Press, New York. b) Glorious, F.; Gnass, Y. Synthesis, 2006, 12, 1899–1930. c) Roos, G. 
Compendium of Chiral Auxiliary Applications, 2002, Academic Press, New York. 
7 For general references on asymmetric catalysis, see: a) Mikami, K.; Lautens, M. New Frontiers in 
Asymmetric Catalysis, 2007, Wiley-VCH, Weihhelm. b) Trost, B. M. Proc. Natl. Acad. Sci. USA, 2004, 101, 
5348–5255. c) Comprehensive Asymmetric Catalysis I-III, Jacobsen, E. N.; Pfaltz, A.; Yamamoto, H. Eds. 
Springer-Verlag Berlin Heidelberg, 1999. 
8 For general reviews on biocatalysis, see: a) De Gonzalo, G.; Lavandera, I.; Gotor, V. Catalytic Methods in 
Asymmetric Synthesis. Advanced Material, Techniques, and Applications, Ed. M. Gruttadauria, F. Giacalone, 
John Wiley and Sons, 2011, 391–527. b) Zagrebelny, N. Russ. Chem. Rev. 2005, 74, 285–296. c) Reetz, M. 
T.; Brunner, B.; Schnerider, F.; Schulz, C. M.; Clouthier, M. M.; Kayser, M. Angew. Chem. Int. Ed. 2004, 
43, 4075–4078. For general reviews on organometallic catalysis, see: a) Leenders, S. H. A. M.; Gramage-
Doria, R.; de Bruin, B.; Reek, J. N. H. Chem. Soc. Rev. 2015, 44, 433–448. b) Steinborn, D. Fundamentals 
of Organometallic catalysis, 2011, Wiley-VCH, Germany. c) Astruc, D. Organometallic Chemistry and 
Catalysis, 2007, Springer-Verlag Berlin Heidelberg. Ref. 7c. 
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- Organocatalysts usually are non-sensitive to the humidity and the atmospheric 
oxygen, easy to handle without the need of dry boxes, inert atmospheres or 
anhydrous solvents. 
- Many organocatalysts are directly available from nature in both enantiomeric 
series, or can be obtained through straight chemical manipulations. 
- The organocatalysts are low or non-toxic, respectful with the environment and 
can be easily isolated from the reaction mixtures avoiding the contamination of 
the final product.  
1.2. Brønsted base catalysis 
The field of organocatalysis has developed so considerably in a relatively short period of 
time owing to the identification of a few generic mechanism of substrate activation and 
stereochemical induction which provided effective tools for reaction invention. Organic 
catalysts can exert their functions by following two different substrate activation patterns: 
covalent and non-covalent based modes of activation.9 
Catalysis by covalent activation is based on the ability of some organic catalysts to 
bind the substrate covalently in a reversible manner to yield a reactive intermediate that can 
participate in a subsequent C-C or C-X bond forming reaction enantioselectively. Chiral 
primary and secondary amines belong to this class, and have the ability to activate carbonyl 
substrates via the formation of nucleophilic enamines from enolizable aldehydes and 
ketones (Scheme 3a),10 electrophilic iminium ions from unsaturated carbonyl compounds 
(Scheme 3b),11 and α-iminylradical cation intermediates in SOMO catalysis with the 
assistance of a (photo)chemical oxidant (Scheme 3c).12 Heterocyclic carbene catalysts offer 
an alternative activation mechanism for aldehydes, conferring an inverted reactivity 
                                                 
9 For a classification of generic mechanisms of organocatalytic reactivity: Silvi, M.; Melchiorre, P. Nature, 
2018, 554, 41–49. 
10 For general reviews on enamine-mediated catalysis: a) Fu, N.; Zhang, L.; Luo, S. Org. Biomol. Chem. 2018, 
16, 510–520. b) Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry, Ed. Springer, New York 2007, 
vol. B, 46–55. c) Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471–5569.  
11 For general reviews on iminium-ion-mediated catalysis: a) Liu, Y.; Melchiorre, P. Science of Synthesis, 1: 
Asymmetric Organocatalysis, 2012, 1, 403–38. b) Erkkila, A.; Majander, I.; Pihko, P. M. Chem. Rev. 2007, 
107, 5416–5470. b) Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta, 2006, 39, 79–87. 
12 For general reviews on SOMO catalysis: a) McMillan, D. W. C.; Rendler, S. Asymmetric Synthesis II, 2012, 
87–94. b) MacMilan, D. W. C.; Beeson, T. D. Science of Synthesis, Asymmetric Organocatalysis, 2012, 1, 
271–307. c) Beeson, T. D.; Mastracchio, A.; Hong, J. B.; Ashton, K.; MacMillan, D. W. C. Science, 2007, 
316, 582–585. 
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(umpolung) to the normally electrophilic carbonyl carbon atom upon formation of Breslow 
intermediates (Scheme 3d),13 which acts as an acyl anion equivalent. 
 
Scheme 3. Covalent-based mechanisms. 
                                                 
13 For general reviews on N-heterocyclic-carbene catalysis: a) Menon, R. S.; Biju, A. T.; Nair, V. Chem. Soc. 
Rev. 2015, 44, 5040–5052. b) Nair, V.; Vellalath, S.; Babu, B. P. Chem. Rev. 2008, 37, 2691–2698. c) 
Breslow, R. J. Am. Chem. Soc. 1958, 80, 3719–3726. d) Enders, D., Niemeier, O.; Henseler, A. Chem. 
Rev.2007, 107, 5606–5655. 
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Non-covalent catalysis approaches are based on, usually many cooperative, weak attractive 
interactions between the catalysts and the substrate.14 Although the catalyst-substrate 
interactions are generally weaker and less directional than their covalent counterparts, non-
covalent interactions operate in concert to ensure a high level of transition state 
organization, ultimately resulting in efficient activation and a high degree of 
enantioselectivity. Hydrogen-bonding activation (Scheme 4a),15 phase–transfer catalysis 
(Scheme 4b),16 anion binding activation (Scheme 4c),17 Brønsted acid catalysis (Scheme 
4d),18 and Brønsted base catalysis (Scheme 4e) 19 are all useful organocatalytic strategies 
for making chiral molecules. 
                                                 
14 For general reviews on non-covalent catalysis: a) Quitavalla, A.; Cerisoli, L.; Elisa, M. Current 
Organocatalysis, 2014, 1, 107–171. b) Knowles, R. R.; Jacobsen, E. N. Proc. Natl. Acad. Sci. USA, 2010, 
107, 20678–20685. 
15 For general reviews on hydrogen-bonding catalysis: a) Nishikawa, Y. Tetrahedron Lett. 2018, 59, 216–
223. b) Doyle, A.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713–5743. c) Schreiner, P. R.; Chem. Soc. Rev. 
2003, 32, 289–296. d) Taylor, M. S.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520–1543.  
16 For general reviews on phase transfer catalysis: a) Tan, J.; Yasuda, N. Org. Process Res. Dev. 2015, 19, 
1731–1746. b) Maruoka, K.; Takashi, O. Chem. Rev. 2003, 103, 3013–3028. c) Takashi, O.; Maruoka, K. 
Angew. Chem. Int. Ed. 2007, 23, 4222–4266. d) Shirakawa, S.; Maruoka, K. Angew. Chem. Int. Ed. 2013, 52, 
4312–4348. e) Shirakawa, S.; Maruoka, K. Angew. Chem. Int. Ed. 2013, 52, 4312–4348. 
17 For general reviews on anion-binding catalysis: a) Visco, M. D.; Attard, J.; Guan, Y.; Mattson, A. E. 
Tetraedron Lett. 2017, 58, 2623–2628. b) Brak, K.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2013, 52, 534–
561. 
18 For general reviews on Brønsted acid catalysis: a) Parmar, D.; Sugiono, E.; Raja, S.; Rueping, M. Chem. 
Rev. 2014, 114, 9047–9153. b) Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem. Int. Ed. 2004, 
43, 1566–1568 
19 For general reviews on Brønsted base catalysis: a) Teng, B. Lim, W. C.; Tan, C. H. Synlett, 2017, 28, 1272–
1277. b) Palomo, C.; M. Oiarbide, M.; Lopez, R. Chem. Soc. Rev. 2009, 38, 632. c) Ojima, I. Catalytic 
Asymmetric Synthesis, Ed. John Wiley and Sons, New York, 2010. d) A. Ting, Gross, J. M.; McDougal, N. 
T.; Schaus, S. E. Top. Curr. Chem. 2010, 291, 145–200. e) Maruoka, K. Asymmetric Organocatalysis 2, 
Brønsted Base and Acid Catalysis, and Additional Topics: Science of Synthesis; Ed. Thieme, Stuttgart, 2012. 
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Scheme 4. Non covalent-activation mechanisms. 
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According to the IUPAC, a Brønsted base (BB) can be defined as a molecular entity 
capable of accepting a hydron (or proton) from an acid or the corresponding chemical 
species. Figure 3 shows a simplified catalytic cycle followed in these reactions. The 
catalytic cycle is initiated via deprotonation of the pro-nucleophile by the basic 
catalyst, forming a chiral ionic pair. The anionic species, reacts with the 
corresponding electrophile in an enantioselective way to provide a Nu-E adduct as the 
ultimate reaction product and liberation of free base catalyst. 
 
Figure 3. Catalytic cycle promoted by Brønsted bases. 
From the perspective of the organic transformations, proton transfer is often considered a 
key activation step that precedes the new bond formation. Chirality transfer during the new 
bond forming process occurs in a chiral ion-pair systems. The intrinsic nondirectional 
nature of electrostatic interactions in these ion-pair complexes makes difficult to predict 
the sense of the stereoinduction exerted from the catalyst. Catalysts that combine a site 
acting as a base and another site with hydrogen-bond donor ability, namely bifunctional 
Brønsted base/H-bond donor catalysts,20 can anchor both nucleophilic and electrophilic 
components in the transition state. As a result, more active catalysts are obtained, and a 
higher degree of stereochemical order is achieved in the transition state (Figure 4). 
                                                 
20 For further information on the concept of bifunctional organocatalysts see: L.-Q. Lu, X.-L. An, J.-R. Chen, 
W.-J. Xiao, Synlett 2012, 23, 490–508. 
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Figure 4.  
Various nitrogen-containing functionalities have been used for the design of chiral BB 
catalysts. Among them, tertiary amines, guanidines,21 amidines, and imidazoles are the 
most prominent (Figure 5a). Stronger bases, such as phosphazines have also been 
developed recently in an attempt to gather less acidic substrates.22 In this context, alkaloids, 
particularly those of the cinchona family, are a source of enantiopure BB catalyst 
candidates providing access to various BBs which display reasonable constitutional and 
stereochemical diversity (Figure 5b).23 Another type of BB catalysts are derived from α-
amino acids, which are cheap starting materials. Other non-natural sources, such as 
synthetic 1,2-diamines and binaphthols, have also been employed as enantiopure materials 
precursor for the designed Brønsted base catalyst. Figure 5c displays three representative 
examples of chiral Brønsted base catalysts. 
                                                 
21 For general reviews on guanidines in asymmetric synthesis, see: a) Ishikawa, T.; Kumamoto, T. Synthesis 
2006, 737–752. b) Ishikawa, T.; Isobe, T. Chem. Eur. J. 2002, 8, 553–557.  
22 Núñez, M. G.; Farley, A. J. M.; Dixon, D. J. J. Am. Chem. Soc. 2013, 135, 16348–16351. 
23 For general reviews on cinchona alkaloids in asymmetric organocatalysis see: a) Marcelli, T.; van 
Maarseveen, J. H.; Hiemstra, H. Angew. Chem. Int. Ed. 2006, 45, 7496–7504. b) Marcelli, T.; Hiemstra, H. 
Synthesis 2010, 1229–1279. c) Yeboah, E.M.O.; Yeboah, S. O.; Singh, G. S.; Tetrahedron. 2011, 1725–1762. 
d) Bryant, L.A.; Fanelli, R.; Cobb, A. Beilstein J. Org. Chem. 2016, 12, 429–443. 
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Figure 5. a) Chiral BB catalysts. b) Alkaloids from cinchona family. c) Some representative chiral 
Brønsted base catalysts. 
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1.3. Amides as enolizable reagents in asymmetric catalysis 
The amide linkage is key in the structure of proteins, peptides, polymers and other 
biologically important molecules. Amide bonds are also present in a huge collection of 
molecules, including drugs.24 For instance, amides are present in around 25% of top-selling 
pharmaceuticals and in many other medically important compounds (Figure 6).25 
 
Figure 6. Different drugs with amide bond. 
Despite the huge importance of amides in organic chemistry, well-established methods for 
their asymmetric synthesis are relatively scarce. 
1.3.1. Chemical modifications of amides 
Carbonyl compounds can serve as nucleophiles through enolate formation or as 
electrophiles if they are conjugated with multiple bonds (Scheme 5). In general, the 
capacity to generate the corresponding enolate by proton abstraction depends on the type 
of carbonyl functional group (Scheme 5a). Thus, the carbon acidity of amides (pKa in 
DMSO ≈ 35) and esters (pKa in DMSO ≈ 31) are much lower than those of aldehydes or 
ketones (pKa in DMSO ≈ 27).26 This is the reason why the C-C bond formation in α-position 
of carbonyl compounds is mostly developed for aldehydes and ketones in sharp contrast to 
esters and amides. In addition, whereas aldehydes and ketones are suitable for enamine 
catalysis, esters and amides are not. 
                                                 
24 Roughley, D. S.; Jordan, A. M. J. Med. Chem. 2011, 54, 3451–3479. 
25 Ghose, A. K.; Viswanadhan, V. N.; Wendoloski, J. J. J. Comb. Chem. 1999, 1, 55–68. 
26 Based on the Bordwell pKa table (see: http://www.chem.wisc.edu/areas/reich/pkatable/index.htm). 
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Scheme 5. Reactivity of amide group. 
The most popular method for C-C bond formations using amides or esters as nucleophiles 
involves irreversible generation of metal enolates using stoichiometric amounts of strong 
bases such as lithium diisopropylamide (LDA), potassium hexamethyldisilazide (KHMDS) 
or alternatively isolable silyl enolates generated from stoichiometric amounts of silicon 
reagents and bases (Scheme 6).27 
 
Scheme 6. Conventional methods for catalyst-controlled nucleophilic reactions of simple amides and esters. 
  
                                                 
27 For general examples of C-C bond formation using amides, see: a) Oare, D. A.; Henderson, M. A.; Sanner, 
M. A.; Heathcock, C. H. J. Org. Chem. 1990, 55, 132–157. b) Fujieda, H.; Kanai, M.; Kambara, T.; Iida, A.; 
Tomioka, K. J. Am. Chem. Soc. 1997, 119, 2060–2061. c) Yamamoto, Y.; Suzuki, H.; Yasuda, Y.; Iida, A.; 
Tomioka, K. Tetrahedron Lett. 2008, 49, 4582. 
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1.3.2. Enantioselective α-functionalization of amides 
The most widespread method for the C-C bond formation in α position to an amide group 
is still the use of stoichiometric amounts of metal enolates with strong bases, the use of 
isolable silicon enolates with stoichiometric amounts of silicon reagents and bases 
(Mukaiyama-type reactions) or the use of modified amides. 28 The main problem to design 
an efficient method for the generation of enolates from amides is that strong bases (e.g. 
lithium diisopropylamide or alkyl lithium) are generally required. Thus, implementation of 
catalytic variants of these procedures is precluded by the difficulties in catalyst turnover. 
In spite of these reasons, some catalytic methods for the enolate mediated Cα 
functionalization of amides have been described. 
In 2006, Kobayashi and co-workers described a highly anti-selective aldol reaction 
of amides and aldehydes using catalytic amounts of barium phenoxide under mild 
conditions (at 0 °C for 24–48 h in most of cases). However, implementation of the 
asymmetric version has remained challenging (Scheme 7).29  
 
Scheme 7. Aldol reaction of amides with aldehydes. 
  
                                                 
28 For more details, see: a) Kumagai, N.; Shibasaki, M. Chem. Eur. J. 2016, 22, 15192–15200. b) Evans, D. 
A.; Takacs, J. M. Tetrahedron Lett. 1980, 21, 4233–4236. c) Evans, D. A.; Takacs, J. M.; McGee, L. R.; 
Ennis, M. D.; Mathre, D. J.; Bartoli, J. Pure Appl. Chem. 1981, 53, 1109–1127. d) Oare, D.; Henderson, M. 
A.; Sanner, M. A.; Heathcock, H. J. Org. Chem. 1990, 55, 132–137.  
29 Saito, S.; Kobayashi, S. J. Am. Chem. Soc. 2006, 128, 8704–8705. 
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In the same year, Rawal and co-workers reported the first example of a metal-free 
Mukaiyama type aldol reaction of an amide derivative with high diastereo and 
enantioselectivities. They used as catalyst tetraaryl-1,3-dioxolane-4,5-dimethanol (taddol) 
(Scheme 8).30 X-ray crystal structure elucidation of a catalyst-aldehyde complex revealed 
the presence of an intramolecular hydrogen bond between the two hydroxy groups of the 
catalyst and an intermolecular hydrogen bond to the carbonyl oxygen atom of p-
anisaldehyde. This complex was consistent with the suggested mode of activation of the 
carbonyl group through a single-point hydrogen bond to a preorganized catalyst. This mode 
of activation represents a form of Lewis acid assisted Lewis acid catalysis. 
 
Scheme 8. Enantioselective Mukaiyama aldol reaction of silicon enolates of amides catalysed by a taddol 
derivative. 
About the same time Maruoka and co-workers described a highly enantioselective 
alkylation of protected glycine amides under phase transfer conditions based on a designer 
chiral quaternary ammonium salt. They achieved the desired α-alkylated amide products 
with high efficiency and enantioselectivity (Scheme 9). 31 
                                                 
30 McGilvra, J. D.; Unni, A. K.; Modi, K.; Rawal, V. H. Angew. Chem. Int. Ed. 2006, 45, 6130–6133. 
31 Ooi, T.; Takeuchi, M.; Kato, D.; Uematsu, Y.; Tayama, E.; Sakai, D.; Maruoka, K. J. Am. Chem. Soc. 2005, 
127, 5073–5083. 
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Scheme 9. Phase transfer catalyzed asymmetric alkylation of protected glycine amide. 
In 2008, Wu and co-workers reported the first highly enantioselective palladium catalyzed 
alkylation of amides using 1 equiv. of LiCl and 1 equiv. of strong base in the presence of 
1,1-P,N ferrocene ligands. In this way, they achieved the corresponding γ, δ-unsaturated 
amides with very high enantioselectivities (Scheme 10).32 
 
Scheme 10. Pd-catalyzed AAA of acyclic amides. 
  
                                                 
32 Zhang, K.; Peng, Q.; Hou, X. L.; Wu, Y. D. Angew. Chem. Int. Ed. 2008, 47, 1741–1744. 
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One year later, the Pd-catalyzed asymmetric cyclopropanation reaction of acyclic amides 
with monosubstituted allylic reagents was reported by the Hou group. In this reaction 
cyclopropane derivatives with two chiral centers are obtained with high diastereo and 
enantioselectivities (Scheme 11).33 
 
Scheme 11. Cyclopropanation of amides with substituted allyl carbonates. 
Kobayashi´s group achieved the activation of simple alkyl amides through silicon-mediated 
catalysis in 2011 by using catalytic amounts of iPr3SiOTf/Et3N for a direct Mannich-type 
reaction with N-Ts imines, leading to high yields and high anti/syn selectivities. 
Unfortunately, once again, it appears that development of an enantioselective variation is 
difficult as they described a single asymmetric entry using CuI/(R)-tol-binap affording a 
69% ee (Scheme 12).34  
 
                                                 
33 Liu, W.; Chen, D.; Zhu, X. Z.; Wan, X. L.; Hou, X. L. J. Am. Chem. Soc. 2009, 131, 8734–8735. 
34 Kobayashi, S.; Kiyohara, H.; Yamaguchi, M. J. Am. Chem. Soc. 2011, 133, 708–711. 
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Scheme 12. Catalytic direct-type addition of amides to imines promoted by iPr3SiOtf/Et3N catalytic system, 
and its enantioselective variant using CuI/(R)-tol-binap. 
Few years later, the same group described the asymmetric direct 1,4-addition reactions of 
simple amides with α,β-unsaturated carbonyl compounds using a catalytic amount of a 
novel chiral catalyst (Scheme 13).35 The desired 1,5-dicarbonyl compounds were obtained 
in high yields with excellent diastereo- and enantioselectivities. In this reaction, the 
intermediate I possesses strong Brønsted basicity for deprotonation of the amides directly. 
 
Scheme 13. Direct catalytic asymmetric conjugate addition of amides to α,β-unsaturated amides promoted 
by KHMDS/chiral crown ether. 
                                                 
35 Suzuki, H.; Sato, I.; Yamashita, Y.; Kobayashi, S. J. Am. Chem. Soc. 2015, 137, 4336–4339. 
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More recently, Zhang and co-workers reported the asymmetric alkylation of glycine 
iminoamides through a synergistic Pd/Cu catalyst system. A range of α-substituted α-amino 
acids are obtained in high yields and with excellent enantioselectivities (Scheme 14).36 
 
Scheme 14. Alkylation of glycine amides. 
.
                                                 
36 Huo, X. Fu, J.; He, X.; Chen, J.; Xien, F.; Zhang, W. Chem. Commun. 2018, 54, 599–602. 
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1.4. Objectives and working hypothesis 
Precedents make clear the scarcity of strategies for the asymmetric α-functionalization of 
amides. In addition, the stereoselective creation of carbon atoms bonded to four different 
substituents (quaternary stereocenters), that are common motifs in complex molecules in 
nature, continues to be a challenge. 37 This realization presents two major problems. On the 
one hand, the formation of the fourth C-C bond must be performed on a central atom that 
it is already hindered for the presence of three preinstalled groups (steric congestion). On 
the other hand, the chiral catalyst substrate complex in the TS should impar enough 
stereoinduction as to differentiate the two faces of the prochiral reaction center.  
The objective of this Ph. D. work has been the design of new methodologies for the 
enantioselective α-functionalization of amides, based on a Brønsted base/H-bonding 
catalysis approach as the main activation element. 
In this context, barbituric acids and derivatives are a particular type of 
(pseudo)symmetrical amides (imides) that have attracted great attention owing to their 
medical use as hypnotic agents, sedatives or anesthesic agents. Thus, the first goal of this 
work is focused on the development of a BB-catalyzed method for the enantioselective α-
functionalization of barbituric acid templates to obtain the corresponding quaternary 
barbiturate. Quaternary stereocenters can be found in a wide range of important compounds 
in pharmaceutical and medical contexts including barbiturates, as well as in a large variety 
of natural products.38  
Due to the (pseudo)symmetrical nature of barbiturates, two different routes were 
proposed to proceed with their desimetrization, route A (Scheme 15), which was the most 
direct and route B (Scheme 15) that consisted of modifying the barbituric acid to break the 
initial symmetry of the compound. If the reaction proceeds in a satisfactory way, the 
obtained Michael adducts could be transformed easily into the corresponding optically 
active barbituric derivatives. So, a new method for the synthesis of a broad-scope of 
enantiopure barbituric acids could be obtained (Scheme 15). 
                                                 
37a) Bella, M.; Caspery, T. Synthsesis, 2009, 1583–1614. b) Das, J. P.; Marek, I. Chem. Commun. 2011, 47, 
4593–4623. c) Hong, A. Y.; Stoltz, B. Eur. J. Org. Chem. 2013, 2745–2759.  
38 Long, R.; Huang, J.; Gong, J.; Yang, Z. Nat. Prod. Rep. 2015, 32, 1584–1601. 
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Scheme 15.  
In the second part of the work, we planned the design of a new amide pronucleophile 
suitable for smooth activation via proton transfer with common Brønsted base catalysts. 
This realization would led optically active α-functionalization amides using a methodology 
that have not been described previously (Scheme 16). 
 
Scheme 16.  
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2. Brønsted base-catalyzed α-functionalization of 
barbituric acids 
2.1. Introduction 
2.1.1. Working hypothesis and synthetic plan 
As mentioned above, the amide group is very important for the synthesis of essential 
molecules in the pharmaceutical and chemical industry. Despite this, there are few methods 
to achieve these compounds asymmetrically. On the other hand, as far as we know, no 
example of asymmetric α-functionalization of amides using organocatalysis has been 
described. For these reasons, we proposed to evaluate the feasibility of a BB-catalyzed 
asymmetric α-functionalization of amides using suitable acceptors (electrophilic reagents) 
(Figure 7). One aspect to evaluate would be the nature of R1 and R2 groups in the amide 
and how they can modulate reactivity. 
 
Figure 7. Research objective. 
For this study, we selected two representative and accesible electrophiles, trans-β-
nitrostyrene and 3-phenylpropanal. 
2.1.2. First amides screening 
We began our study by checking several amides bearing an additional EWG at Cα in the 
Michael addition to trans-β-nitrostyrene using 10 mol % of known thiourea organocatalyst 
C1.39 As plausible substracts malonamides were initially selected given their relatively 
lower pKa. 
In this context, several α-substituted (thio)malonamides derivatives namely 2-
benzyl-N1,N3-diphenylmalonamide 1,  methyl 2-benzyl-3-oxo-3-
(phenylamino)propanoate 2 and O-methyl 2-benzyl-3-(phenylamino)-3-
                                                 
39 a) Ono, N. The nitro group in Organic Synthesis, Wiley-VCH, Weinheim, 2001. b) Barrett, A. G.; Graboski, 
G.G. Chem. Rev. 1986, 86, 751–762. c) Ballini, R.; Bosica, G.; Fiorini, D.; Palmieri, A.; Petrini, M. Chem. 
Rev. 2005, 105, 933 –971. d) Rosini, G.; Ballini, R. Synthesis, 1988, 833–847. e) Tamura, R.; Kamimura, A.; 
Ono, N. Synthesis, 1991, 423–434. 
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thioxopropanethioate 3 were synthetized following standard procedures (Scheme 17). The 
experimental procedure for these catalytic reactions was the same in all cases. To a mixture 
of the corresponding starting (thio)malonamide (1 equiv., 0.2 mmol) in dichloromethane, 
catalyst C1 (10 mol %) and nitrostyrene (1.5 equiv., 0.3 mmol) were added. Then, the 
reactions were stirred at rt for 72 h and monitored by NMR every 24 hours.We observed 
that in neither case the reactions did work. At this point, it reminded unclear whether these 
results can be explained by retroaddition reaction of the product under the reaction 
conditions. 
 
Scheme 17. Attempted catalytic reaction between α-substituted (thio)malonamides and nitrostyrene. 
Then, we decided to test the corresponding (thio)malonamides 4-6 which lack any 
substitution at the methylene unit (Scheme 18). N,N-tetraethylmalonamide 4 was checked 
but the reaction did not work. We tried the thioamide derivative, 5 too but, unfortunately, 
the reaction did not give the desired product neither. Finally, we checked too 
dithiomalonamide 6, but even so, the reaction did not work. 
 
Scheme 18. Michael addition of malonamides to nitrostyrene. 
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Following with our approach, we shifted from (thio)malonamides to β-ketoamide 7, 
featurig a secondary amide, but it was not the solution for our problem (Scheme 19). 
Similarly, no reaction was observed with β-ketoester 8 (Scheme 19). 
 
Scheme 19. The attempts with diphenyl amides and ester. 
In view of these unsatisfactory results, we move from the acyclic to the cyclic congeneus 
with the hope that both acidy and nucleophilicity of the eventually formed enolates would 
get increased (Scheme 20). On the other hand, barbiturates are medically interesting 
compounds belong to this structural class of molecules. 
 
Scheme 20.  
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2.1.3. Barbituric acids 
The chemistry of barbituric acid and its derivatives has been studied for over 100 years. In 
1864, phenobarbital (Figure 8), the parent compound of this class, was prepared by von 
Baeyer40 and in 1873 was Muleder who confirmed its chemical structure. Barbituric acids 
and derivatives are very interesting 1,3-diamide scaffolds for the development of 
therapeutic agents and functional materials. In 1903 Fisher and von Mering41 reported the 
therapeutic value of the 5,5-diethylbarbituric acid (barbital) as a hypnotic agent and since 
that time chemical and pharmacological studies on barbiturates has continued. 
Nowadays, barbiturates are used in specific therapeutic applications. Phenobarbital 
and butabarbital (Figure 8) are still used as sedatives in cases of gastrointestinal and 
asthmatic functional disorders. Phenobarbital is also used like hypnosedative agent. In the 
field of neurology, barbiturates are still employed, in the treatment of certain types of 
epilepsy and in the emergency treatment of some types of convulsions, such as those 
associated with tetanus, cerebral haemorrhage, status epilepticus, or different forms of 
poisoning. In addition, the barbiturates present other current uses; phenobarbital is capable 
of improving the hepatic transport of bilirubin in patients with haemolytic jaundice.42 At a 
diagnostic level, amobarbital (Figure 8), in low doses, can be injected directly into the 
carotid artery prior to neurosurgency to identify the dominate cerebral hemisphere.42 
Finally, anesthetic doses of barbiturates can attenuate post-surgical cerebral enemas and 
have positive effects in case of cardiac and cerebral ischemia reducing the size of the 
infarcted region.42 
Barbiturates were introduced into the clinical practice at the beginning of the 20th 
century and since then they are well positionated in the group of central nervous system 
agents. These drugs are highly addictive too and are often used as recreational drugs.43 For 
example, the commercially available barbiturates secobarbital, pentobarbital, and 
amobarbital (Figure 8) are no longer routinely recommended for the treatment of insomnia 
because of their ability to cause dependence, tolerance, and withdrawal. In addition, they 
have significant secundary effects when taken in large doses and can cause respiratory 
failure and death.  
                                                 
40 Von Baeyer, A. Ann. Chem. Pharm. 1864, 130, 129–175. 
41 Fisher, E.;Von Mering, J. R. Ther. Ggw. 1903, 44, 97–101. 
42 Muñoz, F.; Ucha-Udabe R.; Alamo, C. Neuropsychiatr. Dis. and treat. 2005, 4, 329–343. 
43 Dhiman, P. Drug Discov and The. 2013, 8, 15–22. 
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Figure 8. Examples of barbituric acids with therapeutic uses. 
2.1.3.1. Chemical properties of barbituric acids 
Most barbiturates used in medical application contain a “balance” of hydrophilic character, 
that depends on the ring structure, and lipophilic character, which depends on the nature of 
substituents at C5. The equilibrium between these properties allow them to go through the 
hematoencephalic membrane and interact with the central nervous system.  
The lipophilic character could be tunned by changing the substituent at C5 position 
(Figure 9). Normally, with large aryl or aliphatic groups, the lipophilic character increases 
and the acidity decreases. 
 
Figure 9. General structure of the barbituric acids. 
If one of the amide nitrogens is substituted, the lipophilicity could be increased too. Finally, 
both the acidity and the lipophilicity increase upon shifting from barbituric to the 
corresponding thiobarbituric analogs. 
On the other hand, the acid-base equilibria are strongly dependent on the site of 
substitution and the inductive effects of substituents (Figure 10). Acid strenght is almost 
independent of the length of the straight-chain alkyl groups attached to the C5 atom of the 
heterocyclic ring. Attachment of a phenyl group to C5 of barbituric acid decreases the pKa, 
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whereas barbiturates with alkyl groups at that position have an increased pKa. On the other 
hand, the alkyl substitution of N3 causes a slight increase in the value of the pKa.44 
 
Figure 10. Relative acidity of different barbiturates. 
In the solid state the parent barbituric acid exists as two anhydrous forms (polymorph III 
and IV) (Figure 11a) and the dihydrate phase which differs mainly in the hydrogen 
pattern.45 In the dihydrate structure (Figure 11b), the barbituric acid molecules form chains 
via hydrogen bonds involving the donor and the acceptor groups which are in 1 and 4 
position, respectively. The barbituric acid molecules in the chain are related by screw axes, 
so that the CH2 groups are in alternated positions. These chains are bridged by water 
molecules forming a 2-D netwoork.46 In solution, the barbituric acid may exists as 11 
possible tautomers. The tautomeric forms are very difficult to detect, but they are supposed 
important intermediates in many reactions (Figure 12).47  
                                                 
44 Bojarski, J.; Mokrosz, J.; Barton, H. J.; Paluchowska, M. H. Adv. Heterocycl. Chem. 1985, 38, 229–297 
45 Jeffrey, G. A.; Ghose, S.; Warwicker, J. O. Acta Crystallogr. 1961, 14, 881–887. 
46 Braga, D.; Codoni, M.; Grepioni, F.; Maini, L.; Rubini, K. Cryst. Eng. Commun. 2006, 8, 756–763. 
47 Chierotti, M.; Gobetto, R.; Pellegrino, L.; Milone, L.; Venturello, P. Cryst. Growth Des. 2008, 8, 1454–
1457. 
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Figure 11. Hydrogen bond network in anhydrous forms III and IV (a) and dihydrate form (b) of barbituric 
acid. 
 
Figure 12. Eleven possible tautomers of the barbituric acid. 
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2.1.3.2. Synthesis of barbituric acid derivatives 
2.1.3.2.1. Construction of the core structure 
Since the first introduction of barbituric acids for medical use as early as 1900s, more than 
2500 derivatives have been synthesized, and about 50 were marketed, mainly for 
pharmacological use. By far the most common procedure for the synthesis of barbituric 
acids is the condensation of urea with the appropiate diethyl malonate in the presence of 
sodium ethoxide in anhydrous alcohol (Scheme 21a). This method has been generally 
adopted for the industrial production of barbituric acids and represents the most common 
laboratory procedure as well. Another manner to access barbituric acid is the condensation 
between urea and the corresponding malonic acid or malonyl chloride (Scheme 21b). 48 
 
Scheme 21. Traditional synthesis of barbituric acids. 
2.1.3.2.2. Modifications of the core structure 
Barbituric acid and derivatives can be modified at the C5 and the two N-positions.  
2.1.3.2.2.1. Achiral approaches 
Non asymmetric modification of the barbituric acid core have been developed mainly 
through Mannich and Knoevenagel reactions. Alternatively, alkylation of barbiturics acids 
has been carried out based on metal catalyzed coupling procedures. Although many types 
                                                 
48 Mahmudov, K. T.; Kopylovich, M. N.; Maharramov, A. M.; Kurbanova, M. M.; Gurbanov, A. V.; 
Pombeiro, J. L. Coord. Chem. Rev. 2014, 265, 1–37. 
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of reactions have been described, only the ones with the most representative reaction 
conditions will be mentioned in the following sections.49 
2.1.3.2.2.1.1. Mannich type reactions 
The Mannich reaction is a powerful method for the preparation of β-amino carbonyl 
compounds, an important class of building blocks of pharmaceutically relevant compounds. 
Mannich-type transformations have been carried out at both C5 (Mannich reaction) and N-
positions (pseudo Mannich or aza-Mannich). 
Sladowska reported one of the first examples of Mannich reaction through C5 to 
obtain a series of 5-alkyl-5-aminomethyl-1,3-dicyclohexyl-barbituric acids (Scheme 22). 
Some of these compounds showed a strong anti-inflammatory activity in biological tests.50 
 
Scheme 22. Mannich reaction at C5 position of barbituric acid derivatives. 
In 2005, Kidwai and coworkers described the one pot synthesis of substituted barbituric 
and thiobarbituric acids via the Mannich reaction of barbiturates and thiobarbiturates with 
furan-2-carbaldehyde and other heteroaromatic carbaldehydes (1H-indole-3-carbaldehyde) 
and aryl amines using montmotillonite clay in dry media under microwave irradiation. The 
same reaction under conventional heating conditions was complete in 10-12 hours, but led 
to moderate yields, whereas excellent yields were obtained within few minutes under MWI 
irradiation (Scheme 23).51  
                                                 
49a) Bojarski, J. T.; Mokrosz, J. L.; Barton, H. J.; Oaluchowska, M. H. Adv. Heterocyclic Chem. 1985, 38, 
229–297. b) Ziarani, G. M.; Aleali, F.; Lashgari, N. RSC Adv. 2016, 6, 50895–50922. 
50 Sladowska, H. Farmac. Ed. Sci. 1977, 32, 866–871. 
51 Kidway, M.; Thakur, R.; Mohan, R. Acta. Chim. Slov. 2005, 52, 88–92. 
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Scheme 23. Microwave assisted C5-functionalization of thiobarbituric acid. 
An unusual Mannich type reaction of tertiary aromatic amines, formaldehyde and N,N´-
dimethylbarbituric acid was described to produce 5-dialkylaminoaryl-1,3-dimethyl-
pyrimidine-2,4,6-triones in aqueous micelles catalyzed by boric acid. The reaction is highly 
regioselective, and para functionalized products are formed exclusively with high yields 
(Scheme 24).52 
 
Scheme 24. Mannich reaction of N,N-dimethylbarbiturate catalyzed by boronic acid. 
  
                                                 
52 Kumar, A.; Maurya, R. A. Tetrahedron Lett. 2008, 49, 5471–5474. 
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Recently, Arslan group described the synthesis of 1,3-dicarbonyl substituted sulfonamide 
derivatives using N,N-dimethylbarbiturate and triethyl(orthoformate) in refluxing ethanol 
(Scheme 25).53 
 
Scheme 25. Synthesis of 1,3-dicarbonyl substituted sulphonamide derivatives. 
On the other hand, Mannich-type reactions through N-1 of barbituric acids have also been 
developed. A classic example is the N-aminomethylations of 5,5-diethyl- and 5-ethyl-5-
phenylbarbituric acids using formaldehyde and morpholine as reagents (Scheme 26).54 
 
Scheme 26. Mannich reaction at the N of the barbituric acid. 
More examples about the aminoamination at nitrogen have been described in the 
literature.55 
  
                                                 
53 Demirci, T.; Arslan, M.; Bilen, C.; Demir, D.; Gencer, N.; Arslan, O. J. Enz. Inhib. Med. Chem. 2014, 29, 
132–136. 
54 Danielsson, B.; Dolby, J. Acta Pharm. Suec. 1964, 1, 233–236. 
55 Werner, W.; Frietzsche, H. Arch. Pharm. 1969, 302, 188–196. 
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2.1.3.2.2.1.2. Knoevenagel reactions 
The Knoevenagel reaction consists of the condensation of aldehydes or ketones with active 
methylene compounds usually performed in a weakly basic medium. Some N,N´-
dimethylbarbituric acid derivatives are interesting compounds for pharmacology, and this 
type of reaction has been used for their synthesis. 
In 2008, Kolos and co-workers described the synthesis of 5,5-(2-arylethylidene-2-
oxo)-1,3-dimethylpirimidine-2,4,6-triones obtained by Knoevenagel reaction of 1,3-
dimethylbarbituric acid and arylglyoxals. The reaction was accomplished in glacial acetic 
acid at room temperature overnight (Scheme 27 path a).56 In addition, the interaction of 
1,3-dimethylbarbituric acid, with different glyoxals and dimethylurea in methanol with 
catalytic amounts of glacial acetic acid leads to the corresponding condensation products 
(Scheme 27 path b). 
 
Scheme 27. Barbiturate C5-functionalization via Knoevenagel reaction.  
In another example, the group of Padmaja and co-workers described a new class of tris-
heterocyclic systems, that were prepared by the condensation of barbituric acid derivatives, 
carbon disulfide and 1,3,4-oxadiazole/thiadiazole under base catalyst (Scheme 28).57 
                                                 
56 Gozalishvili, L.; Beryozkina, T. V.; Omelchenko, I. V.; Zubatyuk, R. I.; Shishkin, O. V.; Kolos, N. N. 
Tetrahedron 2008, 64, 8759–8765. 
57 Padmavathi, V.; Reddy, G. D.; Venkatesh, B. C.; Padmaja, A. Arch. Pharm. 2011, 344, 165–169. 
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Scheme 28. Sythesis of tris-heterocyclic systems using a Knoevenagel reaction. 
To date, the Knoevenagel reaction constitutes the most common method employed for the 
synthesis of barbituric acid derivatives.58 
2.1.3.2.2.1.3. Methods based on metal catalyzed couplings 
Alkylation of barbituric acids via traditional methods using alkyl halides are ineffective 
because of multiple alkylations occur at both C5 and N-1. The poly-alkylation problem on 
the synthesis of monoalkylated barbituric acids has been overcome by using metal-
catalyzed approaches.  
For example, in 2015, Ohta and co-workers described the Pd-catalyzed alkylation 
of heterocyclic compounds including barbituric acid derivatives using alcohols as the 
alkylating agents. This method gives the corresponding mono-alkylated heterocyclic 
compounds with yields from 17 to 99% (Scheme 29).59 
 
Scheme 29. C-alkylation of barbituric acid derivatives with alcohol using a Pd-catalyzed reaction. 
  
                                                 
58 Moskvin, A. V.; Reznikova, N. R.; Ivin, B. A. Russ. J. Org. Chem. 2002, 38, 463–474. 
59 Putra, A. E.; Oe, Y.; Ohta, T. Eur. J. Org. Chem. 2015, 35, 7799–7805. 
58 CHAPTER 2   
 
In 2017, the same group described the alkylation of barbituric acids with alcohols as 
electrophiles via ruthenium catalysis. The corresponding 5-(alkyl)barbituric acids were 
obtained in good to excellent yields with low catalyst loading (Scheme 30).60 
 
Scheme 30. Alkylation of babituric acid derivatives using a Ru-catalyzed reaction. 
2.1.3.2.2.2. Asymmetric approaches 
In contrast to the ample precedents concerning the synthesis of racemic barbituric acids and 
derivatives, very few approaches to construct chiral non-racemic barbiturates have been 
reported. Chiral barbituric acids can be grouped in two categories: (i) those in which the 
chirality is outside of the ring, that is, the synthesis of derivatives with a chiral substituent 
chain at either C5 or N and (ii) those in which the chirality resides in the ring (Figure 13). 
Whereas there are several methods to construct stereoselectively chiral compounds of type 
(i), only a few enantioselective approaches for the synthesis of compounds of type (ii) are 
known. 
 
Figure 13. Two possibilities of chirality in barbituric acids. 
In 2000, Trost and co-workers described the enantioselective Pd-catalyzed allylic 
alkylation of 5-allylpyrimidine and 5-ethyl pyrimidine with cyclopent-2-en-1-yl methyl 
carbonate and (E)-methyl pent-3-en-2-yl carbonate respectively, affording the quaternary 
adducts in good yield and 91% and 72% enantioseletivities (Scheme 31). The use of a C2-
                                                 
60 Putra, A. E.; Oe,Y.; Ohta, T. Tetrahedron Letters, 2017, 58, 1098–1101. 
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symmetric diamide diphosphine chiral ligand was key.61 Further reduction of the C=C with 
H2/Pd/C afforded pentobarbital with a 81% ee after recrystallization. 
 
Scheme 31. Trost asymmetric synthesis of pentobarbital. 
Once our work was in progress a few novel organocatalytic protocols appeared. In 2016, 
Guo´s group described an enantioselective formal [3+2] annulation of alkyliden 
barbiturates with Morita-Baylis-Hillman carbonates catalyzed by a chiral phosphine-amide 
catalyst to afford a variety of chiral spirobarbiturate cyclopentenes (Scheme 32).62  
 
Scheme 32. Synthesis of spirobarbiturate cyclopentenes catalyzed by a chiral phosphine amide. 
                                                 
61 Trost, B. M.; Getchen, M. S. J. Org. Chem. 2000, 65, 1569–1573. 
62 Liu, Y.; Yang, W.; Wu, Y.; Mao, B.; Gao, X.; Liu, H.; Sun, Z.; Xiao, Y.; Guoa, H. Adv. Synth. Catal. 2016, 
358, 2867–2872. 
60 CHAPTER 2   
 
This same year Liu´s group described a novel formal [3+2] cycloaddition of the 5-
alkylidenbarbiturate with 3-isothiocyanatooxindoles catalyzed by a thiourea catalyst and 
benzoic acid as additive. Generally, good yield and diastereo and enantioselectivities were 
obtained (Scheme 33).63  
 
Scheme 33. Formal [3+2] cycloaddition reaction of 5-alkylidenbarbiturate and 3-isothiocyanatooxindoles. 
More recently, Rawal and coworkers described the addition of barbituric acid derivatives 
to nitroolefins using a new class of bifunctional catalyst based on thiosquaramides (Scheme 
34). They achieved a battery of asymmetric compounds with high yields and high 
enantioselectivities.64 
 
Scheme 34. Bifunctional thiosquaramide/amine-catalyzed conjugate addition of barbituric acid derivatives 
to nitroolefins. 
  
                                                 
63 Zhao, H. W.; Tian, T.; Pang, H. L.; Li, B.; Chen, X. Q.; Yang, Z.; Meng, W.; Song, X. Q.; Zhao, Y. D.; 
Liu, Y. Y. Adv. Synth. Catal.  2016, 358, 2619–2630. 
64 Rombola, M.; Chintan, S. S.; Montgomery, T. D.; Rawal, V. H. J. Am. Chem. Soc. 2017, 139, 5297–5300. 
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Also very recently Wang and co-workers described an asymmetric Michael reaction of 
N,N-dialkylbarbiturates catalyzed by a cinchona alkaloid-based bifunctional squaramide 
with good yields and enantioselectivity (Scheme 35).65 
 
Scheme 35. Catalytic asymmetric Michael reaction of N,N-dialkilbarbituric acids to enones. 
On the other hand, Peng´s group described66 an asymmetric three-component tandem 
organocatalytic Michael-Michael-aldol reaction involving alkyliden barbiturates. In this 
reaction, three new bonds are formed with excellent diastereo and enantioselectivity 
leading to spirobarbiturates, a type of barbiturates that also showed a range of 
pharmacological and physiological activities (Scheme 36). 
 
Scheme 36. Synthesis of the spirocyclic compounds derived from barbituric acids. 
All these examples imply the asymmetric synthesis of chiral barbiturates with chirality 
outside the ring. In contrast, the enantioselective synthesis of chiral barbiturates with in-
ring chirality remains essentially unsolved, in spite of the fact that pharmacological activity 
of R and S enantiomers of the barbiturics acids can be different. Only a few examples have 
been published, all relying on metal catalysis. 
  
                                                 
65 Liu, Y.; Zhang, Y.; Duan, H. X.; Wanyan, D.; Wang, Y. Q. Org. Biomol. Chem. 2017, 15, 8669–8679. 
66 Han, B.; Huang, W.; Ren, W.; He, G.; Wang, J.; Peng, C. Adv. Synth. Catal. 2015, 357, 561–568. 
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Brunner and coworkers in 1994 described the Pd-catalyzed asymmetric α-allylation of N-
methyl barbituric acid based on a new chiral diphosphine-amide-ester ligand. Using this 
procedure yields between 68% and 78% are achieved and the highest enantiomeric excess 
was a 12.7% (Scheme 37).67  
 
Scheme 37. Pd-catalyzed allylic alkylation of N-methyl barbituric acid. 
Few years later, the same group described an improved variant that affords the quaternary 
barbituric acid derivatives with good yield, although still low ee (34%) (Scheme 38).68 
 
Scheme 38. Brunner 2nd generation allylic alkylation of 1,5-dimethylbarbituric acid. 
  
                                                 
67 Brunner, H.; Fürst, J. Inorg. Chim. Acta. 1994, 220, 63–66. 
68 Brunner, H.; Deml, I.; Dimberger, W.; Nuber, B.; Reiβer, W. Eur. J. Inorg. Chem. 1998, 43–54. 
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In 2015, Lam´s group described the Rh (III)-catalyzed oxidative annulations of cyclic 1,3-
dicarbonyl compounds with alkynes, including a single example involving barbiturates that 
yields the corresponding spiroindene adduct in 11% ee (Scheme 39).69 
 
Scheme 39. Rh (III)-catalyzed oxidative annulations. 
In spite of the importance of the asymmetric synthesis of barbituric acids with in-ring 
chirality, the realization of that goal via catalysis remained unsolved. 
  
                                                 
69 Chidipudi, S. R.; Burns, D. J.; Khna, I.; Lam, H. W. Angew. Chem. Int. Ed. 2015, 54, 13975–13979. 
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2.2. Results and discussion 
As shown above, methods to generate barbituric acid derivatives enantioselectively with 
an in-ring stereogenic carbon were scarce. This is so probably because the intermediate 
enolate is pseudo-symmetric and therefore discrimination between both enantiotopic faces 
is challenging (Scheme 40).  
 
Scheme 40.  Scheme option A. 
For first assessment of the likelihood of the approach, we started by exploring the behaviour 
of several “conventional” barbituric and thiobarbituric acid derivatives in their Michael 
reaction with vinyl ketones in presence of a BB catalysts. 
2.2.1. Initial attempts with conventional (thio)barbituric acid derivatives 
(Thio)barbituric acid derivatives 9/12 were prepared by heating at reflux a mixture of 
(thio)urea and the corresponding ethyl malonate in ethanol during 16 hours, following the 
procedure described by Borrell and co-workers in 2015 (Scheme 41).70  
 
Scheme 41. Synthesis of (thio)barbituric acid derivatives. 
On the other hand, (thio)barbituric acid derivatives 10/11 were prepared by heating at reflux 
a mixture of corresponding (thio)urea and the diethyl 2-methylmalonate in isopropanol for 
16 hours (Scheme 42). After the reaction was complete, aqueous hydrochloric acid was 
added to make the solution acidic. Then, the precipitate was washed with methanol and 
dried at vacuum (735 mmHg) in a bath at 80 °C affording the products as white solids. 
                                                 
70 Puig-de-la-Bellacasa, R.; Giménez, L.; Pettersson, S.; Gonzalo, P.; Esté, J. A.; Clotet , B.; Borrell, J. I. Eur. 
J. Med. Chem., 2012, 54, 159-174. 
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Scheme 42. Synthesis of N,N-disubstituted barbiturates. 
Firstly, barbiturates 9/10 as well as their thio-analogues 11/12 were treated with vinyl 
ketone 14a in the presence of 10 mol % catalyst C2 (Scheme 43). The corresponding 
adducts 15-18 were obtained as essentially racemic material (< 20% ee at best). Reaction 
reversibility (retro Michael process) as a cause of the low enantiocontrol could be discarded 
as no crossover products were detected when adducts 15 and 16 were admixed with vinyl 
ketone 14b in the presence of a base catalyst. We thought, as in the previous section is 
explained, that the major problem of this type of structures is the pseudo symmetrical 
structure of 1,3-diamide moiety which makes enantioface discrimination complicated. In 
addition, the starting barbiturates exhibited very low solubility in CH2Cl2, which was also 
poor in THF.
71  
 
Scheme 43. First essays of the Michael addition of barbiturates to enone 14a. 
                                                 
71 Chidipudi, S. R.; Burns, D. J.; Khan, I.; Lam, H. W. Angew. Chem. Int. Ed. 2015, 54, 13975–13979. 
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In order to assess whether the lack of selectivity in the above reactions was catalyst-
dependent, additional bifunctional BB catalysts were also tested. As results in Table 1 show 
both C4 and C6 were checked but the obtained adducts were racemic in all the cases. 
Table 1. Screening of donor barbiturates and BB catalysts for the Michael reaction with 14a 
 
 
R X Donor/adduct Catalyst Yield (%) ee (%) 
H O 9/15 
C4 63 0 
C6 64 0 
H S 12Aa/18 
C4 67 0 
C6 69 0 
PhCH2 O 10/16 
C4 70 0 
C6 74 0 
PhCH2 S 11/17 
C4 75 0 
C6 79 0 
Reaction conditions: donor (1 equiv., 0.2 mmol), 14a (3 equiv., 0.6 mmol); yields of isolated product after 
column chromatography. 
In view of these unsatisfactory results and taking into account our group precedent,72 we 
designed another pronucleophile for solving the above mentioned problems. As part of their 
Doctoral Thesis in our laboratory, Etxabe, Izquierdo, et al. described the use of 2-
(benzylthio)-1,5-dihydro-4H-imidazol-4-ones as synthetic equivalents of imidazolones in 
reactions that proceed under Brønsted base/H-bonding catalysis (Scheme 44). 
                                                 
72 Etxabe, J.; Izquierdo, J.; Aitor, l.; Oiarbide, M.; Palomo, C. Angew. Chem. Int. Ed. 2015, 54, 6883–6886. 
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Scheme 44. Our laboratory precedents in the use of S-benzyl heterocycles as proNu in BB-cat additions. 
Inspired by these precedents, we proposed a similar scheme to apply to our case. The 2-
benzylthio-4,6-dioxopyrimidine structure would meet the following characteristics: (i) easy 
conversion into the barbituric acid via standard hydrolytic conditions, (ii) enhancement of 
structural dissymmetry as compared to the nearly symmetric starting diimides and (iii) 
suitability toward deprotonation promoted by a weak base, because the formed enolate 
would be pseudoaromatic (Scheme 45). 
 
Scheme 45. Similar strategy for the barbituric acids.  
To validate our hypothesis we selected three different electrophiles for study, on the one 
hand, vinyl ketones and acrylates or acrylate equivalents as Michael acceptors and Morita-
Baylis-Hillmann type allyl bromides as alkylating agents. To achieve our goal we chose 
different Brønsted bases and, at the same time, a new ones were synthetized for achieve 
this purpose (Scheme 46).  
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Scheme 46. General scheme. 
2.2.2. Synthesis of 2-benzylthio-4,6-dioxopyrimidines 13 
The synthesis of the new BnS-derivatives 13 was carried out by treatment of thiobarbituric 
acids 12 with sodium hydroxide and benzyl chloride, in a mixture of dioxane/water.73 When 
the reaction finished, the mixture was treated with hydrochloric acid to make the solution 
acidic, and the resulting precipitate was filtered and washed with methanol and dried (735 
mmHg, 80 °C). In this way, products 13 were obtained as white, high melting point solids 
(above 180 °C) (Table 2) with yields from moderate to good. 
  
                                                 
73 Rakhimov, A. I.; Avdeev, S. A.; Chang, L. T. D. Russ. J. Gen. Chem. 2009, 79, 338–339. 
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Table 2. Synthesis of 2-benzylthio-4.6-dioxopyrimidines. 
 
Entry  R1 R2 Yield (%) 
1 13Aa Me Me 91 
2 13Ab Me Bn 48 
3 13Ac Me Pent 51 
4 13Ad Me Ph 46 
5 13Ae Me 3,5-
bis(trifluoromethyl)phenyl 
57 
6 13Ba Et Me 58 
7 13Ca Bn Me 68 
8 13Da iBut Me 52 
9 13Ea iProp Me 78 
10 13Fa Allyl Me 57 
 
As judged by the 1H NMR of the crude sample (e.g. 13Aa, Figure 14), it seems that the 
enolic form is predominant in CDCl3 solution, as we can observe clearly a singlet signal for 
the Me at C5 position (1.97 ppm).  
 
Figure 14. Sample NMR spectrum. 
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2.2.3. Michael addition of 13 to enones 
With the new barbituric acid equivalents 13 in hand, their behaviour in the BB-catalyzed 
Michael reactions with enones was explored first. The study began with the evaluation of 
several Brønsted base catalysts for the addition reaction of 2-(benzylthio)-derivative 13Aa 
to aryl vinyl ketone 14a. It was gratifying to observe that the reaction in CH2Cl2 at rt for 16 
h in the presence of known thiourea catalyst C1 and urea catalyst C2 (10 mol %), afforded 
product 19 in isolated yields of 71% and 67%, respectively, and 36% ee and 66% ee. In 
order to improve yield, but especially enantioselectivity, a set of additional bifunctional 
BB/H-bond catalysts were tried .Using as catalyst squaramide C374 the reaction showed 
very low reactivity, so, the ee was not determined, and with squaramide catalyst C475 the 
ee was 32%, yet unsatisfactory. In view of these results, we prepared and checked some 
catalysts with a modified aromatic moiety at the squaramide N-terminus. Thus the ester and 
amide bearing catalysts C5-C9 all led to the desired addition adduct in selectivities in the 
range 54-75% ee´s. C6 gives the lowest value of ee (54%).Then, cat C10 and C11 both 
with a polyaromatic congested group, and concomitantly developed in our group,76 were 
evaluated. Catalyst C10 provided product 19 in good yield (72%) and with 80% ee at room 
temperature (96% ee at 0 °C). The O-silyl analogue C11 gave similar selectivity but the 
reaction was comparatively much slower (Table 3). 
  
                                                 
74 a) Jiang, H.; Paixão, M. W.; Monge, D.; Jørgensen, K. A. J. Am. Chem. Soc. 2010, 132, 2775–2783. b) 
Malerich, J. P.; Hagihara, K.; Rawal, V. R. J. Am. Chem. Soc. 2008, 130, 14416–14417. 
75 a) Dai, L.; Wang, S. X.; Chen, F. E. Adv. Synth. Catal. 2010, 352, 2137–2141. b) Yang, W.; Du, D. M. 
Org. Lett. 2010, 12, 5450–5453. 
76 Odriozola, A.; Oiarbide, M.; Palomo, C. Chem. Eur. J. 2017, 23, 12758–12762. 
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Table 3. Catalyst screening for the reaction of 13Aa with 14a to give 19. 
 
Reaction conditions: 13Aa (1 equiv., 0.2 mmol), 14a (3 equiv., 0.6 mmol); yields of isolated product after 
column chromatography; reaction time 16 h except for the catalyst C3 (48 h); ee´s determinated by chiral 
HPLC column IA eluting with Hex/iPrOH 80:20 f = 0.5 mL/min. 
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Figure 15 shows the 1H NMR spectrum of the crude material for the C10 catalyzed reaction 
between 13Aa and aryl vinyl ketone 14a after 16 h.  
  
Figure 15. 1H-NMR spectrum of crude reaction product between 14a and 13Aa catalyzed by C10. 
2.2.3.1. Reaction scope 
Once with the optimal conditions in hand, a range of dioxopyrimidines 13 were evaluated 
for the addition to several aryl vinyl ketones 14. The catalytic reaction was robust with 
respect to the acceptor enone, and aryl vinyl ketone with either electron withdrawing (14b) 
or donor aryl groups (14a, 14c, 14d and 14e) were well tolerated giving ee´s from 85% to 
96%. As the data in Table 4 show, apart from the 5-Me substituted template, derivatives 
with a Et, Bn, and allyl R1 group at C5, all worked well, affording the corresponding 
quaternary products in yields ranging from 65% to 75% and excellent ee for all the cases. 
We also checked the reaction of templates 13 with different substitution at N position. Thus, 
it was confirmed that the reaction worked very well with 2-benzylthio-4,6-
dioxopyrimidines bearing Me, Bn, bis(trifluoromethyl)phenyl , and n-pentyl R groups 
affording products in 65-73% yield and with ee´s from 90% to 92% (Table 4). 
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Table 4. Scope of the reaction of 2-benzylthio-4,6-dioxopyrimidines 13 with aryl vinyl ketones 14. 
 
Reaction conditions: 13 (1 equiv., 0.2 mmol), 14 (3 equiv., 0.6 mmol); yields of isolated product 
after column chromatography. 
Crystallization of adduct 25, obtained from the Michael addition of 13Ca to enone 14e, 
allowed to obtain a crystalline compound for X-ray structure analysis and unambiguous 
determination of its absolute configuration (Figure 16). Configuration of the remaining 
adducts was assigned by analogy and by assuming an uniform reaction mechanism. 
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Figure 16. ORTEP diagram of compound 25 
As these results show the method is general for a range of aryl vinyl ketones as 
electrophiles. However, attempts to expand this protocol to different unsaturated ketones 
such as methyl vinyl ketone and β-substituted aryl vinyl ketones, failed. For example, the 
reaction of 13Aa with methyl vinyl ketone using C10 as catalyst did not work, probably 
because of the comparatively lower reactivity of this electrophile. Similarly, the attempted 
reaction of 13Aa with β-substituted phenyl vinyl ketone using the same catalyst did not 
proceed and starting material was recovered unchanged. In this case, the lower reactivity 
could be due to steric reasons (Table 5). 
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Table 5. Different ketones. 
 
Reaction conditions: 13Aa (1 equiv., 0.2 mmol), but-3-en-2-one or (E)-3-phenyl-1-(p-tolyl)prop-2-en-1-one 
(3 equiv., 0.6 mmol), catalyst C10 (10 mol %) were stirred at room temperature for 72 h in CH2Cl2 (0.5 mL). 
2.2.4. Michael addition of 13 to α´-oxy enones as enabling acrylate ester 
equivalent. 
Similarly, attempts to apply the method to common Michael acceptors other than enones, 
such as unsaturated esters and aldehydes, were unfruitful too. For example, the reaction of 
13Aa with an α,β-unsaturated ester using C10 as catalyst did not work. However, in 
opposite direction, the more reactive but less sterically demanding acrolein, upon reaction 
with 13Aa, led to, after hydrolysis, adduct 30, but with a poor 48% ee (Table 6). 
Table 6. Different carbonylic Michael acceptors. 
 
Reaction conditions: 13Aa (1 equiv., 0.2 mmol), methyl acrylate or acrolein (3 equiv., 0.6 mmol), catalyst 
C10 (10 mol %) were stirred at room temperature for stated time in CH2Cl2 (0.5 mL); yields of isolated 
product after column chromatography. 
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To solve these limitations that hamper extension of the approach to the obtention of relevant 
ester and aldehyde products, we turned our attention to the use of α-silyloxy enone as an 
equivalent of either acrylates/acrolein/vinyl ketones (Figure 17). This type of bidentated 
acceptor has demonstrated to be very versatile for a number of BB-catalyzed asymmetric 
conjugate additions of C-centered soft nucleophiles,77 by virtue of its ability for internal 
1,4-H (or 1,4-metal) chelation and also H-bond networking with the catalyst. 
 
Figure 17. Synthetic equivalents of the ketol moiety. 
In a first experiment, 13Aa was reacted with 31a giving the desired product (32Aa) in 76% 
yield and 60% ee, demonstrating that this type of enones are more active as it has been 
indicated above. Subsequently, the reaction with α´-silyloxy 31b was checked. The crude 
reaction product in this case was treated with HCl 6M to deprotect the silyl ether, and same 
adduct 32Aa was obtained in 78% yield after two steps and with 93% ee (Scheme 47). 
These results encouraged us to explore the scope of the reaction for differently 
substituted 13 using silyloxy enone 31b. 
                                                 
77 For more information about α-hydroxyenone reactions: a) Sanchez-Duque, M. M.; Basle, O.; Isambert, N.; 
Gaudel, N.; Siri, A.; Genisson, Y.; Plaquevent, J. C.; Rodriguez, J.; Constantieux, T. Org.Lett. 2011,13, 3296–
3299. b) Heathcock, C. H.; Pirrung, M. C.; Buse, C. T.; Hagen, J. P.; Young, S. D.; Sohn, J. J. Am. Chem.Soc. 
1979, 101, 7077–7079. c) Palomo, C.; Oiarbide, M.; Garcia, J. M.; Gonzalez, A.; Lecumberri, A.; Linden, A. 
J. Am.Chem. Soc. 2002, 124, 10288–10289. d) Badiola, E.; Fiser, B.; Gomez-Bengoa, E.; Mielgo, A.; 
Olaizola, I; Urruzuno, I.; Garcia, J. M.; Odriozola, J. M.; Razkin, J.; Oiarbide, M.; Palomo, C. J. Am. Chem. 
Soc. 2014, 136, 17869–17881. 
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Scheme 47. Michael addition of 13Aa to α´-oxy enones.  
2.2.4.1. Reaction scope 
Next, the generality of the reaction with respect to the 2-bezylthio-4,6-dioxopyrimidines 
templates was evaluated. Adducts from these reactions were isolated after acidic hydrolysis 
leading to barbituric acids 32. As data in the Table 7 show, products 32 bearing 
linear/branched alkyl or allyl R1 substituents are isolated in good yields and 
enantioselectivities typically above 90%, with isopropyl being an exception, probably due 
to steric reasons. Different R substitutions were checked too, with Me, Bn, Ph and pentyl 
groups, all leading to proceed in good yields and enantioselectivities above 90% (Table 7). 
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Table 7. Scope of the reaction of 2-benzylthio-4,6-dioxopyrimidines 13 with α´-silyloxy enone 31b. 
 
Reaction conditions: 13 (1 equiv, 0.2 mmol), 31b (3 equiv, 0.6 mmol); yields of isolated product 
after column chromatography. 
The absolute configuration of adduct 32aD was determined by a single-crystal X-ray 
analysis (Figure 18), it was the same as with previous enones and that of the remaining 
adducts was assumed based on a uniform reaction mechanism.  
 
Figure 18. ORTEP diagram of compound 32Ad. 
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Once again, we confirmed that designed 2-benzylthio-4,6-dioxopyrimidine reagent was 
essential for successful reactivity and selectivity. As data in Table 8 show, when 
(thio)barbituric acids 9 and 12Aa were used instead, adduct 32Aa was obtained with good 
yields (61-69%) but essentially racemic. Similarly, the N-Bn analogues 10 and 11 gave 33 
and 34, respectively, as racemic compounds too, irrespective of the catalyst employed. 
Table 8. Results using (thio)barbituric substrates 9-12. 
 
 
R X Pro-Nu Catalyst Adduct Yield (%) ee (%) 
H O 9 
C2 
32Aa 
62 0 
C4 61 0 
C6 61 0 
H S 12Aa 
C2 
32Aa 
67 0 
C4 64 0 
C6 69 0 
PhCH2 O 10 
C2 
33 
72 0 
C4 60 0 
C6 68 0 
PhCH2 S 11 
C2 
34 
63 0 
C4 73 0 
C6 74 0 
 
  
80 CHAPTER 2   
 
2.2.5. Mechanistic proposal 
We assume that these catalytic reactions proceed along the generally accepted activation 
mechanisms for these types of bifunctional catalysts. First step would be deprotonation of 
the dihydropyrimidine by the tertiary amine group, forming a highly nucleophilic enolate 
specie (VI). Then, the C-C bond forming approaching takes place wherein the electrophile 
interacts with the protonated amine moiety via H-bond, enhancing, this way, the 
electrophilic character of the reacting carbon center and the enolate coordinates to the other 
H-bond donor site of the catalyst (TS VII) (Scheme 48). 
 
Scheme 48. Supposed global process 
For the stereochemistry determining step, two different geometries can be envisaged for 
the Nu-cat-E ternary complex (Scheme 49): in (A) the electrophile (E+) is H-bonded to the 
thiourea and the nucleophile (Nu-) coordinates to the tertiary amine (Takemoto model),78 
while in (B), the electrophile and nucleophile reactants swicht their coordination position 
relative to the catalyst (Pápai model).79 In model B, the thiourea, an efficient anion 
                                                 
78 Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2005, 127, 119–125. 
79 Kótai, B.; Kardos, G.; Hamza, A.; Farkas, V.; Pápai, I.; Soós, T. Chem. Eur. J. 2014, 20, 5631–5639. For 
similar models, see: b) Almasi, D.; Alonso, D. A.; Gomez-Bengoa, E.; Nájera, C. J. Org. Chem. 2009, 74, 
6163–6168. c) Tan, B.; Lu, Y.; Zeng, X.; Chua, P. J.; Zhong, G. J. Org. Lett. 2010, 12, 2682–2685. d) Han, 
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acceptor, binds the anionic nucleophile, while the protonated quinuclidine activates and 
positions the electrophile. 
 
 
Scheme 49. Transition-state variants of the bifunctional mechanisms. 
According to these premises, the two models in Figure 19 may account for the observed 
stereochemistry. However, we believed that model b is more favorable than a due to in 
model a steric interactions between R and the Nitrogen atom of quinuclidine ring, making 
more difficult the interactions between the nucleophile and the catalyst.  
 
Figure 19. Plausible transition states. 
  
                                                 
X.; Lee, R.; Chen, T.; Luo, J.; Lu, Y.; Huang, K. W. Sci. Rep. 2013, 3, 2557–2563. e) Azuma, T.; Kobayashi, 
Y.; Sakata, K.; Sasamori, T.; Tokitoh, N.; Takemoto, Y. J. Org. Chem. 2014, 79, 1805–1817. 
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2.2.6. Extension to other acceptors: vinyl sulfones and 
azodicarboxylates 
Vinyl sulfones: 
As a logical continuation of the study, we set to validate this template-catalyst system 
against vinyl sulfones and azodicarboxylates as two additional examples of relevant 
electrophilic reagents. Since sulfone functionality can be removed by various 
desulfonylation methods, aryl sulfones have been employed as electron withdrawing 
groups to increase the electrophilicity or nucleophilicity of a parent reagent. Thus, 
subsequent desulfonation of adducts gives raise to a wide range of enantiomerically 
enriched building blocks.80 We checked the reaction of 2-benzylthio-4,6-dioxopyrimidine 
13Aa with vinyl sulfone 35 bearing the 1H-tetrazole moiety, with different Brønsted bases 
(Table 9). The product 36 was afforded in yields ranging from 58%-73%. However, using 
the thiourea catalyst C1, the urea catalyst C2 and the ureidopeptide catalyst C16 the product 
was obtained racemic. By using the new squaramide Brønsted base catalysts C10, C11 and 
C20 product 36 was obtained, but with ee in the range from 20% to 40%, so, further 
optimization is necessary. This reaction is currently under further optimization atudies. 
  
                                                 
80 Nielsen, M.; Jacobsen, C. B.; Holub, N.; Paixão, M. W.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2010, 49, 
2668–2679. 
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Table 9. Screening of catalyst. 
Reaction conditions: 13Aa (1 equiv, 0.2 mmol), 35 (1.2 equiv, 0.24 mmol); yields of isolated product after 
column chromatography; ee´s determinated by chiral HPLC: column IC eluting with Hex/iPrOH 50:50 f = 
1.0 mL/min. 
Azadicarboxylates: 
Besides C-alkylation reactions that afford quaternary all carbon stereocenters at C5 of the 
barbituric system, C-amination reactions are an interesting entry to tetrasubstituted C-N 
systems.81  
We decided to test the reaction with 2-benzylthio-4,6-dioxopyrimidines 13Aa and 
the commercially available di-tert-butyl (E)-azo-1,2-dicarboxylate in CH2Cl2 at rt using a 
10 mol % of different catalysts (Table 10). Using thiourea catalyst C1 and urea catalyst C2 
in 10 mol % catalytic loading, afforded the product 37 in moderate yields (45% and 58% 
respectively) but very low ee´s, 8% and 10% respectively. Then, the squaramide-based 
bifunctional catalysts C10 and C11 were tested. With C10 the yield was improved up to 
68% but the ee´s did not improve, 20% and 12% respectively. Finally, an ureidopeptide 
type catalyst C16 was checked and we obtained the product with 58% yield but 0% ee was 
                                                 
81 a) Suri, J. T.; Steiner, D. D.; Barbas, C. F. Org. Lett. 2005, 18, 3885–1888. b) Dalko, P.; Moisan, L. Angew. 
Int. Ed. 2004, 43, 5138–5175.  
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achieved. As in the previous case, further optimization is needed and other type of catalysts 
are currently being analyzed with the hope to obtain useful results.  
Table 10. Catalyst screening for the reaction of 13Aa with di-tert-butyl (E)-azo-1,2-dicarboxylate . 
Reaction conditions: 13Aa (1 equiv, 0.2 mmol), di-tert-butyl (E)-diazene-1,2-dicarboxylate (1.2 equiv, 0.24 
mmol); yields of isolated product after column chromatography; ee´s determinated by chiral HPLC: column 
IC eluting with Hex/iPrOH 80:20 f = 0.5 mL/min. 
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2.2.7. Extension to allylic alkylation with Morita-Baylis-Hillmann type 
(pseudo)halogenides. 
2.2.7.1. Initial experiments  
MBH-type (pseudo)halides (A, Scheme 50) are synthetically useful electrophilic reactants 
because the adducts resulting from a nucleophilic displacement (B or C, Scheme 50) 
display a densely functionalized architecture amenable for further organic 
transformations.82 
 
Scheme 50. SN2 and SN2´reaction pathways of MBH-type adducts. 
In our own research group MBH type allylic bromides were employed in the first enamine-
mediated direct asymmetric α-alkylation of aldehydes, in which the reaction is believed to 
proceed through a double SN2`-type addition-elimination mechanism (Scheme 51).
83 
 
Scheme 51. Amine-catalyzed α-alkylation of aldehydes with allyl halides. 
Once the BB-catalyzed conjugate additions of barbituric acid equivalents 13 to enones was 
demonstrated, we decided to test a slightly different type of reactivity with the same 
nucleophilic templates, in order to open a synthetic route to a broader range of quaternary 
barbituric acid derivatives. Specifically, we envisaged the use of allylic reagents 38/39 
(MBH type (pseudo)halogenides), electrophilic reagents amenable to undergo a sequential 
addition/elimination pathway. 
                                                 
82 For general reviews: a) Wei, Y.; Shi, M. Chem. Rev. 2013, 113, 6659–6690. b) Liu, T. Y.; Xie, M.; Chen, 
Y. C. Chem. Soc. Rev. 2012, 41, 4101–4112. 
83 Gómez-Bengoa, E.; Landa, A.; Lizarraga, A.; Mielgo, A.; Oiarbide, M.; Palomo, C. Chem. Sci. 2011, 2, 
353–357. 
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Allyl bromides were synthetized in two steps according to the procedure of Zhang84 which 
involves Baylis-Hillman reaction of acrylate ester with formaldehyde followed by 
transformation of the resulting hydroxy ester into the corresponding bromide under usual 
conditions (Scheme 52). 
 
Scheme 52. Shyntesis of allyl bromides 38 and 39. 
For initial evaluation, bromide 38 was selected and the reaction with 13Aa was carried out 
in the presence of 10 mol % catalyst C10 and 1 equiv. of K2CO3, giving rise product 40 in 
62% yield and 54% ee (Table 11, entry 1). We decided to increase the steric impediment 
in the electrophile, so, the tBu ester derivative 39 was applied leading to product 41Aa with 
a significant increase in ee (entry 2, Table 11, 99% ee). The reaction in the absence of 
catalyst at rt after 72 h, also yielded 41 with similar yield and obviously in racemic form 
(entry 3, Table 11). However, lowering the temperature to 0 °C, < 5% of conversion was 
observed indicating that background reaction is cancelled at this temperature (entry 4). 
Among the bases examined, K3PO4 also provided a good ee (97% ee, entry 5), whereas 
Cs2CO3 led to a reduced 77% ee and tertiary amines were completely ineffective in terms 
of enantioselectivity (entry 7 and 8). On the contrary, it was demonstrated that the reaction 
without base do not work (entry 9). This result is consistent with catalyst reaction through 
either: (i) acid-base neutralization by the evolving HBr, or (ii) competitive irreversible N-
alkylation of the catalyst by the allylic halide.  
  
                                                 
84 Pautigny, C.; Séverine Jeulin, T.; Ayad, Z.; Zhang, J.; Genêt, V.; Vidal, R. Adv. Synth. Catal. 2008, 350, 
2525–2532 
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Table 11. Screening of bases for the allylic alkylation with MBH bromide [a]. 
 
Entry R Cat. Base Yield (%) ee (%) 
1 Et C10 K2CO3 62 54 
2 tBu C10 K2CO3 63 99 
3b tBu -- K2CO3 62 0 
4c tBu -- K2CO3 -- -- 
5 tBu C10 K3PO4 61 97 
6 tBu C10 Cs2CO3 65 77 
7 tBu C10 Et3N 71 10 
8 tBu C10 DMAP 68 24 
9 tBu C10 -- -- -- 
[a] Reaction conditions: 38/39 (1 equiv., 0.2 mmol), 13 (1 equiv., 0.2 mmol), catalyst (10 mol %) and base (1 
equiv., 0.2 mmol) were stirred at 0 ºC for 16 h in CH2Cl2 (0.5 mL); yields of isolated product after column 
chromatography; ee´s determinated by chiral HPLC: column IA eluting with Hex/iPrOH 80:20 f = 0.5 
mL/min. [b] Reaction carried out at rt for 72 h. [c] Reaction carried out at 0 °C for 72 h. 
2.2.7.2. Scope of the reaction regarding the nucleophilic template  
With 10 mol % catalyst C10 and 1 equiv of K2CO3 at 0 °C selected as the best conditions, 
the reaction of bromide 39 with a series of 2-benzylthio-4,6-dioxopyrimidines 13 was 
screened. As the data in Table 12 show, the reaction with 5-methyl templates 13Aa-c all 
afforded the corresponding adducts in yields ranging from 61 to 77% and high ee (99, 90 
and 99%, respectively). On the other hand, the reaction tolerates well barbiturate templates 
with C5 substituents other than Me. For example, with Et, Bn and Allyl groups at C5 
position the corresponding quaternary adducts 41Ba, 41Ca and 41Fa were synthetized with 
good yields and enantioselectivities up to 96%. 
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Table 12. Scope of the allylic alkylation of barbituric template 13. 
 
Reaction conditions: 39 (1 equiv., 0.2 mmol), 13 (1 equiv., 0.2 mmol; yields of isolated product after column 
chromatography; ee´s determinated by chiral HPLC. 
Figure 20 shows an example of a 1H NMR experiment for compound 41Aa before 
purification by chromatography column. 
  
Figure 20. 1H-NMR spectrum of the reaction crude for adduct 41Aa. 
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2.2.8. Elaboration of the adducts 
In order to illustrate the potential of the present catalytic method for the C5-
functionalization of barbiturate surrogates 13, some selected transformations of adducts 
were carried out. For example, adduct 32Aa was transformed quantitatively into the 
carboxylic acid 42 through oxidative treatment with NaIO4 in a mixture of MeOH/H2O 
(2:1). In its turn, applying a reduction /1,2-diol cleavage sequence, aldehyde 30 was 
produced in 88% overall yield. Then, Wittig reaction of aldehyde 30 with the corresponding 
triphenylphosphonium bromide and tBuOK gave rise the quaternary barbiturates 43, 44 and 
45 with an elonged carbon chain in yields of 72%, 69% and 68%, respectively (Scheme 
53). 
 
Scheme 53. Several possibilities for elaboration of the ketol moiety in adducts. 
On the other hand, Grignard reaction of adduct 32Aa with p-tolylmagnesium bromide 
followed by an oxidation process with NaIO4 of the resulting 1,2-diol afforded adduct 15. 
Same compound was obtained through hydrolysis of previously prepared 19, which served 
to confirm the assigned configuration of adducts (Scheme 54). 
 
Scheme 54. Chemical correlation between adducts 32Aa and 19. 
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Regarding adducts obtained through catalytic allylic alkylation reaction, adduct 41Fa was 
transformed into spiranic compound 46 through ring-closing metathesis reaction with 
Grubbs 2nd generation catalyst in good yield. Subsequent, acid hydrolysis afforded spiranic 
barbituric acid 47 in 61% (Scheme 55). Spirobarbiturates represent a family of structurally 
unique spiroheterocycles and possess a wide range of biological and pharmacological 
activities.85 
 
Scheme 55. Synthesis of spiranic compound. 
On the other hand, N-arylation and N-alkylation protocols were also evaluated in order to 
demonstrate how the method may combine with other intermediate transformations to 
obtain differently N-substituted derivatives. For instance, treatment of 43 with DIPEA and 
benzyl or allyl bromide allowed access to the desired N-alkylated products 48 and 49 in 
71% and 63% yield (Scheme 56). In another instance, the N-arylated product 50 could be 
prepared with 68% yield by treatment of 43 with Cu(OAc)2, Et3N and phenylboronic acid 
in dichloroethane at reflux (Scheme 56). 
 
Scheme 56. Alkylation and arylation of the amide. 
                                                 
85 For selected examples: a) Barakat, A.; Islam, M. S.; Al-Majid, A. M. Bioorg. Med. Chem. 2015, 23, 6740–
2748. b) Fessenden, R. J.; Larsen, J. G.; Coon, M. D.; Fessenden, J. S. J. Med. Chem. 1964, 7, 695–698. c) 
King, S. B.; Stratford, E. S.; Craig, C. R.; Fider, E. K. Pharm. Res. 1995, 12, 1240–1243. d) Galati, E. M.; 
Monforte, M. T.; Miceli, N.; Rameri, E. Il farmaco, 2001, 56, 459–461. e) Kim, S. H.; Pudzianowski. A. T.; 
Leavitt, K. J.; Barbosa, J.; Mcdonell, P. A.; Metzler, W. J.; Rankin, B. M.; Liu, R.; Vaccaro, W.; Pitts, W. 
Bioorg. Med. Chem. Lett. 2005, 15, 1101–1106. f) Ingle, V. N.; Gaidhane, P. K.; Dutta, S. S.; Naha, P. P.; 
Sengupta, M. S. J. Carbohydr. Chem. 2006, 25, 661–671. 
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3. Brønsted base-catalyzed reactions of α-iminoamides 
3.1. Introduction 
As in the previous section is explained, the essays to achieve the desymmetrization of 
acyclic amides using Brønsted bases were unfruitful, so, the second part of this work is 
focused on getting the addition in α position to acyclic amides synthesizing a new 
pronucleofile modifying R1, R2 and Y (Scheme 57). 
 
Scheme 57.  
3.2. Results and discussion 
3.2.1. Design of a new amide-type nucleophile 
Due to our problems to achieve the Michael addition of acyclic amides to trans-β-
nitrostyrene (Chapter 2, section 2.1.2 p. 45), we decided to explore new types of amide 
nucleophiles with adjacent activating elements. In the literature, we can find various 
examples in which intramolecular hydrogen bonds have been used as a preactivation 
element to make subsequent catalyst-assisted reaction acceleration plausible (Figure 21).86  
                                                 
86 a) Inokuma, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2006, 128, 9413–9419. b) Talavera, G.; Reyes, 
E.; Vicario, J. L.; Carrillo, L. Angew. Chem. Int. Ed. 2012, 51, 4104–4107. c) Badiola, E.; Fiser, B.; Gómez-
Bengoa, E.; Mielgo, A.; Olaizola, I.; Urruzuno, I.; Garcia, J. M.; Odriozola, J. M.; Razkin, J.; Oiarbide, M.; 
Palomo, C. J. Am. Chem. Soc. 2014, 136, 17869–17881. d) Jung, C. K.; Krische, J. M. J. Am. Chem. Soc. 
2006, 128, 17051–17056. e) Guerrero-Corella, A.; Esteban, F.; Iniesta, M.; Martín-Somer, A.; Parra, M.; 
Díaz-Tendero, S.; Fraile, A.; Alemán, J. Angew. Int. Chem. Ed. 2018, 57, 5350–5354. 
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Figure 21. Previous examples of intramolecular hydrogen bond activated Elec/Nu in asymmetric (organo) 
catalysis. 
Our plan was to evaluate the β,γ-unsaturated anilide 51 as a suitable donor amide reagent 
in BB-catalyzed addition reactions. This template should be easier to deprotonate due to 
the conjugate system that is formed upon deprotonation. However, the resulting dienolate 
(Scheme 58) presents two reactive carbons and there are two possible positions for the 
addition. In addition, a nitro group was inserted in ortho position in the N-aromatic ring 
could form an hydrogen bond with the NH amide and thus increase both the carbonyl 
electrophilicity87 but also the α carbon acidity. Unfortunately, the reaction did not work. 
 
Scheme 58. Amide activated through a nitro group. 
Based on our previous experiments, a new pronucleophile more prone to deprotonation was 
designed. A benzophenone imine group was included in the molecule, which could also 
form hydrogen bonds with the amidic NH and increase the acidity of the adjoining carbon 
(Scheme 59).  
                                                 
87 Darvesh, S.; McDonald, R. S.; Darvesh, K.; Mataija, D.; Mothana, S.; Cook, H.; Carneiro, K.; Richard, N.; 
Walsh, R.; Martin, N. Bioorg. Med. Chem., 2006, 14, 4586–4599. 
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Scheme 59.  
3.2.2. Synthesis of 56 
Preparation of α-imino amides 56 (and 57) was carried out by the coupling of N- (tert-
butoxycarbonyl)glycine with the 2-nitroaniline, through initial attempts were 
unsuccessfull. Several standard procedures for the acid coupling were tried, including the 
transformation of the carboxylic acid into different leaving groups, but these procedures 
did not work. Finally, the procedure reported by Tesser and co-workers using pyridine as 
solvent and phosphorous oxychloride as the condensing agent worked well, affording 52 in 
61% yield. The p-nitroanilide 53 was also prepared in 69% yield for comparative 
purposes.88 Removal of the BOC group and condensation with the benzophenone imine in 
dichloromethane,89 led to the o-nitroanilide 56 and the p-nitroanilide derivatives 57 in good 
yields (Scheme 60). 
  
                                                 
88 Rijkers, D. T. S.; Adams, H.; Hemker, C.; Tesser, G. I. Tetrahedron, 1995, 51, 11235–11250. 
89 Abaskharon, R. M.; Brown, S. P.; Zhang, W.; Chen, J.; Smith, A. B.; Gai, F. Chemical Physics Letters, 
2017, 683, 193–198. 
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Scheme 60. Synthesis of the starting materials. 
These intramolecular interactions could be confirmed in the X-ray structure analysis of 
compound 56 (Figure 22). 
 
Figure 22. ORTEP diagram of compound 56. 
Once with the substrates in hand, we proceeded to study the behaviour of these amides in 
the aldol reaction promoted by several BB catalysts. 
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3.2.3. Reactivity of glycine benzophenone imine. 
Corey and coworkers reported the synthesis of chiral β-hydroxy-α-amino acids by aldol 
coupling of aldehydes with the trimethylsilyl enol ether derivative of tert butylglycinate 
benzophenone Schiff base, using the chinchonidine derived quaternary ammonium salt as 
catalyst (Scheme 61).90 
 
Scheme 61.  
Shibasaki and coworkers described in 2002 a direct aldol reaction of gycinate Schiff bases 
with aldehydes using heteroarobimetallic asymmetric complexes as a catalyst. In this way, 
anti-β-hydroxy-α-amino acid esters were obtained as the major diastereomers with 
generally low ee (Scheme 62).91 
 
Scheme 62.  
                                                 
90 Horikawa, M.; Busch-Petersen, J.; Corey, E. J. Tetrahedron Lett. 1999, 40, 3843–3846. 
91 Yoshikawa, N.; Shibasaki, M. Tetrahedron, 2002, 58, 8289–8298. 
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In 2004, Maruoka and coworkers described an asymmetric aldol reaction of glycine 
benzophenone imine with aldehydes using chiral quaternary ammonium salts as a phase-
transfer catalysts affording the corresponding anti-β-hydroxy-α-amino esters with good 
stereochemical control and ee´s up to 98% (Scheme 63).92 
 
Scheme 63. Aldol reaction using phase-transfer catalysis. 
  
                                                 
92 Ooi, T.; Kameda, M.; Taniguchi, M.; Maruoka, K. J. Am. Chem. Soc. 2004, 126, 9685–9694. 
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Ten years later, Trost described an asymmetric aldol reaction between glycine Schiff base 
derivatives and different aldehydes using a zinc-prophenol catalyst, in this way, syn β-
hydroxy-α-amino esters were obtained with good diastereo and enantioselectivities 
(Scheme 64).93 Obtention of syn diastereomer proved problematic94 and, as far as we know, 
this is the only example in the literature. 
 
Scheme 64. Aldol reaction using a dinuclear zinc complex as catalyst. 
We started our study exploring the aldol addition of iminoacetamides 56 with 3-
phenylpropanal using different bifunctional BB catalysts. First experiment carried out in 
CH2Cl2 using 20 mol % of ureidopeptide catalyst C16 developed in our group gave the 
desired aldol products 59/60 with 61% yield, 83:17 dr but with a low ee (Scheme 65). 
However, a second product was also formed which was identified as the cyclic oxazolidine 
compound 61 which may arise from an intramolecular cyclization of 59. NMR monitoring 
of the reaction progress showed that the amount of oxazolidine 61 increases over time. 
Thus, while after 48 h at r.t. the ratio of 59 + 60/61 is 93:7, after 5 days changed to 22:78 
(Figure 23).  
                                                 
93 Trost, B. M.; Miege, F. J. Am. Chem. Soc. 2014, 136, 3016–3019. 
94 a) Kano, T.; Lan, Q.; Wang, X.; Maruoka, K. Adv. Synth. Catal. 2007, 349, 556–560. b) Kitamura, M.; 
Shirakawa, S.; Arimura, Y.; Wang, X.; Maruoka, K. Chem. Asian, J. 2008, 3, 1702–1714. 
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Scheme 65.  
In addition, it is appreciated that while the amount of diastereomer 60 remains constant, the 
amount of initially major diastereomer 59 varies drastically from 82% at 48 h to 11% after 
5 days. According to literature precedents, syn imine aldol adduct seems to cyclize faster.92 
Therefore, we assume that the initially major diastereomer in the reaction was the syn 
diasteroisomer. 
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Figure 23. 1H-NMR monitoring of 59, 60 and 61 after 5 days. 
When the same aldol reaction was attempted under otherwise identical conditions (in 
CH2Cl2 and 20 mol % of catalyst C16), but using the p-nitrophenyl amide 57 instead, no 
reaction was observed. This observation could be attributed to the inability of the NO2 
group in para to participate in internal H-bond, thus supporting the importance of the amide 
design (Scheme 66a). Similarly, the reaction using the α-imino ester 58 neither worked 
under the described conditions. This result seems to indicate that the amide NH group is 
essentially for carrying out the reaction (Scheme 66b).  
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Scheme 66.  
3.2.3.1. Catalyst screening 
Once the feasibility of the aldol reaction between α-iminoamide 56 with 3-phenylpropanal 
in CH2Cl2 was confirmed, a range of bifunctional BB-catalysts were tested in order to 
improve the reaction outcome. As the data in Table 13 show using known thiourea catalyst 
C1 and urea catalyst C2 moderate conversions were obtained (48% and 66% respectively), 
a syn/anti ratios above 85:15, and, essentially racemic product. 
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Table 13. Screening of catalysts for the aldol reaction between 56 and hydrocinamaldehyde. 
 
Reaction conditions: 56 ( 1 equiv., 0.2 mmol), phenylpropanal (3 equiv., 0.6 mmol) and 0.2 mL of CH2Cl2; 
Reaction time 48 h; dr refers to the ratio of 59+61/60; ee´s are determinated for the major diastereoisomer 
(59) by chiral HPLC, column IC eluting with Hex/EtOH 90:10 f = 0.5 mL/min. 
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Further catlyst screening revealed that the best conversion was obtained with C4 (90%) 
whereas C6 and C11 gave low conversions after 48 h (39% and 27% respectively). The 
ee´s were moderate in all of cases, (56%, 70%) and dr varies from 70:30 (C4) and 63:37 
(C6) to 80:20 with C11. 
Then, squaramide type catalyst C12, C13, C14, and C15 were checked, but the 
results were still unsatisfactory. 
Finally, ureidopeptide type catalysts C16, C17 and C18 were screened. Both C16 
and C17 afforded good conversion (91% and 95% respectively) but C17 was the best in 
terms of stereocontrol (dr >98:2 and 80% of ee). 
The treatment of a mixture of 60 and 62 with NaBH3CN in AcOH/MeOH gave rise 
to amino alcohol product 63 in 86% yield (Scheme 67). 
 
Scheme 67.  
The scope of this catalytic and enantioselective aldol reaction of α-imino amide 56 is 
currently being investigated in own laboratory. 
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4. Conclusions 
We have investigated α-functionalization reactions of a set of amides promoted by chiral 
Brønsted base catalysts. 
In one set, the reactions of barbituric acid and derivatives were evaluated. Attempts 
with barbituric acids and thiobarbituric acids led to the corresponding C5-quaternary 
derivatives in good yields but racemic products were obtained. Therefore, 
desymmetrization of these substrates relying in BB-H-bond cat seems unsuitable. 
As a solution to this defficiency, 2-benzylthio-4,6-dioxopyridines were design as a 
new barbiturate template. The BB-catalyzed addition of these templates to enones, 
particularly aryl vinyl ketones proceeds effiently and with high enantioselectivity. Best 
selectivities (up to 97% ee) were obtain with catalyst C10. On the other hand, using α´-
silyloxy enone, products were obtained in good yields and good enantioselectivities too (up 
to 93% ee). Finally, the allylic alkylation with Morita-Baylis Hillmann type 
(pseudo)halogenides allowed to obtain the synthesis of the corresponding barbiturates 
derivatives with good yields and good ee´s (up to 99%). 
On the other hand, we have developed the α-desymmetrization of acyclic amides 
using a new designed amide-type nucleophile based on a glycine benzophenone imine 
derivative, in an aldol reaction. In this way, the product was obtained with good yield and 
good enantio and diastero ratio using an ureidopeptide type catalyst C16. 
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5. Experimental section 
5.1. Materials and Generals Techniques 
5.1.1. Reagents and solvents 
Reagents were purchased from commercial suppliers (Aldrich, Across, Alfa Aesar, Fluka, 
TCI, Merck, Fluorochem, etc.), stored as specified by the manufacturer and used without 
previous purification unless otherwise stated.  
Triethylamine, DBU, DIPA and DIPEA were purified by distillation. Liquid 
aldehydes were purified by distillation before usage and stored in the fridge at –30 °C under 
nitrogen.  
When anhydrous solvents were required, they were dried following established 
procedures.95 Dichloromethane was dried over CaH, diethyl ether and tetrahydrofuran were 
dried by filtration through activated alumina (powder 150 mesh, pore size 58 Å, basic Sigma 
Aldrich) columns. 
5.1.2. General experimental 
All non-aqueous reactions were performed under inert atmosphere using oven-dried 
glassware and were magnetically stirred. Yields refer to chromatographically purified and 
spectroscopically pure compounds, unless otherwise stated. 
Heat requiring reactions were performed using a hotplate with a sand bath and a 
condenser. Reactions requiring low temperatures were performed using cooling bath 
circulators Huber T100E and acetone or isopropanol baths. 
Organic layers washed with aqueous phases were dried over MgSO4 or Na2SO4 and 
filtered through cotton. 
Organic solvents were evaporated under reduced pressure using rotary evaporator 
Büchi R-100, R-200 and R-210, the latter equipped with a Büchi V-700 vacuum pump and 
a Büchi V-850 vacuum controller, appropriate for the evaporation of solvents when 
products were volatile compounds. For the complete removal of solvents vacuum pump 
Telstar Top-3 (≈ 0.5 mmHg) was employed. 
                                                 
95 Armanego, W. L. F.; Perrin, D. D. Purification of laboratory Chemicals, 3rd Edition Butterworth-
Heinemann, Oxford, 1988. 
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5.1.3. Chromatography 
Reactions and flash chromatographic columns were monitored by thin layer 
chromatography (TLC) using Merck silica gel 60 F254 plates and visualized by 
fluorescence quenching under UV light, Fisher Biolock lamp VL-4LC, λ = 254 and 365 
nm. In addition, TLC plates were stained with a dipping solution of potassium 
permanganate (1g) in 100 ml of water (limited lifetime), followed by heating. 
Chromatographic purification was performed on Merck ROCC 60 silica gel 40-63 
µm as stationary phase and a suitable mixture of solvents (typically hexane: ethyl acetate, 
pentane: diethyl ether or dichloromethane: methanol) as eluent. 
5.1.4. Optical rotation 
Optical rotations were recorded using a Jasco P-2000 polarimeter; specific rotation (SR) 
([α]D) are reported in 10-1 deg.cm2.g-1; concentrations (c) are quoted in g/100 mL; D refers 
to the D-line of sodium (589 nm); temperatures (T) are given in degree Celsius (°C). 
5.1.5. Melting points 
Melting points were determined in open capillaries in a Stuart SHP3 melting point 
apparatus and microscope and were uncorrected. 
5.1.6. NMR spectra 
NMR spectra were recorded using a Bruker Avance 300 (300 MHz for 1H, 75 MHz for 13C) 
spectrometer, Bruker 400 spectrometer (400 MHz for 1H, 100 MHz for 13C) Varian 400 
MR (400 MHz for 1H, 100 MHz for 13C) or Bruker AV-500 spectrometer (500 MHz for 
1H, 125 MHz for 13C). Chemical shifts (δ) are quoted in parts per million referenced to the 
residual solvent peak, usually CDCl3, 
1H (δ = 7.26) and 13C (δ = 77.0). The multiplicity of 
each signal is designated using the following abbreviations: s, singlet; d, doublet; t, triplet; 
q, quartet; m, multiplet; brs, broad singlet. Coupling constants (J) are reported in Hertz 
(HZ).  
MestrReNova Mnova 8.1 program was used to process and edit the registered 
spectra. 
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5.1.7. Mass spectra 
Ms spectra were recorded on an ESI-ion trap Mass spectrometer (Agilent 1100 series 
LC/MSD, SL model) on a UPLC-DAD-QTOF, Ultra High Performance Liquid 
Chromatography-Mass spectrometer, Waters UPLC ACQUITY, Waters PDA detector, 
Waters Sunapt G2 or on an Agilent Thermoquest LCT spectrometer. Mass spectrometry 
analyses were performed in the General Research Service (SGIker) of the University of the 
Basque Country (UPV/EHU). 
5.1.8. Infrared spectra 
Infrared spectra were recorded on a Bruker Alpha FT-IR spectrometer as a thin film. 
5.1.9. X-Ray diffraction analysis 
The X-ray diffraction analysis experiments were conducted in the General Research 
Service (SGIker) of the University of the Basque Country (UPV/EHU) using difractometers 
for monocrystals. 
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5.2. Preparation of catalysts 
5.2.1.  Preparation of catalysts C1-C9 
5.2.1.1. Preparation of 9-amino-(9-deoxy)epiquinine96 
 
Step 1: A mixture of quinine (16.2 g, 50 mmol, 1 equiv.) and triethylamine (25.1 mL, 180 
mmol, 3.6 equiv.) in dry THF (250 mL) was cooled to 0 ºC and then methanesulfonyl 
chloride (7.0 mL, 90 mmol, 1.8 equiv.) was added dropwise. The mixture was stirred 
overnight at room temperature. The reaction was quenched with water (40 mL) and then 
THF was removed under vacuum. The residue was dissolved in dichloromethane (40 mL) 
and washed with water (30 mL) and saturated sodium bicarbonate (30 mL). The organic 
layer was dried over MgSO4, filtered and concentred under vacuum to afford the crude 
product in 96 % yield, which was used in the next step without further purification. 
Step 2: The crude product (19.3 g, 48 mmol, 1 equiv.) was dissolved in DMF (150 
mL). The solution was cooled to 0 °C and NaN3 (6.2 g, 96 mmol, 2 equiv.) was added 
portionwise. The mixture was stirred at 40 oC for 48 h and after this time the reaction was 
quenched with water (80 mL) and then ethyl acetate (150 mL) was added. The organic layer 
was separated and washed with saturated NaCl (5 x 60 mL), dried over MgSO4, filtered 
and evaporated under reduced pressure to obtain the crude product in quantitative yield, 
which was used in the next step without further purification. 
                                                 
96 Adapted from: Brunner, H.; Büegler, J.; Nuber, B. Tetrahedron: Asymmetry, 1995, 6, 1699–1702. 
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Step 3: The crude product was dissolved in THF (250 mL) and PPh3 (12.6 g, 48 
mmol, 1 equiv.) was added. The reaction mixture was heated to 40 °C and stirred until the 
gas evolution ceased (~5 h). Then H2O (8 mL) was added and the mixture was stirred 
overnight at 40 °C. The solvent was removed under vacuum and the residue was dissolved 
in dichloromethane (150 mL). HCl 6 M (250 mL) was added and the aqueous phase was 
separated and washed with dichloromethane (2 x 100 mL). Then the aqueous layer was 
cooled to 0 °C and basified until pH > 10 with NaOH 40%. The aqueous phase was then 
extracted with dichloromethane (3 x 150 mL), dried over MgSO4 and concentrated under 
reduced pressure to afford 9-amino-(9-deoxy)epiquinine  as a yellow viscous oil. Yield: 8.7 
g, 26.9 mmol, 56 %. All data were consistent with those previously reported.96 1H NMR 
(300 MHz, CDCl3), δ 8.75 (d, J = 4.6 Hz, 1H), 7.36 – 8.05 (m, 4H), 5.79 – 5.75 (m, 1H), 
4.97 (m, 2H), 4.57 (d, J = 10.4 Hz, 1H), 3.97 (s, 3H), 3.02 – 3.34 (m, 3H), 2.75 – 2.77 (m, 
2H), 2.27 – 2.24 (m, 1H), 2.08 (s, 2H), 1.26 – 1.63 (m, 4H), 0.80 – 0.78 (m, 1H). 
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5.2.1.2.  Preparation of catalysts C197and C298 
 
To a solution of 9-amino-(9-deoxy)epiquinine (1.6 g, 5 mmol, 1 equiv.) in dry THF (7.5 
mL) at 0 °C, a solution of bis(trifluomethyl)phenyl isothiocyanate (1.5 g, 5.5 mmol, 1.1 
equiv.) or bis(trifluomethyl)phenyl isocyanate (0.6 mL, 5.5 mmol, 1.1 equiv.) in dry THF 
(2.5 mL) was added dropwise. The reaction mixture was stirred overnight at room 
temperature and then concentrated under reduced pressure. The residue was purified by 
flash column chromatography on non acid silica gel (eluent with hexane: ethyl acetate, 
80:20 → ethyl acetate). 
1-(3,5-Bis(trifluoromethyl)phenyl)-3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)thiourea C1 
White solid. Yield: 2.6 g, 4.4 mmol, 88 %. M. p. = 123 – 125 
°C. All data were consistent with those previously reported.97 1H 
NMR (300 MHz, CD3OD) δ 8.68 (d, J = 4.7 Hz, 1H), 8.11 (brs, 
2H), 8.07 (d, J = 2.6 Hz, 1H), 7.95 (d, J = 9.3 Hz, 1H), 7.59 (brs, 
1H), 7.55 (d, J = 4.7 Hz, 1H), 7.44 (dd, J = 9.3, 2.6 Hz, 1H), 
6.32 (d, J = 11.0 Hz, 1H), 5.84 (ddd, J = 17.2, 10.5, 6.2 Hz, 1H), 5.02 (dt, J = 10.5, 1.5 Hz, 
1H,), 4.98 (dt, J = 17.2, 1.5 Hz, 1H), 4.03 (s, 3H), 3.56 – 3.53 (m, 1H), 3.39 – 3.37 (m, 1H), 
3.29 (dd, J = 13.6, 9.9 Hz, 1H), 2.82 (ddd, J = 15.6, 13.8, 4.9 Hz, 1H), 2.79 (ddd, J = 13.6, 
4.7, 2.3 Hz, 1H), 2.38 – 2.35 (m, 1H), 1.71 – 1.68 (m, 2H), 1.64 – 1.61 (m, 1H), 1.45 (ddd, 
J = 13.3, 10.4, 2.7 Hz, 1H), 0.89 (dd, J = 13.3, 10.4 Hz, 1H). 
  
                                                 
97 Adapted from: Vakulya, B.; Varga, S.; Csámpai, A.; Soós, T. Org. Lett. 2005, 7, 1967–1969. 
98 Greenaway, K.; Dambruoso, P.; Ferrali, A.; Hazelwood, A. J.; Sladojevich, F.; Dixon, D. J. Synthesis, 2011, 
12, 1880–1886. 
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1-(3,5-Bis(trifluoromethyl)phenyl)-3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)urea C2 
White solid. Yield: 2.4 g, 4.1 mmol, 82 %. M. p. = 132 – 134 
°C. All data were consistent with those previously reported.98 
1H NMR (300 MHz, CD3OD) δ 8.58 (d, J = 4.5 Hz, 1H), 7.90 
– 7.88 (m, 3H), 7.66 (d, J = 2.5 Hz, 1H), 7.51 (d, J = 4.5 Hz, 
1H), 7.36 (d, J = 1.5 Hz, 1H), 7.34 (d, J = 2.5 Hz, 1H), 5.83 – 
5.89 (m, 1H), 5.65 (brs, 1H), 5.18 (d, J = 17.5 Hz, 1H), 5.09 
(d, J = 10.5 Hz, 1H), 3.91 (s, 3H), 3.47 – 3.52 (m, 1H), 3.35 – 3.41 (m, 1H), 3.03 – 3.15 
(m, 4H), 2.41 – 2.43 (m, 1H), 1.40 – 1.73 (m, 3H), 1.17 – 1.25 (m, 3H). 
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5.2.1.3. Preparation of catalyst C399 
 
Step 1: synthesis of squaric ester monoamide intermediate 
To a solution of dimethyl squarate (142 mg, 1.0 mmol, 1 equiv.) in CH2Cl2 (4 mL) was 
added a solution of 3,5-bis(trifluoromethyl)benzylamine (255 mg, 1.1 mmol, 1.1 equiv.) in 
CH2Cl2 (1 mL) and the mixture was stirred at room temperature for 48 h. The reaction 
mixture was filtered, and the filtrate was washed with (aq) 1 M HCl (10 mL), dried with 
Na2SO4, filtered again, and concentrated to afford 3-((3,5-
bis(trifluoromethyl)benzyl)amino)-4-methoxycyclobut-3-ene-1,2-dione as a white solid. 
Yield: 309 mg, 0.87 mmol, 87%. 1H NMR (300 MHz, CDCl3) δ 7.87 (s, 1H), 7.77 (s, 2H), 
4.78 (bs, 1H), 4.41 (s, 3H). 
Step 2: coupling to final squaramide C3  
To a solution of previously obtained material (309 mg, 0.87 mmol, 1.2 equiv.) in 
MeOH (10 mL) at room temperature was added a solution of 9-amino-(9-deoxy)epiquinine 
(236 mg, 0.73 mmol, 1 equiv.) in MeOH (3 mL). After stirring the mixture for 24 h, the 
solvent was evaporated under reduced pressure and the residue was purified by non acid 
column chromatography (Hex: EtOAc, 50:50) to afford the desired squaramide C3 as a 
white solid. Yield: 227 mg, 0.35 mmol, 50 %. All spectroscopic data were identical to those 
reported in the literature.99 1H NMR (300 MHz, CDCl3) δ 8.67 (s, 1H), 7.91 – 7.94 (m, 1H), 
7.77 (s, 1H), 7.51 – 7.34 (m, 5H), 5.74 – 5.68 (m, 1H), 5.00 – 4.91 (m, 2H), 4.52 (bs, 2H), 
3.88 (s, 3H), 3.24 – 3.19 (m, 3H), 2.77 – 2.68 (m, 1H), 2.31 (bs, 1H), 1.69 – 1.43 (m, 5H), 
0.88 (bs, 1H). 
                                                 
99 Reproduced from: Malerich, J.; Hagihara, K.; Rawal, H. J. Am. Chem. Soc. 2008, 130, 14416–14417. 
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5.2.1.4.  Preparation of catalyst C4100 
 
Step 1: preparation of squaric ester monoamide intermediate 
To a solution of dimethyl squarate (1.42 g, 10 mmol, 1 equiv.) in MeOH (20 mL) 
was added 3,5-bis(trifluoromethyl)aniline (1.56 mL, 10 mmol, 1 equiv.). The reaction 
mixture was stirred at room temperature for 48 h. The formed precipitate was filtered and 
dried in vacuo to give the desired product. Yield: 2.25 g, 6.6 mmol, 66 %. M.p. = 179 – 
181 °C. All spectroscopic data where consistent with those reported in literature.100 1H 
NMR (300 MHz, DMSO-d6) δ 11.18 (s, 1H), 8.04 (s, 2H), 7.78 (s, 1H), 4.41 (s, 3H). 
Step 2: coupling to final squaramide C4 
To a solution of the above obtained material (339 mg, 1.0 mmol, 1 equiv.) in CH2Cl2 
(5 mL) 9-amino-(9-deoxy)epiquinine (323 mg, 1.0 mmol, 1 equiv.), was added. The 
reaction mixture was stirred at room temperature for 48 h. Then the solvent was evaporated, 
and the product submitted to purification by silica gel column chromatography (eluent 
dichloromethane: methanol, 98:2). White solid. Yield: 441 mg, 0.7 mmol, 70%. M.p. = 224 
– 225 °C. All spectroscopic data were identical to those reported in the literature.100 1H 
NMR (300 MHz, DMSO-d6) δ 9.88 (brs, 1H), 8.80 (d, J = 4.5 Hz, 1H), 8.36 (brs, 1H), 8.04 
– 7.86 (m, 3H), 7.76 (d, J = 10.0 Hz, 1H), 7.67 (d, J = 4.5 Hz, 1H), 7.58 (s, 1H), 7.47 (d, J 
= 6.8 Hz, 1H), 6.19 – 5.73 (m, 2H), 5.13 – 4.92 (m, 2H), 3.95 (s, 3H), 3.52 – 3.42 (m, 1H), 
3.30 – 3.25 (m, 1H) 2.77 – 2.58 (m, 2H), 2.35 – 2.20 (m, 1H), 1.60 – 1.47 (m, 4H), 0.66 
(m, 1H). 
  
                                                 
100 Reproduced from: Yang, W.; Du, D. M. Org. Lett. 2010, 12, 5450–5453. 
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5.2.1.5. Preparation of catalyst C5 
 
Step 1: preparation of ester monoamide intermediate 
To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (147 mg, 1.0 mmol, 1 equiv.) in 
MeOH (5 mL) the methyl 3-amino-5-(trifluoromethyl)benzoate (227 mg, 1.0 mmol, 1 
equiv.) was added at room temperature. The mixture was stirred at room temperature for 
15 h. The white precipitate was filtered and washed with MeOH. The obtained white solid 
was dried in vacuo to give the title product as a white solid. Yield: 403 mg, 0.65 mmol, 65 
%. M.p. = 219 – 221 °C. 1H NMR (300 MHz, CDCl3) δ 8.13 (d, J = 15.0 Hz, 2H), 7.83 (d, 
J = 2.4 Hz, 1H), 4.58 (s, 3H), 4.02 (s, 3H). UPLC-DAD-QTOF: C14H10F3NO5 [M+H]
+ 
calcd.: 330.0511, found: 330.0411. 
Step 2: coupling to final squaramide C5 
To a solution of the above obtained material (150 mg, 0.5 mmol, 1 equiv.) in CH2Cl2 
(2.5mL) 9-amino-(9-deoxy)epiquinine (180 mg, 0.5 mmol, 1 equiv.) was added and the 
reaction mixture was stirred at room temperature for 16 h. The solvent was evaporated, and 
the residue was submitted to purification by silica gel column chromatography (eluent 
dichloromethane: methanol, 98:2). White solid. Yield: 441 mg, 0.34 mmol, 67 %. M.p. = 
184 – 187 °C. 1H NMR (300 MHz, CDCl3) δ 8.63 (d, J = 4.4 Hz, 1H), 7.98 (d, J = 9.1 Hz, 
1H), 7.88 (s, 1H), 7.74 (d, J = 23.1 Hz, 2H), 7.62 (s, 2H), 7.38 – 7.32 (m, 1H), 6.28 (s, 1H), 
5.93 – 5.72 (m, 1H), 5.12 – 4.87 (m, 2H), 3.94 (s, 3H), 3.70 (s, 3H), 3.47 (dd, J = 11.4, 5.7 
Hz, 1H), 3.20 (q, J = 9.4 Hz, 1H), 3.00 – 2.62 (m, 2H), 2.40 – 2.23 (m, 1H), 1.75 – 1.52 
(m, 4H), 0.82 (d, J = 11.9 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 184.3, 181.8, 170.2, 
165.5, 163.6, 159.3, 148.2, 145.3, 143.5, 141.35, 139.9, 132.5, 132.4, 132.3, 132.1, 128.5, 
123.1, 122.1, 121.9, 121.1, 119.9, 115.7, 102.0, 60.9, 56.5, 56.4, 54.5, 53.1, 41.1, 39.9, 
28.1, 28.0, 26.5. UPLC-DAD-QTOF: C33H31F3N4O5 [M+H]
+ calcd.: 620.2247, found: 
620.2330.  
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5.2.1.6. Preparation of catalyst C6101 
 
Step 1: preparation of 3-nitro-5-(trifluoromethyl)benzoic acid 
To a solution of 3- trifluoromethylbenzoic acid (2 g, 10 mmol) in concentrated sulphuric 
acid (10 mL ) was added nitric acid (2 mL) at 0 °C over 15 min. The mixture was stirred at 
35 °C for 3 h, and slowly poured onto ice. The precipitate was filtered and dissolved in 
ethyl acetate (50 mL). The ethyl acetate solution was washed with water (100 mL), dried 
with Na2SO4, filtered and  concentrated under reduced pressure to give 3- nitro-5-
(trifluoromethyl) benzoic acid as a white powder. Yield: 2,16 g, 9.2 mmol, 92 %. All 
spectroscopic data were identical to those reported in the literature.101 1H NMR (300 MHz, 
CDCl3) δ 8.69 (s, 1H), 8.74 (s, 1H), 9.1 (s, 1H). 
Step 2: preparation of 3-amino-5-(trifluoromethyl)benzoic acid 
To a solution of the nitrocompound (1.56 g, 6.68 mmol) in EtOAc (15 mL) under 
inert atmosphere, Pd/C (Pd 10% in activated carbon, 10 % in weight) was added and the 
reaction mixture was stirred under H2 atmosphere (1 atm.) at room temperature for 20 h. 
The solution was filtered over celite and the filtrate was concentrated under reduced 
pressure to 3-amino-5-(trifluoromethyl)benzoic acid as a white solid. Yield: 1.08 g, 5.3 
mmol, 79 %. All spectroscopic data were identical to those reported in the literature.101 1H 
NMR (300 MHz, CDCl3): δ 7.10 (s, 1H), 7.53 (s, 1H), 7.72 (s, 1H). 
  
                                                 
101 Reproduced from: Badiola, E.; Olaizola, I.; Vázquez, A.; Vera, S.; Mielgo, A.; Palomo, C. Chem. Eur. J. 
2017, 23, 8185–8195. 
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Step 3: preparation of 3-((2-methoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-5-
(trifluoromethyl)benzoic acid 
To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (710 mg, 5.0 mmol, 1 
equiv.) in MeOH (5 mL) at room temperature the 3-amino-5-(trifluoromethyl)benzoic acid 
(685 mg , 5.0 mmol, 1 equiv.) was added. The mixture was stirred at the same temperature 
for 15 h. The white precipitate was filteredand washed with MeOH. The obtained yellow 
solid was dried in vacuo. Yield: 1.5 g, 4.8 mmol, 96 %. All spectroscopic data were 
identical to those reported in the literature.101 1H NMR (300 MHz, Acetone-d6) δ 9.88 (s, 
1H), 8.38 (s, 1H), 8.16 (s, 1H), 8.00 (s, 1H), 4.50 (s, 3H). 
Step 4: preparation of 3-((2-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-
(trifluoromethyl)benzoic acid 
To a suspension of the above obtained material (630 mg, 2.0 mmol, 1 equiv.) in 
CH3CN (2 mL) at room temperature, Et3N (0.3 mL, 2.0 mmol, 1 equiv.) and (R,R)-9-deoxy-
9-epiaminoquinine (646 mg, 2.0 mmol, 1 equiv.) was added. The reaction mixture was 
stirred vigorously at room temperature for 16 h. The reaction mixture was directly 
submitted to purification by purified by flash column chromatography (CH2Cl2: MeOH, 
99:1). The obtained yellow solid was dried in vacuo. Yield: 570 mg, 0.94 mmol, 47 %. All 
spectroscopic data were identical to those reported in the literature.101 1H NMR (300 MHz, 
Acetonitrile-d3) δ 11.51 (brs, 1H), 10.17 (bs, 1H), 8.85 (d, J = 4.5 Hz, 1H), 8.38 (s, 1H), 
8.07 – 7.56 (m, 5H), 7.32 (dd, J = 9.2, 2.5 Hz, 1H), 6.40 (bs, 1H), 5.86 (ddd, J = 17.2, 10.4, 
6.8 Hz, 1H), 5.32 – 4.97 (m, 2H), 4.50 (s, 1H), 4.05 – 3.53 (m, 5H), 3.51 – 3.11 (m, 2H), 
2.84 (d, J = 9.0 Hz, 1H), 2.25 – 1.97 (m, 4H), 1.78 (t, J = 12.4 Hz, 1H), 1.22 (d, J = 13.9 
Hz, 1H). 
Step 5: preparation of N-(3,5-bis(trifluoromethyl)phenyl)-3-((2-(((S)-(6-
methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-
dioxocyclobut-1-en-1-yl)amino)-5-(trifluoromethyl)benzamide C6 
1-Methylimidazole (0.2 mL, 2.5 mmol, 2.5 equiv.) was added to a slurry of the 
above obtained material (570 mg, 1.0 mmol, 1 equiv.) in CH3CN (2.5 mL) at 0 °C, and the 
mixture was stirred for 10 min then a solution of MsCl (0.17 mL, 1.5 mmol, 1.5 equiv.) in 
CH3CN (0.1 mL) was added. After the mixture was stirred at 0 °C for 20 min, 3,5-
bis(trifluoromethyl)aniline (0.15 mL, 1.0 mmol, 1 equiv.) was added and the mixture was 
stirred at room temperature over night. H2O (10 mL) was added to the mixture causing a 
precipitate, which upon addition of EtOAc (10 mL) redissolved. The layers were separated 
and the organic layer was washed with brine (3 x 50 mL) and dried with anhydrous MgSO4. 
After filtration, the solvent was evaporated under reduced pressure and the crude was 
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crushed with diethyl ether to afford the compound C6 as a yellow solid. Yield: 556 mg, 6.8 
mmol, 68 %. All spectroscopic data were identical to those reported in the literature.101 
[α]D25 =  ̶  52.7 °(C = 0.5, MeOH). M.p. = 195.6 – 197.2 °C. 1H NMR (300 MHz, DMSO-
d6) 10.94 (s, 1H), 10.16 (s, 1H), 8.80 (d, J = 4.5 Hz, 1H), 8.47 (d, J = 1.8 Hz, 2H), 8.27 (s, 
1H), 8.17 (s, 1H), 7.97 (t, J = 4.5 Hz, 3H), 7.84 (s, 1H), 7.76 (s, 1H), 7.67 (d, J = 4.6 Hz, 
1H), 7.45 (dd, J = 9.2, 2.4 Hz, 1H), 6.22 – 5.82 (m, 2H), 5.30 – 4.81 (m, 2H), 3.96 (s, 3H), 
3.56 – 3.06 (m, 4H), 2.85 – 2.55 (m, 2H), 2.28 (q, J = 8.0, 7.2 Hz, 1H), 1.84 – 1.34 (m, 4H), 
0.68 (s, 1H). 13C NMR (75 MHz, DMSO-d6) δ 184.6, 180.1, 168.5, 164.4, 163.0, 157.9, 
147.8, 144.3, 143.1, 142.1, 140.7, 140.3, 136.0, 131.5, 130.9, 130.5, 127.5, 125.1, 121.2, 
120.0, 118.0, 117.5, 116.8, 114.3, 101.5, 58.9, 55.7, 27.3, 26.0. UPLC-DAD-QTOF: 
C40H33N5O4F9 [M+H]
+ calcd.: 818.2389, found: 818.2398.  
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5.2.1.7. Preparation of catalyst C7102, C8 and C9 
 
5.2.1.7.1. Preparation of N-alkyl benzylamines103 
 
To a stirred solution of 3,5-bistrifluoromethylbenzylmine (1.22 g, 5.0 mmol, 1 equiv.) in 
THF (15 mL) Boc2O (1.30 g, 6.0 mmol, 1.2 equiv.) was added and an aqueous saturated 
solution of NaHCO3 (15 mL) were successively added. The resulting mixture was stirred 
at room temperature for 1 h, quenched with water (15 mL) and extracted with EtOAc (2 x 
15 mL). The combined organic layers were washed with brine, dried over MgSO4 and the 
solvent was eliminated under reduced pressure. The product obtained was dissolved in 
DMF (15 mL) and cooled to 0 °C. NaH (60 % in oil) previously washed with hexane (383 
mg, 10 mmol, 2 equiv.) was slowly added to the solution and the resulting mixture was 
allowed to stir at room temperature for 20 min. Then methyl or n-propyl iodide (5.0 mmol, 
1 equiv.) was added and the mixture was allowed to stir for a further 1.5 h. The reaction 
was stopped by adding water (15 mL) and the mixture was extracted with EtOAc (3 x 15 
mL). The combined organic layers were washed with brine (5 x 15 mL), dried over MgSO4, 
filtered, and the solvent was eliminated under reduced pressure. The crude obtained was 
then dissolved in MeOH (7.5 mL) and 4 M HCl solution was added and the resulting 
solution was stirred at room temperature for 3 h. The reaction was slowly quenched with a 
saturated aqueous solution of NaHCO3 (3 x 15 mL). The mixture was extracted with EtOAc 
(3 x 15 mL) and the combined organic layers were washed with brine (3 x 15 mL), dried 
over MgSO4, filtrate, and the solvent was eliminated under reduced pressure. The product 
                                                 
102 Reproduced from: Badiola, E.; Olaizola, I.; Vázquez, A.; Vera, S.; Mielgo, A.; Palomo, C. Chem. Eur. J. 
2017, 23, 8185–8195. 
103 Kataja, O. A.; Koskinen, A. M. P. ARKIVOK, 2010, 205–223. 
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obtained was used without further purification. All spectroscopic data were identical to 
those reported in the literature.  
1-(3,5-bis(trifluoromethyl)phenyl)-N-methylmethanamine  
The title compound was prepared from methyl iodide (0.93 mL, 15 mmol, 
3 equiv.) according to the general procedure. Yellow oil. Yield: 1.03 g, 
4.3 mmol, 85%. All data were consistent with those previously 
reported.103 1H NMR (300 MHz, CDCl3) δ 7.81 (s, 2H), 7.77 (s, 1H), 3.89 (s, 2H), 2.48 (s, 
3H), 1.47 (s, 1H). 
N-propyl-1-(3,5-bis(trifluoromethyl)benzyl)methanamine  
The title compound was prepared from n-propyl iodide (2.44 mL, 25 
mmol, 5 equiv.) according to the general procedure. Yellow oil. Yield: 
1.06 g, 3.9 mmol, 79%. All data were consistent with those previously 
reported.103 1H NMR (300 MHz, CDCl3) δ 7.12 (s, 2H), 6.92 (s, 2H), 
4.07 (s, 1H), 3.13 (td, J = 7.0, 5.5 Hz, 2H), 1.76 – 1.60 (m, 2H), 1.03 (t, J = 7.4 Hz, 3H). 
N-Benzyl-3,5-bis(trifluoromethyl)aniline  
 
A solution of 3,5-bis(trifluoromethyl)phenyl aniline (2.4 g, 10 mmol, 1 equiv.), benzyl 
bromide (1.18 mL, 10 mmol, 1 equiv.) and potassium carbonate (1.38 g, 10 mmol, 1 equiv.) 
in DMF (10 mL) was stirred at 90 °C. After 20 h the mixture was cool at room temperature, 
the mixture was diluted with EtOAc and the organic phase was washed with brine (6 x 40 
mL). Drying MgSO4 filtration and evaporation gave the corresponding crude that was 
purified by flash column chromatography on silica gel (hexane: EtOAc, 99:1-95:5) to 
afford the desired product as a yellow pale oil. Yield: 1.13 g, 7.1 mmol, 71%. All data were 
consistent with those previously reported.104 1H NMR (300 MHz, CDCl3) δ 7.42 – 7.30 (m, 
5H), 6.98 (s, 2H), 4.45 (d, J = 4.3 Hz, 1H), 4.38 (d, J = 5.3 Hz, 2H). 
5.2.1.7.2. Coupling of acids with anilines to benzamides 
1-Methylimidazole (0.2 mL, 2.5 mmol, 2.5 equiv) was added to a slurry of previously 
prepared 3-((2-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-
yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(trifluoromethyl)benzoic acid 
(606 g, 1.0 mmol, 1 equiv.) in CH3CN (2.5 mL) at 0 °C, and the mixture was stirred for 10 
                                                 
104 Matsumura, T.; Nakada, M. Tetrahedron Lett. 2014, 55, 1829–1834. 
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min. MsCl (0.17 mL, 1.5 mmol, 1.5 equiv.) in CH3CN (0.1 mL) was added at the same 
temperature, and the mixture was stirred for 20 min. the correspondent benzamide (1.0 
mmol, 1 equiv.) was then added and the mixture was stirred at room temperature over night. 
H2O (10 mL) was added to the mixture, causing a precipitate, which upon addition of 
EtOAc (10 mL) redissolved. The organic layer was washed with brine (3 x 50 mL), dried 
with anhydrous MgSO4, filtered, and the solvent was evaporated under reduced pressure 
and the crude was crushed with diethyl ether. 
N-(3,5-bis(trifluoromethyl)phenyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)-N-methyl-5-(trifluoromethyl)benzamide C7 
The title compound was prepared from 1-(3,5-
bis(trifluoromethyl)phenyl)-N-methylmethanamine 
according to the general procedure. Yellow solid. Yield: 639 
mg, 0.7 mmol, 77%. M.p. = 165 – 170 °C. [α]D = – 115.9 (c 
= 1, CH2Cl2). 
1H NMR (300, CDCl3) δ 8.59 (s, 1H), 7.96 (d, 
J = 9.1 Hz, 1H), 7.87 – 7.16 (m, 8H), 6.90 (s, 1H), 6.19 (s, 
1H), 5.87 – 5.66 (m, 1H), 5.15 – 4.82 (m, 2H), 3.96 (s, 3H), 
3.45 (s, 4H), 3.21 (d, J = 19.8 Hz, 2H), 2.73 (s, 2H), 2.31 (s, 
1H), 1.75 – 1.36 (m, 4H), 0.77 (s, 1H). 13C NMR (75 MHz, CDCl3) δ 184.6, 181.2, 169.0, 
163.5, 159.1, 147.6, 145.2, 144.9, 143.2, 140.6, 140.1, 137.0, 133.1, 133.1, 132.7, 132.0, 
131.8, 128.1, 127.1, 124.9, 124.5, 123.0, 121.2, 120.9, 118.9, 117.3, 116.6, 115.4, 101.2, 
77.6, 77.4, 77.2, 76.8, 60.2, 56.2, 55.8, 53.9, 41.1, 39.2, 38.6, 27.4, 26.0. UPLC DAD – 
QTOF: C41H38N5O4F6 [M+H]
+ calcd.: 831.2593, found: 831.2596.  
N-(3,5-bis(trifluoromethyl)phenyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)-N-propyl-5-(trifluoromethyl)benzamide C8 
The title compound was prepared from N-propyl-1-(3,5-
bis(trifluoromethyl)benzyl)methanamine according to the 
general procedure. Yellow pale solid. Yield: 610 mg, 0.71 
mmol, 71%. M.p. = 168 – 173 °C. [α]D25 = –  48.2 (c = 1, 
CH2Cl2). 
1H NMR (300, CDCl3) δ 8.57 (s, 1H), 7.95 (d, J = 
9.0 Hz, 1H), 7.73 (s, 1H), 7.66 (s, 2H), 7.52 (s, 2H), 7.36 (d, J 
= 8.9 Hz, 2H), 7.18 (s, 1H), 6.85 (s, 1H), 6.17 (s, 1H), 5.90 – 
5.68 (m, 1H), 5.18 – 4.89 (m, 2H), 3.94 (d, J = 10.7 Hz, 3H), 3.92 – 3.72 (m, 2H), 3.44 (d, 
J = 6.9 Hz, 2H), 3.16 (d, J = 10.2 Hz, 1H), 2.92 – 2.60 ( m, 2H), 2.33 (s, 1H), 1.89 – 1.42 
(m, 5H), 0.90 (t, J = 7.2 Hz, 3H), 0.79 (s, 1H). 13C NMR (75 MHz, CDCl3) δ 184.3, 181.1, 
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169.1, 168.8, 159.1, 147.5, 144.8, 144.0, 139.9, 137.5, 133.2, 132.8, 131.6, 128.2, 124.8, 
124.4, 122.9, 121.5, 121.1, 120.8, 119.1, 117.2, 116.5, 115.0, 101.4, 60.2, 56.1, 52.3, 41.0, 
39.6, 27.6, 26.2, 21.2, 11.2. UPLC-DAD-QTOF: C34H39N5O4F9 [M+H]
+ calcd.: 860.2858, 
found: 860.2842.  
N-benzyl-N-(3,5-bis(trifluoromethyl)phenyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)-5-(trifluoromethyl)benzamide C9 
The title compound was prepared from N-Benzyl-3,5-
bis(trifluoromethyl)aniline according to the general procedure. 
Yellow pale solid. Yield: 708 mg, 0.8 mmol, 78%. M.p. = 155 – 
168 °C. [α]D25 = – 47.2 (c = 1, CH2Cl2). 1H NMR (300, CDCl3) δ 
8.56 (s, 1H), 8.02 – 7.66 (m, 3H), 7.57 (s, 1H), 7.43 – 7.02 (m, 
10H), 6.85 (s, 1H), 6.17 (s, 1H), 5.81 – 5.62 (m, 1H), 5.05 – 4.91 
(m, 4H), 3.93 (s, 3H), 3.63 – 3.30 (m, 2H), 3.13 (s, 1H), 2.78 (s, 
1H), 2.66 (s, 1H), 2.30 (s, 1H), 1.63 (brs, 4H), 0.84 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 
184.3, 181.1, 168.9, 163.5, 159.0, 147.6, 144.8, 143.8, 137.0, 135.7, 129.1, 128.4, 122.8, 
121.6, 121.1, 120.7, 119.2, 117.1, 116.5, 115.2, 101.4, 60.6, 56.1, 55.9, 54.2, 41.1, 39.3, 
27.4, 26.0. UPLC-DAD-QTOF: C47H39N5O4F9 [M+H]
+ calcd.: 908.2858, found: 908.2855.  
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5.2.1.8. Preparation of catalysts C10 and C11105 
 
Step 1: preparation of methyl 3-acetamido-5-(trifluoromethyl)benzoate106 
To a solution of the obtained methyl 3-amino-5-(trifluoromethyl)benzoate (2.192 g, 10 
mmol, 1 equiv.) and Et3N (1.40 mL, 10 mmol, 1 equiv.) in CH2Cl2 (50 mL) acetyl chloride 
(0.757 mL, 10.5 mmol, 1.5 equiv.) was added dropwise at 0 °C. After 7 hours at room 
temperature, the reaction mixture was washed with water and brine, dried over MgSO4 and 
concentrated to provide the title compound as white solid. Yield: 2.534 g, 9.7 mmol, 
97%.Which was used in the next step without further purification. 1H RMN (300 MHz, 
CDCl3) δ 8.20 (d, J = 5.4 Hz, 2H), 8.03 (s, 1H), 7.44 (s, 1H), 3.95 (s, 3H), 2.23 (s, 3H). 
Step 2: preparation of N-(3-(hydroxydiphenylmethyl)-5-
(trifluoromethyl)phenyl)acetamide106 
A solution of the crude material of the previous reaction (1.31 g, 5.0 mmol, 1 equiv.) 
in THF (10 mL) was added dropwise at 0 °C to a solution of phenyl magnesium bromide 
(0.5 M in THF, 15 mmol, 3 equiv.). The mixture was stirred at room temperature overnight. 
The reaction was quenched with NH4Cl saturated solution, the solvent was evaporated 
under reduced pressure and diluted with water (20 mL). The mixture was extracted with 
CH2Cl2 (3 × 10 mL), the combined organic layers was dried over MgSO4 and concentrated 
under reduced pressure. The crude material was purified by flash column chromatography 
                                                 
105 Reproduced from: Odriozola, A.; Oiarbide, M.; Palomo, C. Chem. Eur. J. 2017, 23, 12758–12762. 
106 Adapted from: Yang, H.; Zhou, L.; Wang, P. Photochem. Photobiol. Sci. 2012, 11, 514–517. 
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on silica gel (eluting with hexane: ethyl acetate, 7: 3) to give the title compound as a yellow 
solid. Yield: 1.67 g, 4.3 mmol, 86%. 1H RMN (300 MHz, CDCl3) δ 8.00 (s, 1H), 7.39 (d, J 
= 1.8 Hz, 2H), 7.36 – 7.30 (m, 5H), 7.27 – 7.21 (m, 5H), 2.87 (s, 1H), 2.13 (s, 3H). 
 
Step 3: preparation of (3-amino-5-(trifluoromethyl)phenyl)diphenylmethanol106 
To a solution of the acetamide obtained above (770 mg, 2.0 mmol, 1 equiv.) in 
MeOH (15 mL), H2O (2 mL) and NaOH (1.60 g, 40 mmol, 20 equiv.) was added and the 
mixture was heated at 85 °C for 3 d. The reaction mixture was neutralized with HCl 1M 
until pH 7, extracted with CH2Cl2 (3 × 10 mL), the combined organic layers were dried 
over MgSO4 and the solvent was evaporated under reduced pressure to give the title 
compound as a yellow solid. Yield: 651 mg, 1.9 mmol, 95%. 1H RMN (300 MHz, CDCl3) 
δ 7.35 – 7.23 (m, 10H), 6.97 (dd, J = 1.6, 0.8 Hz, 1H), 6.81 (s, 1H), 6.76 (s, 1H), 3.87 (s, 
3H). 
Step 4: preparation of 3-((3-(hydroxydiphenylmethyl)-5-
(trifluoromethyl)phenyl)amino)-4-methoxycyclobut-3-ene-1,2-dione107 
To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (142 mg, 1.0 mmol, 1 
equiv.) in MeOH (4 mL) was added the free aniline obtained above (343 mg, 1.0 mmol, 1 
equiv.) and the mixture was stirred at room temperature for 14 h. The solvent was 
evaporated under reduced pressure and the crude material was purified by flash column 
chromatography on silica gel (eluting with Hexane: ethyl acetate, 7:3) to give the title 
compound as a yellow solid. Yield: 316 mg, 0.7 mmol, 70%. M.p. = 100 – 110 °C. 1H RMN 
(300 MHz, CDCl3) δ 7.53 (s, 1H), 7.48 (s, 2H), 7.39 – 7.32 (m, 5H), 7.27 – 7.23 (m, 5H), 
4.37 (s, 3H), 2.89 (s, 1H). UPLC-DAD-QTOF: C25H19NO4F3 [M+H]
+ calcd.: 454.1266, 
found: 454.1260. 
  
                                                 
107 Adapted from: Qian, Y.; Ma, G.; Lv, A.; Zhu, H.-L.; Zhao, J.; Rawal, V. H. Chem. Commun. 2010, 46, 
3004–3006. 
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Step 5: preparation of 3-((3-(Hydroxydiphenylmethyl)-5-
(trifluoromethyl)phenyl)amino)-4-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione C10 
To a suspension of the hemisquaramide obtained above (227 mg, 0.5 mmol, 1 
equiv.) in CH2Cl2 (2 mL) was added (R,R)-9-deoxy-9-epiaminoquinine (162 mg, 0.5 mmol, 
1 equiv.) and the reaction mixture was stirred at room temperature for 2 days. The solvent 
was evaporated in the rotary evaporator and the oil residue was submitted to purification 
by silica gel column chromatography (CH2Cl2: MeOH, 98:2) to give the pure C10 catalyst 
as a yellow solid. Yield: 253 mg, 0.34 mmol, 68%. All spectroscopic data were identical to 
those reported in the literature.105 M.p.= 185 – 198 °C.1H NMR (300 MHz, MeOD) δ 8.63 
(d, J = 4.7 Hz, 1H), 7.94 – 7.82 (m, 2H), 7.82 – 7.71 (m, 1H), 7.51 (d, J = 4.8 Hz, 1H), 7.41 
– 7.29 (m, 2H), 7.29 – 7.10 (m, 10H), 6.20 (d, J = 11.1 Hz, 1H), 5.84 (ddd, J = 17.4, 10.3, 
7.3 Hz, 1H), 5.09 – 4.93 (m, 2H), 3.93 (s, 3H), 3.54 (ddd, J = 21.8, 17.1, 8.7 Hz, 2H), 3.29 
– 3.26 (m, 1H), 3.26 – 3.19 (m, 1H), 2.91 – 2.67 (m, 2H), 2.43 – 2.26 (m, 1H), 1.71 – 1.50 
(m, 4H), 0.77 – 0.63 (m, 1H). 13C NMR (75 MHz, MeOD) δ 185.3, 181.9, 169.6, 165.5, 
160.4, 152.1, 148.3, 147.8, 145.4, 145.0, 141.9, 140.1, 131.7, 129.3, 129.1, 128.9, 128.3, 
124.4, 122.8, 120.4, 120.3, 115.5, 114.9, 102.0, 82.3, 61.1, 56.7, 54.7, 41.8, 40.2, 28.6, 
27.9, 27.0. UPLC-DAD-QTOF: C44H40N4O4F3 [M+H]
+ calcd.: 745.3002, found: 745.2998. 
Step 6: preparation of 3-((3-(bis(3,5-
bis(trifluoromethyl)phenyl)((trimethylsilyl)oxy)methyl)-5-(trifluoromethyl) 
phenyl)amino)-4-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-
yl)methyl) amino)cyclobut-3-ene-1,2-dione C11 
To a suspension of catalyst C10 (102 mg, 0.1 mmol, 1 equiv.) and DMAP (20 mg, 
0.15 mmol, 1.5 equiv.) in CH2Cl2 (0.2 mL) was added dropwise chlorotrimethylsilane (20 
μL, 0.15 mmol, 1.5 equiv.) and the reaction mixture was stirred for 14 h at room 
temperature. Then, CH2Cl2 (2 mL) was added and the organic layer was washed twice with 
water and HCl 1 M, dried over MgSO4 and the solvent was evaporated. The product was 
purified by column chromatography on silica gel (CH2Cl2: MeOH, 98:2) to give pure 
catalyst C11 as a yellow solid. Yield: 93.6 mg, 0.086 mmol, 86%. All spectroscopic data 
were identical to those reported in the literature.105 M.p. = 160 – 165 °C. 1H NMR (300 
MHz, MeOD) δ 8.74 (d, J = 4.6 Hz, 1H), 8.07 (t, J = 1.8 Hz, 1H), 8.00 (s, 6H), 7.98 – 7.92 
(m, 2H), 7.76 (d, J = 2.6 Hz, 1H), 7.71 – 7.63 (m, 2H), 7.41 (dd, J = 9.3, 2.5 Hz, 1H), 7.32 
(s, 1H), 6.34 (d, J = 11.4 Hz, 1H), 5.96 (ddd, J = 17.4, 10.4, 7.2 Hz, 1H), 5.27 – 5.06 (m, 
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2H), 4.04 (d, J = 10.3 Hz, 1H), 3.97 (s, 3H), 3.82 – 3.67 (m, 1H), 3.52 (dd, J = 13.4, 10.2 
Hz, 1H), 3.25 – 2.98 (m, 2H), 2.7 – 2.57(m, 1H), 1.37 – 1.11 (m, 2H), 1.02 – 0.87 (m, 1H), 
0.12 (s, 9H). 13C NMR (75 MHz, MeOD) δ 185.8, 181.3, 169.5, 166.0, 160.7, 149.1, 148.4, 
145.5, 143.8, 141.6, 140.7, 133.3, 132.8, 131.8, 129.4, 129.1, 126.3, 124.6, 123.3, 122.7, 
122.3, 120.4, 119.6, 119.1, 116.4, 115.9, 115.9, 101.7, 84.6, 61.2, 56.7, 56.1, 42.2, 39.4, 
28.4, 26.8, 26.3, 1.4. UPLC-DAD-QTOF: C42H22NO3F24 [M+H]
+ calcd.: 1044.1216, 
found: 1044.1239. 
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5.2.1.9. Preparation of catalysts C12108 and C13108 
These catalysts were prepared according to the following two-step sequence that involves 
a squaric ester monoamide intermediate. 
 
5.2.1.9.1. Preparation of common squaric ester monoamide intermediate109 
To a solution of 3,4-dimethoxy-3-cyclobute-1,2-dione (1.42 g, 10.0 mmol, 1 equiv.) in 
MeOH was added the corresponding aniline or benzyl amine (10 mmol, 1 equiv.). The 
reaction mixture was stirred at room temperature for 48 h. The formed precipitate was 
filtered and dried in vacuo to give the desired products. 
3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-methoxycyclobut-3-ene-1,2-dione 
The title compound was prepared from 3,5-
bis(trifluoromethyl)aniline. White solid. Yield: 2.23 g, 6.6 mmol, 
66%. All spectroscopic data were identical to those reported in 
literature.110 1H NMR (300, DMSO-d6) δ 11.18 (s, 1H), 8.04 (s, 
2H), 7.78 (s, 1H), 4.41 (s, 3H). 
3-((3,5-bis(trifluoromethyl)benzyl)amino)-4-methoxycyclobut-3-ene-1,2-dione 
The title compound was prepared from (3,5-
bis(trifluoromethyl)phenyl)methanamine. White solid. Yield: 2.68 
g, 7.6 mmol, 76%. All spectroscopic data were identical to those 
reported in literature.110 1H NMR (300, DMSO-d6) δ 11.18 (s, 1H), 
8.04 (s, 2H), 7.78 (s, 1H), 4.41 (s, 3H). 
  
                                                 
108 Alegre-Requena, J. V.; Marqués-López, E.; Herrera, R. P. RSC Adv. 2015, 5, 33450–33462. 
109 Yang, W.; Du, D. M. Org. Lett. 2010, 12, 5450–5453. 
110 Badiola, E.; Fiser, B.; Gómez-Bengoa, E.; Mielgo, A.; Olaizola, I.; Urruzuno, I.; García, J. M.; Odriozola, 
J. M.; Razkin, J.; Oiarbide, M.; Palomo, C. J. Am. Chem. Soc. 2014, 136, 17869–17881. 
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5.2.1.9.2. Synthesis of the (1R,2R)-2-(piperidin-1-yl)cyclohexan-1-amine111  
 
Glutaraldehyde (50 wt % in H2O, 1.90 mL, 10.4 mmol, 1.04 equiv.) was added dropwise 
into a mixture of diamine (1.140 g, 10 mmol, 1 equiv.), and NaBH(OAc)3 (8.5 g, 40 mmol, 
4 equiv.), in ClCH2CH2Cl (60 mL) at room temperature. The resulting mixture was stirred 
at room temperature for 3 hours, and quenched with NaOH aq solution (6 M, 30 mL). The 
organic layer was separated and the aqueous layer was extracted with CH2Cl2 (3 x 30 mL). 
The combined organic layers were concentrated. The residue was dissolved in 50 mL 
CH2Cl2, washed with brine (20 mL), dried over MgSO4, filtered, and concentrate to give 
1.6 g product as a yellow liquid. Yield: 1.61 g, 8.9 mmol, 89%. All spectroscopy data were 
identical to those reported in the literature. 1H NMR (300, CDCl3) δ 2.87 – 2.68 (m, 1H), 
2.67 – 2.49 (m, 3H), 2.41 – 2.19 (m, 2H), 2.16 – 1.92 (m, 2H), 1.88 – 1.34 (m, 8H), 1.31 – 
0.97 (m, 4H). 
5.2.1.9.3. Coupling to final squaramide 
 
To a solution of squaric ester monoamide (1.0 mmol, 1 equiv.) in 5 mL of CH2Cl2 was 
added 2-(piperidin-1-yl)ciclohexanamine (379 mg, 1.0 mmol, 1 equiv.). The reaction 
mixture was stirred for 48 hours at room temperature. After solvent evaporation the crude 
material was subjected to silica gel column chromatography (eluent CH2Cl2: MeOH, 98:2). 
3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-(((1S,2S)-2-(piperidin-1-
yl)cyclohexyl)amino)cyclobut-3-ene-1,2-dione C12 
The title compound was prepared from 3-((3,5-
bis(trifluoromethyl)phenyl)amino)-4-methoxycyclobut-3-ene-
1,2-dione. White solid. Yield: 347 mg, 0.7 mmol, 71%. All 
spectroscopic data were identical to those reported in literature.108 
1H NMR (300, CDCl3) δ 7.88 (s, 2H), 7.43 (s, 1H), 4.00 – 3.80 
                                                 
111 Zhu, Y.; Malerich, J. P.; Rawal, V. H. Angew. Chem. Int. Ed. 2010, 49, 153–156. 
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(m, 1H), 2.66 – 2.49 (m, 2H), 2.39 – 2.14 (m, 3H), 1.93 – 1.59 (m, 4H), 1.48 – 0.98 (m, 
10H). 
3-((3,5-bis(trifluoromethyl)benzyl)amino)-4-(((1S,2S)-2-(piperidin-1-
yl)cyclohexyl)amino)cyclobut-3-ene-1,2-dione C13 
The title compound was prepared from 3-((3,5-
bis(trifluoromethyl)benzyl)amino)-4-methoxycyclobut-3-ene-
1,2-dione. White solid. Yield: 301 mg, 0.6 mmol, 60%. All 
spectroscopic data were identical to those reported in 
literature.107 1H NMR (300, CDCl3) δ 7.91 (s, 2H), 7.40 (s, 1H), 
4.82 – 4.78 (m, 2H), 4.00 – 3.80 (m, 1H), 2.69 – 2.59 (m, 2H), 2.49 - 2.24 – 2.20 (m, 3H), 
1.90 – 1.58 (m, 4H), 1.45 – 0.98 (m, 10H). 
5.2.1.10. Preparation of catalysts C14112 and C15112 
These catalysts were prepared according to the following two-step sequence that involves 
a squaric ester monoamide intermediate. 
 
5.2.1.10.1. Preparation of common squaric ester monoamide intermediate113 
3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-methoxycyclobut-3-ene-1,2-dione 
To a solution of 3,4-dimethoxy-3-cyclobute-1,2-dione (1.42 g, 10.0 
mmol, 1 equiv.) in MeOH was added 3,5-bis(trifluoromethyl)aniline 
(2.29 g, 10 mmol, 1 equiv.). The reaction mixture was stirred at room 
temperature for 48 h. The formed precipitate was filtered and dried in 
vacuo to give the desired product as a white solid. Yield: 2.23 g, 6.6 mmol, 66%. All 
spectroscopic data were identical to those reported in literature. 1H NMR (300, DMSO-d6) 
δ 11.18 (s, 1H), 8.04 (s, 2H), 7.78 (s, 1H), 4.41 (s, 3H). 
  
                                                 
112 Badiola, E.; Olaizola, I.; Vázquez, A.; Vera, S.; Mielgo, A.; Palomo, C. Chem. Eur. J. 2017, 23, 8185–
8195. 
113 Yang, W.; Du, D. M. Org. Lett. 2010, 12, 5450–5453. 
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N-(3,5-bis(trifluoromethyl)phenyl)-3-nitro-5-(trifluoromethyl)benzamide114  
 
1-Methylimidazole (1.99 mL, 25 mmol, 2.5 equiv.) was added to a slurry of the 3-nitro-5-
(trifluoromethyl)benzoic acid (2.3 g, 10 mmol, 1 equiv.) in CH2Cl2 (25 mL) at 0 °C, and 
the mixture was stirred for 10 min. MsCl (1.16 mL, 15 mmol, 1.5 equiv.) in CH2CL2 (1 
mL) was added to the mixture under – 5 °C. After the mixture was stirred under that 
temperature for 20 min, 3,5-bis(trifluoromethyl)aniline (1.56 mL, 10 mmol, 1 equiv) was 
added. Then the mixture was stirred at room temperature for 2 hours. H2O (100 mL) was 
added to the mixture and a solid precipitated, which was solved with EtOAc (100 mL). The 
organic layer was washed with brine (3 x 50 mL) and dried with anhydrous MgSO4. The 
solvent was evaporated under reduced pressure and the crude was crushed with diethyl 
ether to afford the title product as a white solid. Yield: 4.5 g, 10 mmol, > 99%. 1H NMR 
(300 MHz, CD3OD) δ 9.10 (s, 1H), 8.72 (s, 2H), 8.43 (s, 2H), 7.72 (s, 1H). 13C NMR (75 
MHz, CD3OD) δ 164.9, 150.3, 141.9, 138.7, 134.3, 133.3, 131.6, 131.5, 127.5, 124.8, 
124.7, 121.7, 121.6, 118.7. UPLC-DAD-QTOF: C16H6F9N2O3 [M+H]
+ calcd.: 445.0235, 
found: 445.0233. 
3-Amino-N-(3,5-bis(trifluoromethyl)phenyl)-5-(trifluoromethyl)benzamide  
 
To a solution of the protected aniline (4.5 g, 10 mmol) in EtOH (20 mL) and EtOAc (2 mL) 
under inert atmosphere, Pd/C was added (450 mg, Pd 10% in activated carbon, 10% in 
weight). The reaction mixture was stirred under H2 atmosphere (1 atm) at room temperature 
for 20 h. After the solution was filtered over celite and the filtrate was concentrated under 
reduced pressure to afford the hydrogenated product. Yield: 4.2 g, 10 mmol, > 99%. 1H 
NMR (300 MHz, CD3OD) 8.40 (s, 2H), 7.77 (s, 1H), 7.68 (s, 1H), 7.49 – 7.42 (m, 1H), 
7.42 – 7.38 (m, 1H), 7.12 (s, 1H). 13C NMR (126 MHz, CD3OD) δ 168.4, 151.1, 142.3, 
                                                 
114 Adapted from: Mao, L.; Wang, Z.; Li, Y.; Han, X.; Zhou, W. Synlett 2011, 1, 129–133. 
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137.4, 133.3 (q), 132.4 (q), 121.5, 118.2, 117.8, 115.0, 115.0, 113.1, 113.1. UPLC-DAD-
QTOF: C16H10N2OF9 [M+H]
+ calcd.: 417.0649, found: 417.0638. 
N-(3,5-Bis(trifluoromethyl)phenyl)-3-((2-methoxy-3,4-dioxocyclobut-1-en-1-
yl)amino)-5-(trifluoromethyl)benzamide 
 
To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (711 mg, 5.0 mmol, 1 equiv.) in 
MeOH (10 mL) was added the free aniline (2.29 g, 5.5 mmol, 1.1 equiv.) at room 
temperature. The mixture was stirred at room temperature for 15 h. The white precipitate 
was filtrated and washed with MeOH. Obtained white solid was dried in vacuo to give the 
title product as a white solid. Yield: 2.31 g, 4.4 mmol, 88%. 1H NMR (300 MHz, Acetone-
d6) δ 10.71 (s, 1H), 10.52 (s, 1H), 8.03 (s, 2H), 7.73 (s, 1H), 7.64 (s, 1H), 7.59 (s, 1H), 7.39 
(s, 1H), 3.96 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 187.5, 184.4, 179.6, 169.2, 164.2, 
140.7, 139.5, 136.0, 130.5 (q), 129.5 (q), 125.0, 122.6, 121.4, 120.1, 119.1, 118.7, 116.8, 
60.8. UPLC-DAD-QTOF: C21H12F6N2O4F9 [M+H]
+ calcd.: 527.0653, found: 527.0655.  
5.2.1.10.2. Synthesis of the (S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-amine110 
 
Na2CO3 (2.12 g, 20 mmol, 2 equiv.) and Boc2O (3.3 g, 15 mmol, 1.5 equiv.) were added to 
a solution of tert-leucine (1.31 g, 10 mmol, 1 equiv.) in water (20 mL) an THF (5 mL) at 0 
°C. After stirring for 12 h at room temperature HCl (10 %) was added until pH 2 and the 
mixture was extracted with EtOAc (3 x 30 mL). The aquous phases were combined, washed 
with brine (50 mL) and dried over MgSO4. After removing the solvent under reduced 
pressure, the resulting residue was redissolved in dry DMF (20 mL) and DIPEA (2.6 g, 20 
mmol, 2 equiv.) and HBTU (5.7 g, 15 mmol, 1.5 equiv.) were added. After stirring for 1 h 
piperidine (0.94 g, 11 mmol, 1.1 equiv.) was added and the mixture was stirred for further 
16 h. The reaction was quenched adding HCl 1 M (20 mL) and the mixture was extracted 
with EtOAc (2 x 20 mL). The organic phases were combined and washed with HCl 1 M 
and brine (20 mL). The solvent was then removed under reduced pressure and the resulting 
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residue was purified by flash column chromatography on silica gel (eluting with hexane: 
EtOAc, 85:15) to afford tert-butyl (S)-(3,3-dimethyl-1-oxo-1-(piperidin-1-yl)butan-2-
yl)carbamate as a white solid. Yield: 1.6 g, 8.3 mmol, 83%. All spectroscopy data were 
identical to those reported in the literature.110 1H NMR (300 MHz, CDCl3) δ 0.98 (s, 9H), 
1.43 (s, 9H), 1.52 – 1.62(m, 6H), 3.46 – 3.69 (m, 4H), 4.54 (d, J = 9.7 Hz, 1H), 5.38 (d, J 
= 9.6 Hz, 1H). 
The previously obtained amide (1.6 g, 8 mmol, 1 equiv.) was dissolved in a mixture 
of CH2Cl2 (8 mL) and trifluoroacetic acid (2 mL) and stirred at 40 °C until no more starting 
material was observed by TLC (eluting with hexane: EtOAc, 70:30). The solvent was then 
removed under reduced pressure and the residue was redissolved in CH2Cl2 (10 mL). The 
solution was washed with NaOH (40 %), dried over MgSO4 and the solvent was removed 
under reduced pressure to afferd the aminoamide as a yellow oil. The aminoamide was then 
dissolved in dry diethyl ether (10 mL) and was added dropwise over a suspension of lithium 
aluminiumhydride (879 mg, 24 mmol, 3 equiv.) in diethyl ether (40 mL) at 0 °C under 
nitrogen atmosphere. The mixture was stirred at the same temperature for some minutes 
and afterwards it was stirred at room temperature for 16 h. The reaction was quenched by 
the addition of water (5 mL) and NaOH 15 % (1.2 mL) al 0 °C. The resulting mixture was 
filtered and the filtrate was extracted with diethyl ether (2 x 10 mL). The combined organic 
layers were dried over MgSO4 and the solvent was eliminated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (eluting with hexane: 
EtOAc, 1:1) to afford (S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-amine as yellow oil. 
Yield: 1.4 g, 7.4 mmol, 92%. 1H NMR (500 MHz, CDCl3) δ 2.66 (dd, J = 11.0, 2.5 Hz, 
1H), 2.52 (d, J = 12.3 Hz, 4H), 2.28 (dd, J = 12.3, 2.8 Hz, 3H), 2.13 (dd, J = 12.1, 11.2 Hz, 
1H), 1.61 – 1.53 (m, 4H), 1.44 – 1.42 (m, 2H), 0.90 (s, 9H). 
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5.2.1.10.3. Coupling to final squaramide 
 
To a solution of squaric ester monoamide (1.0 mmol, 1 equiv.) in 5 mL of MeOH was 
added (S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-amine (169 mg, 1.0 mmol, 1 equiv.). The 
reaction mixture was stirred for 48 hours at room temperature. The formed white precipitate 
was filtered and washed with CH2Cl2 to afford essentially pure the desired compounds.  
(S)-3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-((3,3-dimethyl-1-(piperidin-1-
yl)butan-2-yl)amino)cyclobut-3-ene-1,2-dione C14 
The title compound was prepared from 3-((3,5-
bis(trifluoromethyl)phenyl)amino)-4-methoxycyclobut-3-ene-
1,2-dione. White solid. Yield: 289 mg, 0.59 mmol, 59%. All 
spectroscopic data were identical to those reported in 
literature.110 1H NMR (300 MHz, CDCl3) δ 10.09 (s, 1H), 8.08 (s, 2H), 7.64 (s, 1H), 4.07 
– 3.93 (m, 1H), 2.49 – 2.04 (m, 5H), 1.51 – 1.22 (m, 6H), 0.93 (s, 9H). 
(S)-N-(3,5-bis(trifluoromethyl)phenyl)-3-((2-((3,3-dimethyl-1-(piperidin-1-yl)butan-
2-yl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(trifluoromethyl)benzamide C15 
The title compound was prepared from N-(3,5-
bis(trifluoromethyl)phenyl)-3-((2-methoxy-3,4-
dioxocyclobut-1-en-1-yl)amino)-5-
(trifluoromethyl)benzamide. White solid. Yield: 440 mg, 
0.65 mmol, 65%. All spectroscopic data were identical to 
those reported in literature.112 1H NMR (300 MHz, CDCl3) δ 
11.01 (s, 1H), 10.01 (s, 1H), 8.61 (s, 2H), 8.46 (s, 1H), 8.01 
(s, 1H), 8.00 (s, 1H), 7.61 (s, 1H), 7.56 (s, 1H), 4.02 – 3.98 (m, 1H), 2.51 – 2.47 (m, 2H), 
2.48 – 2.44 (m, 1H), 2.36 – 2.33 (m, 2H), 1.49 – 1.40 (m, 6H), 0.98 (s, 9H). 
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5.2.1.11. Preparation of ureidopeptide-based Brønsted base catalysts 
C16115, C17 and C18 
Ureidopeptide-based Brønsted base catalysts were prepared according to the following 
general scheme: 
 
5.2.1.11.1. Preparation of carbamate N-protected α-amino acids 
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3,3-dimethylbutanoic acid116 
 
To a stirred solution of L-tert-leucine (1.31 g, 10 mmol, 1 equiv.) in 10% aqueous Na2CO3 
(26 mL) and dioxane (10 mL), was slowly added at 0 °C a solution of the chloroformiate 
(1.26 mL, 10 mmol, 1 equiv.) in dioxane (30 mL). The mixture was stirred in an ice bath 
for 1 hour and the allowed to warm to room temperature and subsequently stirred at the 
same temperature for 15 hours, poured into water (100 mL) and extracted with Et2O (3 x 
50 mL). The aqueous layer was cooled in an ice bath and acidified with concentrated HCl, 
followed by extraction with EtOAc (3 x 50 mL) and washed with brine (5 x 50 mL). The 
combined extracts were dried over MgSO4 and concentrated to afford the product as a white 
solid. Yield: 3.53 g, 9.5 mmol, 95%. 1H NMR (300 MHz, CD3OD) δ 7.78 (d, J = 7.5 Hz, 
2H), 7.68 (d, J = 6.7 Hz, 2H), 7.39 (t, J = 7.5, 2H), 7.30 (dt, J = 7.5 Hz, 1.0, 2H), 4.50 (s, 
2H), 4.39 - 4.33 (m, 2H), 4.23 (t, J = 6.9 Hz, 1H), 4.05 (d, brs, 1H), 3.66 (s, 1H), 1.03 (s, 
9H). 
  
                                                 
115 Diosdado, S.; Etxabe, J.; Izquierdo, J.; Landa, A.; Mielgo, A.; Olaizola, I.; López, R.; Palomo, C. Angew. 
Chem. Int. Ed. 2013, 52, 11846–11851. 
116 Bain, J. D.; Wacker, D. A.; Kuo, E. E.; Chamberlin, A. R. Tetrahedron, 1991, 47, 2389–2400. 
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(S)-2-(((anthracen-9-ylmethoxy)carbonyl)amino)-3,3-dimethylbutanoic acid115 
 
Step 1: To a stirred solution of p-nitrophenylchloroformate (2.2 g, 11 mmol, 1.1 
equiv.) in dichloromethane (13.6 mL) was added pyridine (0.9 mL, 11 mmol, 1.1 equiv.). 
The white slurry was cooled to 0 oC, and alcohol (10 mmol, 1 equiv.) was added in several 
portions to keep the temperature at 0 oC. After completion of the addition, the mixture was 
allowed to warm to room temperature and stirred overnight. The reaction mixture was 
diluted with CH2Cl2 (40 mL) and subsequently washed with 1 M HCl (20 mL), water (20 
mL) and brine (20 mL). The organic layer was dried over MgSO4, filtered and concentred 
under reduced pressure. The residue was used in the next step without further purification, 
3.6 g, 10 mmol, 91% yield. 
Step 2: To a stirred solution of L-tert-leucine (1.31 g, 10 mmol, 1 equiv.) in 10 % 
aqueous Na2CO3 (26 mL), and dimethylformamide (10 mL) was slowly added at 0 
oC 
solution of the 4-nitrophenyl carbonate (3.6 g, 10 mmol, 1 equiv.) in dimethylformamide 
(30 mL). The mixture was stirred in an ice bath for 1 h and then allowed to warm to room 
temperature and subsequently stirred at the same temperature overnight, poured into H2O 
(100 mL) and extracted with Et2O (3 x 50 mL). The aqueous layer was cooled in an ice 
bath and acidified with concentrated HCl, followed by extraction with EtOAc (3 x 50 mL) 
and washed with brine (5 x 50 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (eluting with hexane: ethyl acetate, 80:20) to afford the (S)-
2-(((anthracen-9-ylmethoxy)carbonyl)amino)-3,3-dimethylbutanoic acid, 2.5 g, 7.2 mmol, 
72% yield. 1H NMR (300 MHz, CDCl3) δ 8.52 (s, 1H), 8.38 (d, J = 8.9 Hz,2H), 8.04 (d, J 
= 8.7 Hz, 2H), 7.65 – 7.54 (m, 2H), 7.53 – 7.46 (m, 2H), 6.18 (q, J = 12.1 Hz, 2H), 5.24 (d, 
J = 10.4 Hz, 1H), 4.28 (d, J = 10.2 Hz, 1H), 1.01 (s, 9H). 
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5.2.1.11.2. Preparation of α-amino acid derived isocyanates and coupling with 
amines117 
 
To a cooled solution of the corresponding N-protected dipeptide (5.0 mmol, 1 
equiv.) in dry THF (20 mL) were added isobutyl chloroformate (0.65 mL, 5.0 mmol, 
1.equiv.), and N-methylmorpholine (0.6 mL, 5.0 mmol, 1 equiv.) and the mixture was 
stirred at – 20 oC for 20 min. Then, a suspension of NaN3 (0.48 g in 5 mL of H2O, 7.5 
mmol, 1.5 equiv.) was added and the reaction mixture was stirred at the same temperature. 
After 30 min, the organic layer was separated, evaporated and the residue was dissolved in 
CH2Cl2 (30 mL), and washed with water (15 mL). The organic phase was dried over 
MgSO4, filtered and concentrated in vacuo to give a yellow oil which was dissolved in dry 
CH2Cl2 (10 mL). The resulting solution was heated at 40 
oC under nitrogen for 1-2 h. The 
reaction was monitored by IR analysis until disappearance of the azide band. After 
completion, the chiral amine was added (3.5 mmol, 0.7 equiv.) and the reaction mixture 
was stirred overnight at room temperature. The solvent was evaporated under reduced 
pressure and the residue was purified by flash column chromatography on silica gel 
(CH2Cl2: MeOH, 95:5). 
(9H-fluoren-9-yl)methyl ((S)-1-(3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)ureido)-2,2-dimethylpropyl)carbamate C16: 
The title compound was prepared from (s)-2-
((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-
3,3-dimethylbutanoic acid and 9-amino-(9-
deoxy)epihydroquinine according to the general 
procedure. White solid. Yield 1.9 g., 2.9 mmol, 
58%. All data were consisted with those 
previously reported.115 1H NMR (300 MHz, 
CDCl3) δ 8.59 (d, J = 4.0 Hz, 1H), 7.97 (d, J = 9.2 Hz, 1H), 7.76 (d, J = 7.5 Hz, 2H), 7.70 
(d, J = 1.7 Hz, 1H), 7.55 (t, J = 8.1 Hz, 2H), 7.43 – 7.24 (m, 6H), 6.35 (s, 1H), 5.25 (s, 1H), 
5.17 – 4.90 (m, 3H), 4.40 (dd, J = 10.5, 7.2 Hz, 1H), 4.30 (dd, J = 10.5, 6.8 Hz, 1H), 4.18 
                                                 
117 Procedure adapted from: Suresh Babu, V. V.; Patil, B. S.; Venkataramanarao, R. J. Org. Chem. 2006, 71, 
7697–7705.  
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(d, J = 6.5 Hz, 1H), 3.93 (s, 3H), 3.21 (dd, J = 16.5, 6.7 Hz, 2H), 3.03 (s, 1H), 2.76 – 2.59 
(m, 1H), 2.44 (d, J = 11.5, 1H), 1.64 – 1.15 (m, 8H), 0.86 (s, 9H), 0.78 (t, J = 7.3, 3H). 
Anthracen-9-ylmethyl ((S)-1-(3-((S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-
yl)ureido)-2,2-dimethylpropyl)carbamate C17: 
The title compound was prepared from (S)-2-
(((anthracen-9-ylmethoxy)carbonyl)amino)-3,3-
dimethylbutanoic acid and (S)-3,3-dimethyl-1-
(piperidin-1-yl)butan-2-amine according to the general 
procedure. The catalyst was purified by filtration affording a white solid. Yield: 1.6 g., 3.0 
mmol, 61%. M.p. = 146 – 148 °C. [α]D25 = – 57.2º (c = 1, CH2Cl2). 1H NMR (300 MHz, 
DMSO-d6) δ 8.67 (s, 1H), 8.38 (d, J = 8.5 Hz, 2H), 8.12 (dd, J = 7.9, 1.8 Hz, 2H), 7.65 – 
7.43 (m, 4H), 7.28 (d, J = 9.2 Hz, 1H), 6.05 (q, J = 12.3 Hz, 2H), 5.87 (dd, J = 13.3, 9.6 
Hz, 1H), 5.20 (t, J = 9.3 Hz, 1H), 3.54 (td, J = 9.2, 3.7 Hz, 1H), 2.42 – 1.93 (m, 6H), 1.40 
(t, J = 5.7 Hz, 4H), 1.33 – 1.26 (m, 2H), 0.81 (s, 18H). 13C NMR (75 MHz, DMSO-d6) δ 
157.1, 155.6, 130.9, 130.5, 128.9, 128.5, 127.4, 126.5, 125.2, 124.1, 64.9, 60.1, 57.7, 54.2, 
53.7, 36.2, 34.6, 26.4, 25.5, 24.1. UPLC-DAD-QTOF: C33H46NO4O3 [M+H]
+ calcd.: 
546.3570, found: 546.3583. 
Anthracen-9-ylmethyl ((1S)-2,2-dimethyl-1-(3-((2S)-2-(piperidin-1-
yl)cyclohexyl)ureido)propyl)carbamate C18: 
The title compound was prepared from (S)-2-
(((anthracen-9-ylmethoxy)carbonyl)amino)-3,3-
dimethylbutanoic acid and (1R,2R)-2-(piperidin-1-
yl)cyclohexan-1-amine according to the general 
procedure. The catalyst was purified by filtration 
affording a white solid. Yield: 1.7 g., 3.1 mmol, 63%. M.p. = 146 – 148 °C. [α]D25 = + 65.5 
(c = 1, CH2Cl2). 
1H NMR (300 MHz, DMSO-d6) δ 8.69 (s, 1H), 8.33 (d, J = 8.5 Hz, 2H), 
8.13 (dd, J = 7.9, 1.8 Hz, 2H), 7.66 – 7.44 (m, 4H), 7.28 (d, J = 9.2 Hz, 1H), 6.10 (q, J = 
12.3 Hz, 2H), 5.97 – 5.89 (m, 1H), 5.20 (t, J = 9.3 Hz, 1H), 3.56 (td, J = 9.2, 3.7 Hz, 1H), 
2.45 – 1.98 (m, 6H), 1.47-1.49 (m, 4H), 1.33 – 1.26 (m, 1H), 0.81 (s, 18H). 13C NMR (75 
MHz, DMSO-d6) δ 157.43, 155.81, 130.94, 130.50, 128.91, 128.55, 127.42, 126.53, 
125.24, 124.15, 67.14, 65.98, 57.84, 54.97, 49.16, 48.64, 35.80, 33.18, 25.99, 25.41, 24.96, 
24.67, 24.37, 24.25, 24.01, 23.84, 22.89.UPLC-DAD-QTOF: C33H44N4O3 [M+H]
+ calcd.: 
544.3413, found: 544.3333. 
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5.3. Experimental section of Chapter 3 
5.3.1. Synthesis of maloimides 
5.3.1.1. Synthesis of 1, 2 and 3 
 
A solution of the corresponding (thio)malonate or (thio)malonamide(3 mmol, 1 equiv.), 
benzyl bromide (0.35 mL, 3 mmol, 1 equiv.) and sodium hydride (72 mg, 3.6 mmol, 1.2 
equiv.) in THF (10 mL) were added and the mixture was stirred at room temperature for 20 
h. Then, the mixture was cooled at room temperature, diluted with EtOAc and washed with 
brine (6 x 40 mL). Drying with MgSO4 filtration and evaporation gave the corresponding 
crude product that was purified by flash column chromatography. 
2-Benzyl-N1,N3-diphenylmalonamide 1: 
The title compound was prepared from N1,N3-
diphenylmalonamide. The product was purified by flash 
column chromatography on silica gel (hexane: EtOAc, 6:1) and 
obtained as a white foam. Yield: 774 mg. 2.2 mmol, 75%. All 
data were consistent with those previously reported.118 1H NMR 
(300 MHz, DMSO-d6) δ 9.97 (brs, 2H), 7.65 – 7.47 (m, 4H), 7.37 – 7.24 (m, 8H), 7.19 (d, 
J = 6.9 Hz, 1H), 7.10 – 6.95 (m, 2H), 3.85 (t, J = 7.5 Hz, 1H), 3.25 (d, J = 7.6 Hz, 
2H).UPLC-DAD-QTOF: C22H20N2O2 [M+H]
+ calcd.: 344.1525, found: 344.1672. 
Methyl 2-benzyl-3-oxo-3-(phenylamino)propanoate 2: 
The title compound was prepared from methyl 3-oxo-3-
(phenylamino)propanoate. The product was purified by flash 
column chromatography on silica gel (hexane: EtOAc, 10:1) and 
was obtained as a yellow oil. Yield: 594 mg, 2.1 mmol, 71%. 1H 
NMR (300 MHz, CDCl3) δ 8.37 (brs, 1H), 7.55 – 7.44 (m, 2H), 
7.39 – 7.10 (m, 8H), 3.69 (s, 3H), 3.70 – 3.58 (m, 1H), 3.47 – 3.20 (m, 2H). 13C NMR (75 
                                                 
118 Kappe, T.; Karem, A. S.; Stadlbauer, W. J. Heterocyclic Chem. 1988, 25, 857–862. 
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MHz, CDCl3) δ 165.2, 162.4, 136.0, 135.9, 129.8, 129.4, 129.2, 128.5, 128.4, 67.8, 48.3, 
37.3. UPLC-DAD-QTOF: C17H17NO3 [M+H]
+ calcd.: 283.1208, found: 283.1467. 
5.3.1.1.1. Synthesis of o-methyl 2-benzyl-3-(phenylamino)-3-
thioxopropanethioate 3: 
 
A solution of methyl 2-benzyl-3-oxo-3-(phenylamino)propanoate 2 (283 mg, 1 
mmol, 1 equiv.) and Lawesson's reagent [2,4-bis(4-methoxyphenyl)-1,3,2,4-
dithiadiphosphetane-2,4-disulphide] (176 mg, 4 mmol, 4 equiv.) in anhydrous toluene (10 
mL) were heated at reflux under nitrogen for 20 h. After completion, the solvent was 
evaporated under reduced pressure and the residue was purified by flash column 
chromatography on silica gel (hexane: EtOAc, 3:1) to afford the O-methyl 2-benzyl-3-
(phenylamino)-3-thioxopropanethioate 3 as a yellow foam, 94 mg, 0.3 mmol, 31% yield. 
1H NMR (300 MHz, CDCl3) δ 10.25 (brs, 1H), 7.69 – 7.51 (m, 2H), 7.50 – 7.13 (m, 8H), 
4.26 (dd, J = 8.5, 6.0 Hz, 1H), 3.68 (s, 3H), 3.44 (dd, J = 18.4, 7.2 Hz, 2H).13C NMR (75 
MHz, CDCl3) δ 171.6, 166.8, 129.5, 129.4, 125.6, 125.5, 125.3, 119.7, 119.6, 119.4, 74.1, 
56.6, 22.6. UPLC-DAD-QTOF: C17H17NOS2 [M+H]
+ calcd.:315.0752, found:315.1179. 
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5.3.1.2. Synthesis of 4, 5 and 6 
 
Step 1: 
N1,N1,N3,N3-tetraethylmalonamide 4 (0.21 mL, 1 mmol, 1 equiv.) and Lawesson's reagent 
[2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulphide] (484 mg, 1.2 
mmol, 1.2 equiv.) in anhydrous toluene (10 mL) were heated at reflux under nitrogen for 
20 h. After completion, the solvent was evaporated under reduced pressure and the residue 
was purified by flash column chromatography on silica gel (hexane: EtOAc, 3:1) to afford 
the 3-(diethylamino)-N,N-diethyl-3-thioxopropanamide 5 as a yellow foam, 78 mg, 0.7 
mmol, 72% yield. 1H NMR (300 MHz, CDCl3) δ 4.03 – 3.72 (m, 4H), 3.73 (q, J = 7.2 Hz, 
2H), 3.50 (q, J = 7.2 Hz, 2H), 3.41 (q, J = 7.1 Hz, 2H), 1.34 – 1.22 (m, 9H), 1.15 (t, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 195.10, 53.65, 48.19, 47.36, 13.81, 11.08. UPLC-
DAD-QTOF: C7H14N2OS [M+H]
+ calcd.: 174.0827, found: 174.1727. 
Step 2: 
To a solution of 5 (87 mg, 0.5 mmol, 1 equiv.) in anhydrous toluene (5 mL) 
Lawesson's reagent (808 mg, 2 mmol, 4 equiv.) was added. The reaction was heated at 
reflux under nitrogen for 20 h. After completion, the solvent was evaporated under reduced 
pressure and the residue was purified by flash column chromatography on silica gel 
(hexane:EtOAc, 3:1) to afford the N1,N1,N3,N3-tetraethylpropanebis(thioamide) 6 as a 
yellow oil, 122 mg, 0.41 mmol, 82% yield. All data were consistent with those previously 
reported.119 1H NMR (300 MHz, CDCl3) δ 4.28 (s, 2H), 4.03 (q, J = 7.1 Hz, 4H), 3.90 – 
3.81 (m, 4H), 1.33 (td, J = 7.2, 1.6 Hz, 12H). 
  
                                                 
119 Hartke, K.; Heinz-Georg, M. Arch. Pharm. 1988, 321,863–871. 
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5.3.1.3. Synthesis of 7 and 8 
5.3.1.3.1. Synthesis of 7 
 
To a solution of malonic acid (2.1 g, 20 mmol, 1 equiv.) SOCl2 was added (3 mL, 40 mmol, 
2 equiv.) and the mixture was heated at reflux under nitrogen for 2 h. After completion the 
excess SOCl2 was evaporated under reduced pressure and the residue was dissolved in Et3N 
(7 mL, 50 mmol, 2.5 equiv.) and phenyl amine (5.5 mL, 60 mmol, 3 equiv.) was added 
dropwise at 0 °C. After completion of coupling reaction, the mixture was diluted in DCM 
(15 mL) and acidified with HCl 3 M to pH 2, the aqueous phase was then extracted with 
dichloromethane (3 x 150 mL), dried over MgSO4 and concentrated under reduced 
pressure. The solid obtained was filtered and the filtrate was washed with diethyl ether. 
N1,N3-diphenylmalonamide 7 was obtained as a white foam. Yield: 3.0 g, 11.8 mmol, 59 
%. All data were consistent with those previously reported.120 1H NMR (300 MHz, DMSO-
d6) δ 10.19 (brs, 2H), 7.69 – 7.54 (m, 4H), 7.32 (dd, J = 8.5, 7.3 Hz, 4H), 7.08 (d, J = 7.3 
Hz, 2H), 3.49 (s, 2H). 
5.3.1.3.2. Synthesis of 8 
 
To a solution of commercially available methyl 3-chloro-3-oxopropanoate (1.18 mL, 11 
mmol, 1.1 equiv.) in DCM (30 mL), Et3N (2.8 mL, 20 mmol, 2 equiv.) and phenyl amine 
(0.9 mL, 10 mmol, 1 equiv.) were added at 0 °C and the mixture was stirred for 20 h. After 
reaction completion, the solvent was evaporated under reduced pressure and the residue 
was purified by flash column chromatography on silica gel (hexane: EtOAc, 5:1) to afford 
methyl 3-oxo-3-(phenylamino)propanoate 8 as a yellow foam. Yield: 1.9 g, 9.8 mmol, 98% 
yield. All data were consistent with those previously reported.121 1H NMR (300 MHz, 
CDCl3) δ 9.19 (brs, 1H), 7.66 – 7.47 (m, 2H), 7.39 – 7.23 (m, 2H), 7.13 (dd, J = 7.5, 1.4 
Hz, 1H), 3.83 – 3.73 (m, 3H), 3.48 (s, 2H). 
                                                 
120 Echi, M.; Azzena, U.; Delussu, M. P.; Dalloccio, R.; Dessi, A.; Cosseddu, A.; Pala, N.; Neamati, N. 
Molecules, 2008, 13, 2442–2461. 
121 Abas, H.; Frampton, C. S.; Spivey, A. C. J. Org. Chem. 2016, 81, 9947–9956. 
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5.3.2. Synthesis of barbituric acid derivative 9 and 12:122 
5.3.2.1. Synthesis of diethyl 2-allylmalonate 
 
Diethyl malonate (5.9 mL, 37.5 mmol, 1.5 equiv.) and allyl bromide (2.16 mL, 25 mmol, 
1 equiv.) were added to a solution of potassium carbonate (17.27 g, 75 mmol, 3 equiv.) in 
acetone (124 mL) and the mixture was stirred for 24 h at 23 °C. The reaction mixture was 
quenched by addition of saturated aqueous ammonium chloride solution (200 mL) and 
extracted with methylene chloride (3 x 100 mL). The combined organic layers were dried 
over sodium sulphate and the solvent was removed under reduced pressure. The oily 
residue was purified by flash-chromatography through silica gel (Hexane: ethyl acetate 
99:1). The product containing fractions were evaporated and the oily residue was distillated 
under reduced pressure (2 mbar, 45 °C, rotary evaporator/heat gun) to remove the excess 
of diethyl malonate. Diethyl 2-allylmalonate was obtained as a colorless oil (6.8 g, 24.0 
mmol, 90%). All the analytical data are consistent with the previously published data.122 
1H NMR (300 MHz, CDCl3) 5.78 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.15 – 5.03 (m, 2H), 
4.19 (dd, J = 7.2, 1.0 Hz, 4H), 3.45 – 3.34 (m, 1H), 2.71 – 2.56 (m, 3H), 1.27 (d, J = 7.2Hz, 
6 H). 
5.3.2.2. Synthesis of monosustituted thioureas 
 
To a solution of 30% aqueous ammonium (6 mL) was added the corresponding isocyanate 
(6 mmol) at room temperature. The mixture was stirred at room temperature for 16 h. The 
product precipitated as a white solid which was filtrated and the filtrate was washed with 
MeOH and the solid residue was dried in vacuo.  
  
                                                 
122 Reproduced of: Klahn, P.; Erhardt, H.; Kotthaus, A.; Kirsch, F. Angew. Chem. Int. Ed. 2014, 53, 7913–
7917. 
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1-(3,5-Bis(trifluoromethyl)phenyl)thiourea  
Prepared according to the general procedure starting from bis(3,5-
trifluoro-methyl)phenylisothiocyanate. M.p: 180 – 185 °C. Yield: 
1.7 g, 5.8 mmol, 98%. 1H NMR (300 MHz, acetone) δ 9.67 (s, 1H), 
8.41 (s, 2H), 7.77 (s, 1H), 7.38 (bs, 2H).13C NMR (75 MHz, 
acetone) δ 184.3, 143.2, 132.2, 126.6, 124.0, 123.9, 122.9, 118.3, 118.3. UPLC-DAD-
QTOF: calcd. for C9H7N2SF6 [M+H]
+, 289.0243; found ,289.0234.  
1-Benzylthiourea  
Prepared according to the general procedure starting from 
benzylisothiocyanato. M.p: 217 – 220 °C. Yield: 6.0 g, 6 mmol, > 
99%. 1H NMR (300 MHz, CDCl3) δ 7.38 (m, 5H), 5.67 (bs, 1H), 4.72 
(s, 2H). UPLC-DAD-QTOF: calcd for C8H11N2S (M, H
+), 167.0641; found, 167.0643. 
1-Pentylthiourea  
Prepared according to the general procedure starting from 
pentylisothiocyanato. M.p: 234 – 236 °C. Yield: 790 mg, 6 mmol, > 99%. 
1H NMR (300 MHz, CDCl3) δ 3.16 (t, 2H), 1.61 (m, 2H), 1.35 – 1.30 (m, 
4H), 0.95 (t, 3H).MS (ESI, m/z): calcd for C6H11N2S (M, H
+), 129.0612; found, 129.17413. 
5.3.2.3. Coupling of thioureas with malonic esters123 (synthesis of 12) 
 
In a 250 mL round-bottom flask fitted with a reflux condenser protected with a calcium 
chloride tube, sodium metal was placed 1.150 g (50 mmol, 1 equiv.) and 20 mL of 
anhydrous MeOH. The mixture was stirred until all the sodium disappeared. Then a 
solution of the respective N-alkyl or N-aryl thiourea (50 mmol, 1 equiv.) in 20 mL of 
anhydrous MeOH,(warming was required in order to set thioureas completly dissolved) 
was added, followed by a dropwise addition of the corresponding malonate ( 50 mmol, 1 
equiv.). The mixture was refluxed for 16 h. A white solid formed rapidly. After the reaction 
                                                 
123 Addapted from: Puig-de-la-Bellacasa, R.; Giménez , G.; Pettersson , S.; Gonzalo, P.; Esté , J. A.; Clotet , 
B.; Borrell, J. I. Eur. J. Med. Chem., 2012, 54, 159–174. 
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was completed, 100 mL of hot (50 °C) water was added and then enough hydrochloric acid 
(2 M) to make the solution acidic. The precipitate was washed with MeOH and dried at 
vacuum (735 mmHg) in a bath at 80 °C. 
1, 5-Dimethyl-2-thioxodihydropyrimidine-4,6 (1H,5H)-dione (12Aa) 
Prepared according to the general procedure starting from 1-
methylthiourea and diethyl 2-methylmalonate. The title compound was 
obtained as a white solid. M.p: 211 – 212 °C. Yield: 5.5 g, 32 mmol, 64%. 
1H NMR (300 MHz, CDCl3) δ 12.78 (s, 1H), 3.91 (s, 3H), 2.92 (p, J = 1.8 
Hz, 1H), 2.18 (s, 3H).13C NMR (75 MHz, DMSO-d6) δ 173.4, 162.7, 155.9, 89.6, 33.2, 
8.3. UPLC-DAD-QTOF: calcd for C6H9N2O2S (M, H
+), 173.0385; found, 173.0387. 
1-Benzyl-5-methyl-2-thioxodihydropyrimidine-4,6(1H,5H) (12Ab)  
Prepared according to the general procedure starting from 1-
benzylthiourea and diethyl 2-methylmalonate. The title compound 
was obtained as a white solid. M.p: 148 – 151 °C. Yield: 10.5 g, 
42.5 mmol, 85%. 1H NMR (300 MHz, MeOD) δ 7.29 – 7.26 (m, 
5H), 5.65 (s, 2H), 1.88 (s, 3H). 13C NMR (75 MHz, MeOD) δ 175.9, 165.4, 158.1, 138.1, 
129.1, 129.1, 128.7, 128.7, 128.0, 91.4, 50.3, 8.01. UPLC-DAD-QTOF: calcd for 
C12H13N2O2S: 249.0698; found, 249.0702. 
5-Metil-1-pentil-2-tioxodihidropirimidin-4,6(1H,5H)-diona (12Ac) 
Prepared according to the general procedure from the 1-pentylthiourea 
and diethyl 2-methylmalonate. The title compound was obtained as a 
white solid. M.p: 176 – 177 °C. Yield: 9.5 g, 41.5 mmol, 83%. 1H NMR 
(300 MHz, CDCl3) δ 9.29 (s, 1H), 4.59 (m, 2H), 3.52 (q, 1H), 1.66 (m, 
2H), 1.62 (d, 3H), 1.34 (m, 4H), 0.90 (t, 3H). 13C NMR (75 MHz, CDCl3) δ 178.6, 167.8, 
166.1, 47.2, 44.9, 28.9, 26.8, 22.4, 14.1, 13.6. UPLC-DAD-QTOF: calcd for C10H17N2O2S: 
229.1011; found, 229.1012. 
5-Methyl-1-phenyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (12Ad) 
Prepared according to the general procedure starting from 1-
phenylthiourea and diethyl 2-methylmalonate. The title compound was 
obtained as a white solid. M.p: 173 – 175 °C. Yield: 8.5 g, 36.5 mmol, 
73%. 1H NMR (300 MHz, DMSO-d6) δ 12.37 (s, 1H), 7.47 – 7.33 (m, 
4H), 7.13 (d, J = 8.0 Hz, 2H), 3.17 (s, 3H). 13C NMR (75 MHz, DMSO-
d6) δ 174.21, 162.91, 156.66, 139.77, 128.88, 128.76, 127.78, 89.97, 48.59, 8.14.UPLC 
(DAD-QTOF [M+H]+) MS (ESI, m/z): calcd for C10H10N2O2S: 234.0463; found, 234.0476. 
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1-(3,5-Bis(trifluoromethyl)phenyl)-5-methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-
dione (12Ae)  
Prepared according to the general procedure starting from 1-(3,5-
bis(trifluoromethyl)phenyl)thiourea and diethyl 2-methylmalonate. 
The title compound was obtained as a white solid. M.p: 165 – 170 
°C Yield: 13.1 g, 35.5 mmol, 71%. 1H NMR (300 MHz, DMSO-
d6) δ 12.66 (s, 1H), 8.13 (s, 1H), 8.04 (d, J = 1.6 Hz, 2H), 1.79 (s, 
3H). 13C NMR (75 MHz, DMSO-d6) δ 174.2, 162.8, 157.3, 141.9, 
131.0, 130.9, 130.6, 124.9, 121.8, 121.3, 90.0, 8.2 .UPLC-DAD-QTOF: calcd for 
C13H9N2O2SF6: 371.0289; found, 371.0284. 
5-Ethyl-1-methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (12Ba) 
Prepared according to the general procedure starting from 1-
methylthiourea and diethyl 2-ethylmalonate. The title compound was 
obtained as a white solid. M.p: 164 – 165 °C. Yield: 10.3 g, 50 mmol, > 
99%. 1H NMR (300 MHz, CDCl3) δ 9.04 (s, 1H), 3.64 (s, 3H), 3.51 (t, J 
= 5.3 Hz, 1H), 2.22 (qd, J = 7.4, 5.4 Hz, 2H), 0.99 (t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 173.6, 162.4, 155.6, 96.1, 33.3, 15.8, 13.2. UPLC-DAD-QTO: calcd for 
C7H11N2O2S (M, H
+), 187.0541; found, 187.0539. 
5-Benzyl-1-methyl-2-thoxodihydropyrimidine-4,6( 1H,5H)-dione (12Ca) 
Prepared according to the general procedure starting from 1-
methylthiourea and diethyl 2-benzylmalonate. The title compound 
was obtained as a white solid. M.p: 163 – 164 °C. Yield: 4.3 g, 36.5 
mmol, 73%. 1H NMR (300 MHz, DMSO-d6) δ 12.17 (s, 1H), 7.34 – 
7.00 (m, 5H), 3.64 (s, 2H), 3.49 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 173.71, 162.32, 
156.74, 140.5 127.99, 127.92, 125.58, 93.35, 33.17, 27.88. UPLC-DAD-QTOF: calcd for 
C12H13N2O2S (M, H
+), 249.0698; found, 249.0694. 
5-Isobutyl-1-methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (12Da) 
Prepared according to the general procedure starting from 1-
methylthiourea and diethyl 2-isobutylmalonate. The title compound 
was obtained as a white solid. M.p: 107 – 111 °C. 5.2 g, 48.5 mmol, 
97%.1H NMR (400 MHz, DMSO-d6) δ 12.24 (s, 1H), 3.50 (s, 3H), 
2.20 (d, J = 7.3 Hz, 2H), 1.84 – 1.71 (m, 1H), 0.83 (d, J = 6.6 Hz, 6H).13C NMR (75 MHz, 
DMSO-d6) δ 12.34, 7.37, 7.36, 7.34, 7.29, 7.29, 7.29, 7.28, 3.56.UPLC-DAD-QTOF: calcd 
for C9H15N2O2S (M, H
+),215.0854; found, 215.0857. 
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5-Isopropyl-1-methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (12Ea) 
Prepared according to the general procedure starting from 1-methylthiourea 
and diethyl 2-isopropylmalonate. The title compound was obtained as a 
white solid. M.p: 94 – 95 °C. Yield: 2.3 g, 45 mmol, 90%. 1H NMR (300 
MHz, CDCl3)
 δ 9.43 (s, 1H), 3.65 (s, 3H), 3.42 (d, J = 4.1 Hz, 1H), 2.65 
(qt, J = 7.0, 3.5 Hz, 1H), 1.14 (dd, J = 7.0, 3.0 Hz, 6H).13C NMR (75 MHz, CDCl3) δ 
179.09, 167.64, 165.67, 55.76, 34.68, 33.53, 19.60, 19.47.UPLC-DAD-QTOF: calcd for 
C8H13O2S (M, H
+), 201.0698; found, 201.0700. 
5-Allyl-1-methyl-2-thioxodihydropyrimidine-4,6 (1H,5H)-dione (12Fa) 
Prepared according to the general procedure starting from 1-
methylthiourea and diethyl 2-allylmalonate. The title compound was 
obtained as a white solid. M.p: 171 – 173 °C. Yield: 3.3 g, 35 mmol, 
71%. 1H NMR (300 MHz, CDCl3) δ 9.15 (s, 1H), 5.70 (ddt, J = 17.2, 
10.1, 7.2 Hz, 1H), 5.23 – 5.11 (m, 2H), 3.62 (s, 4H), 2.95 – 2.89 (m, 2H).13C NMR (75 
MHz, DMSO-d6) δ 173.7, 162.1, 156.1, 135.4, 114.5, 92.0, 33.2, 26.1. UPLC-DAD-
QTOF: calcd for C8H11N2O2S (M, H
+), 199.0542; found, 199.0542. 
5.3.2.4. Synthesis of barbituric acid 9 
1,5-Dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (9) 
The same procedure employed for the synthesis of thiobarbiturates was 
used except that N-methyl urea (450 mg, 5 mmol) was used as the 
coupling partner with diethyl 2-methylmalonate. The title compound 
was obtained as a white solid. M.p: 213 – 216 °C. Yield: 500 mg, 3.2 
mmol, 63%. 1H NMR (300 MHz, CDCl3) δ 7.92 (s, 1H), 3.48 (q, J = 7.5 Hz, 1H), 3.29 (s, 
3H), 1.63 (d, J = 7.5 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 171.2, 170.3, 152.3, 44.7, 
28.2, 13.1. UPLC-DAD-QTOF: calcd for C6H9N2O3 (M, H
+), 157.0613; found, 157.0614. 
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5.3.3. Synthesis of N,N`-disubstituted (thio)barbituric acid derivatives 
10 and 11 
5.3.3.1. Synthesis of N-benzyl-N-methyl urea and thiourea124 
 
To a solution of aqueous methyl amine (6 mL) was added the corresponding N-benzyl 
isocyanate or thioisocyanate (6 mmol) at room temperature, and the mixture was stirred for 
15 h. The white precipitate was filtered and washed with MeOH. The solid was dried in 
vacuo and the products used in the next step without further purification. 
1-Benzyl-3-methylurea 
White solid. M.p: 72 – 74 °C. Yield: 0.95 g, 5.8 mmol, 97%. 1H 
NMR (300 MHz, CDCl3) δ 7.31 – 7.26 (m, 5H), 5.38 (brs, 1H), 5.02 
(bs, 1H), 4.32 (s, 2H), 2.70 (s, 2H). 13C NMR (75 MHz, CDCl3) δ 
159.2, 139.4, 128.5, 127.7, 127.1, 44.3, 27.0. MS (ESI, m/z): calcd for C9H13N2O (M, H+), 
165.1030; found, 165.1028. 
1-Benzyl-3-methylthiourea 
Yellow solid. M.p: 67 – 68 °C. Yield: 1.08 g, 6 mmol, > 99%. 1H 
NMR (300 MHz, CDCl3) δ 7.40 – 7.32 (m, 5 H), 7.30 (brs, 1 H), 
4.82 (d, J = 5.0 Hz, 2H), 2.59 (s, 3 H). MS (ESI, m/z): calcd for 
C9H13N2S (M, H+), 181.0800; found, 181.0799. 
  
                                                 
124 Reproduced from: Klahn, P.; Erhardt, H.; Kotthaus, A.; Kirsch, F. Angew. Chem. Int. Ed. 2014, 53, 7913–
7917. 
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5.3.3.2. Condensation of N,N´disustituted (thio)ureas with diethyl 
methylmalonate 
 
In a 250 mL round-bottom flask fitted with a reflux condenser and protected with a calcium 
chloride tube, sodium metal was placed (1.2 g, 50 mmol, 1 equiv.) and then 20 mL of 
anhydrous iPrOH. The mixture was stirred until all the solid sodium disappeared. Then a 
solution of N-benzyl-N´-methyl (thio)urea (50 mmol, 1 equiv.) in 20 mL of anhydrous 
iPrOH, (warming was required in order the (thio)urea to get completely dissolved ) was 
added followed by a dropwise addition of diethyl methylmalonate (50 mmol, 1 equiv.). The 
mixture was refluxed for 16 h, and a white solid formed rapidly. After the reaction was 
completed, 100 mL of hot (50 °C) water was added and then enough hydrochloric acid (2 
M) to make the solution acidic. The precipitate was washed with MeOH and dried in 
vacuum (735 mmHg) at 80 °C.  
1-benzyl-3,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (10) 
White solid. M.p: 97 – 98 °C. Yield: 8.0 g, 32.5 mmol, 65%. 1H NMR 
(300 MHz, acetone) (enolic form) δ 7.59 – 7.19 (m, 5H), 5.03 (d, J = 3.8 
Hz, 2H), 3.22 (s, 3H), 1.55 (s, 3H).13C NMR (75 MHz, acetone) δ 170.5, 
170.3, 153.2, 138.5, 129.5, 128.5, 45.9, 13.6. UPLC-DAD-QTOF: calcd 
for C13H15N2O3 (M, H+), 247.1083; found, 247.1082. 
1-Benzyl-3,5-dimethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (11) 
White solid. M.p: 109 – 110 °C. Yield: 72%. 1H NMR (300 MHz, 
acetone) (enolic form) δ 7.41 – 7.20 (m, 4H), 5.62 (s, 2H), 3.62 (s, 3H), 
1.58 (s, 3H).13C NMR (75 MHz, acetone) δ: 205.7, 138.1, 129.4, 128.8, 
128.2, 51.8, 36.3, 12.6. UPLC-DAD-QTOF : calcd for C13H15N2O2S (M, 
H+),263.0851; found, 263.0854. 
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5.3.4. Synthesis of 2-pyrimidine-4,6(1H,5H)-diones125 13 
 
To a suspension of the corresponding thiobarbituric acid derivative 12 (10 mmol, 1 equiv.) 
in a mixture of water (10 mL) and dioxane (26 mL) a solution of sodium hydroxide (813 
mg, 20 mmol, 2 equiv.) in 15 mL of water was added dropwise. The mixture was stirred 
until the mixture became completly homogeneous. Then, a solution of benzyl chloride (3.45 
mL, 30 mmol, 3 equiv.) in dioxane 5 mL was added. The mixture was stirred at room 
temperature for 16 h. After the reaction was completed, enough hydrochloric acid (4 M) to 
make the solution acidic was added and the precipitate was filtered and washed with MeOH 
and dried in vacuum (735 mmHg) at 80 °C.  
2-(Benzylthio)-6-hydroxy-3,5-dimethylpyrimidin-4(3H)-one 13Aa  
Prepared according to the general procedure starting from 1,5-dimethyl-2-
thioxodihydropyrimidine-4,6(1H,5H)-dione 12Aa. The title compound 
was obtained as a white solid. M.p.: 175 – 176 °C. Yield: 1.8 g, 9.1 mmol, 
91%.1H NMR (300 MHz, CDCl3) (enolic form) δ 7.41 – 7.28 (m, 5H), 4.36 
(s, 2H), 3.46 (s, 3H), 1.97 (s, 3H).13C NMR (75 MHz, CDCl3) δ 163.3, 162.9, 157.6, 136.8, 
129.3, 128.5, 127.4, 92.5, 34.8, 33.2, 29.9, 8.4. UPLC-DAD-QTOF: calcd for C13H15N2O2S 
(M, H+), 263.854; found, 263.858. 
3-Benzyl-2-(benzylthio)-6-hydroxy-5-methylpyrimidin-4(3H)-one 13Ab 
Prepared according to the general procedure starting from 1-benzyl-5-
methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Ab. The title 
compound was obtained as a white solid. M.p: 186 – 188 °C. Yield: 1.6 
g, 4.8 mmol, 48%. 1H NMR (300 MHz, CDCl3) (enolic form) δ 7.40 – 
7.21 (m, 8H), 5.26 (s, 2H), 4.33 (s, 2H), 3.73 (s, 1H), 2.02 (s, 3H).13C NMR (75 MHz, CDCl3) 
δ 165.2, 162.4, 159.5, 136.0, 135.9, 129.8, 129.4, 129.21, 128.5, 128.4, 67.8, 48.3, 37.3, 8.9. 
UPLC-DAD-QTOF: calcd for C19H19N2O2S (M, H+),339.1167; found, 339.1175. 
                                                 
125 Rakhimov, A. I.; Avdeev, S. A.; Chang, D. Org. Lett. 2009, 79, 348–349. 
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2-(Benzylthio)-3-pentyl-6-hydroxy-5-methylpyrimidin-4(3H)-one 13Ac 
Prepared according to the general procedure starting from 5-methyl-1-
pentyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Ac. The title 
compound was obtained as a white solid. M.p: 174 – 176 °C. Yield: 1.8 g, 
5 mmol, 51%. 1H NMR (300 MHz, CDCl3) (enolic form) 7.42 – 7.28 (m, 
5H), 5.93 (s, 1H), 4.34 (s, 2H), 3.95 – 3.90 (m, 2H), 1.96 (s, 3H), 1.68 – 1.65 (m, 2H), 1.32 
–  1.28 (m, 4H), 0.88 (t, 3H) 13C NMR (75 MHz, CDCl3) δ 164.6, 162.1, 158.1, 135.6, 129.3, 
129.3, 128.9, 128.9, 128.0, 95.3, 45.2, 36.4, 29.1, 27.5, 22.4, 14.1, 8.3. UPLC-DAD-QTOF 
: calcd for C17H23N2O2S (M, H+), 319.1480; found, 319.1482. 
2-(Benzylthio)-5-methyl-1-phenylpyrimidine-4,6(1H,5H)-dione 13Ad 
Prepared according to the general procedure starting from 5-methyl-1-
phenyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Ad. The title 
compound was obtained as a white solid. M.p: 189 – 192 °C. Yield: 1.8 
g, 5.7 mmol, 57%. 1H NMR (300 MHz, DMSO-d6) (enolic form) δ 7.49 
(dd, J = 5.3, 1.8 Hz, 3H), 7.41 (dd, J = 7.9, 1.7 Hz, 2H), 7.33 – 7.21 (m, 
5H), 4.33 (s, 2H), 1.80 (s, 3H).13C NMR (75 MHz, DMSO-d6) δ 163.5, 163.4, 158.18, 
136.7, 136.2, 129.5, 129.3, 129.2, 129.0, 128.4, 127.3, 93.1, 35.3, 8.2. MS (ESI, m/z): calcd 
for C18H16N2O2S (M, H+), 324.0932; found, 324.0740. 
2-(Benzylthio)-1-(3,5-bis(trifluoromethyl)phenyl)-5-methylpyrimidine-4,6(1H,5H)-
dione 13Ae 
Prepared according to the general procedure starting from 1-(3,5-
bis(trifluoromethyl)phenyl)-5-methyl-2-thioxodihydropyrimidine-
4,6(1H,5H)-dione 12Ae. The title compound was obtained as a 
yellow solid. M.p: 192 – 194 °C. Yield: 2.1 g, 4.6 mmol, 46%. 1H 
NMR (300 MHz, CDCl3) δ 7.97 (s, 1H), 7.72 (s, 2H), 7.30 –  7.28 
(m, 3H), 6.05 (s, 1H), 4.28 (s, 2H), 1.98 (s, 3H).13C NMR (75 MHz, 
DMSO-d6) δ 164.7, 163.4, 158.5, 137.4, 135.0, 134.1, 133.6, 133.2, 
132.7, 129.9, 129.2, 129.2, 128.9, 128.9, 128.1, 124.5, 124.2, 95.7,37.0, 8.0. UPLC-DAD-
QTOF: calcd for C20H15N2O2SF6 (M, H
+), 461.0758; found, 461.0759. 
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2-(Benzylthio)-5-ethyl-6-hydroxy-3-methylpyrimidin-4(3H)-one 13Ba  
Prepared according to the general procedure starting from 5-ethyl-1-
methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Ba. The title 
compound was obtained as a white solid. M.p: 186 – 188 °C. Yield: 1.6 g, 
5.8 mmol, 58%. 1H NMR (300 MHz, CDCl3) (enolic form) δ 7.54 – 7.50 
(m, 2H), 7.37 – 7.28 (m, 3H), 4.49 (s, 2H), 3.33 (s, 3H), 2.33 (q, J = 9, 6 Hz, 2H), 0.99 (t, J 
= 6Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 162.8, 162.7, 157.8, 136.8, 129.2, 128.4, 127.4, 
98.7, 34.8, 29.8, 16.1, 12.6. UPLC-DAD-QTOF : calcd for C14H17N2O2S (M, H
+), 277.1011; 
found, 277.1015. 
5-Benzyl-2-(benzylthio)-6-hydroxy-3-methylpyrimidin-4(3H)-one 13Ca 
Prepared according to the general procedure starting from 5-benzyl-1-
methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Ca. The title 
compound was obtained as a white solid. M.p: 209 – 211 °C. Yield: 1.9 
g, 6.8 mmol, 68%.1H NMR (300 MHz, DMSO-d6) (enolic form) δ 7.44 
– 7.10 (m, 10H), 4.35 (s, 2H), 3.80 (s, 2H), 3.44 (s, 3H).13C NMR (75 MHz, DMSO-d6) δ 
163.1, 158.7, 141.0, 136.7, 129.3, 128.5, 128.2, 128.0, 127.5, 125.5, 96.8, 34.9, 30.0, 28.6. 
UPLC-DAD-QTOF: calcd for C19H19N2O2S (M, H
+), 339.1167; found, 339.1166. 
2-(Benzylthio)-6-hydroxy-5-isobutyl-3-methylpyrimidin-4(3H)-one 13Da 
Prepared according to the general procedure starting from 5-isobutyl-1-
methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Da. The title 
compound was obtained as a white solid. M.p: 176 – 177 °C. Yield: 1.5 
g, 5.2 mmol, 52%. 1H NMR (300 MHz, CDCl3) (enolic form) δ 7.43 – 
7.27 (m, 5H), 4.37 (s, 2H), 3.45 (s, 3H), 2.34 (d, J = 7.3 Hz, 2H), 2.06 – 1.89 (m, 1H), 0.93 
(d, J = 6.6 Hz, 6H).13C NMR (75 MHz, DMSO) δ 163.3, 163.2, 157.9, 136.7, 129.3, 128.4, 
127.4, 96.4, 34.9, 31.9, 29.8, 27.0, 22.4, 22.4. UPLC-DAD-QTOF: calcd for C16H21N2O2S 
(M, H+), 305.1324; found, 305.1325. 
2-(Benzylthio)-6-hydroxy-5-isopropyl-3-methylpyrimidin-4(3H)-one 13Ea 
Prepared according to the general procedure starting from 5-isopropyl-1-
methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Ea. The title 
compound was obtained as a white solid. M.p: 196 – 197 °C. Yield: 2.3 g, 
8.7 mmol, 87%. 1H NMR (300 MHz, DMSO-d6) (enolic form) δ 7.41 – 7.27 
(m, 5H), 4.35 (s, 2H), 3.41 (s, 3H), 3.25 (p, J = 7.1 Hz, 1H), 1.25 (d, J = 7.1 Hz, 6H).13C 
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NMR (75 MHz, DMSO-d6) δ 179.09, 167.64, 165.67, 55.76, 34.68, 33.53, 19.60, 19.47. 
UPLC-DAD-QTOF: calcd for C15H19N2O2S (M, H+), 291.1167; found, 291.1171. 
5-Allyl-2-(benzylthio)-6-hydroxy-3-methylpyrimidin-4(3H)-one 13Fa 
Prepared according to the general procedure starting from 5-allyl-1-methyl-
2-thioxodihydropyrimidine-4,6(1H,5H)-dione 12Fa. The title compound 
was obtained as a white solid. M.p: 143 – 144 °C. Yield: 1.6 g, 5.7 mmol, 
57%. 1H NMR (300 MHz, CDCl3) (enolic form) δ 7.42 – 7.32 (m, 5H), 5.96 
(ddt, J = 17.1, 10.0, 6.4 Hz, 1H), 5.20 – 5.02 (m, 2H), 4.36 (s, 2H), 3.47 (s, 3H), 3.29 – 3.26 
(m, 2H).13C NMR (75 MHz, CDCl3) δ 164.0, 162.6, 159.1, 135.3, 135.1, 129.5, 129.1, 128.7, 
128.1, 127.8, 115.1, 97.0, 36.3, 30.6, 27.4. UPLC-DAD-QTOF: calcd for C15H17N2O2S (M, 
H+), 289.1011; found, 289.1014. 
  
164 CHAPTER 5  
 
5.3.5. Synthesis of vinyl aryl ketones 14:126 
 
To a solution of the corresponding acetophenone (10.0 mmol, 1 equiv.) and 
paraformaldehyde (606 mg, 20.0 mmol, 2 equiv.) in dry THF (10.0 mL) was added 
diisopropylammonium trifluoroacetate (2.05 g, 10.0 mmol, 1 equiv.) and trifluoroacetic 
acid (0.08 mL, 1 mmol, 10 mol %). The reaction mixture was stirred at reflux for 2 h, then 
cooled down to room temperature and a second portion of paraformaldehyde (606 mg, 20 
mmol, 2 equiv.) was added. Next, the reaction mixture was stirred at reflux overnight. Then 
the mixture was cooled down and the solvent was removed under reduced pressure. The 
residue was dissolved in Et2O and washed with 1N HCl (3 x 10 mL), 1N NaOH (3 x 10 
mL), and brine (3 x 10 mL). The resulting solution was dried over Na2SO4, filtered and 
concentrated under vacuum. The crude product was purified by silica gel column 
chromatography (eluent hexane: ethyl acetate, 99:1). 
1-(p-Tolyl)prop-2-en-1-one) (14a) 
Prepared according to the general procedure starting from 1-(p-
tolyl)ethan-1-one. The title compound was obtained as a yellow oil. 
Yield: 723.9 mg, 5.4 mmol, 54%. 1H NMR (300 MHz, CDCl3 δ 7.93 – 
7.77 (m, 2H), 7.31 – 7.05 (m, 3H), 6.42 (ddd, J = 17.1, 2.9, 1.5 Hz, 1H), 5.87 (d, J = 10.5 
Hz, 1H), 2.38 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 190.3, 143.8, 134.7, 132.3, 129.5, 
129.3, 128.8, 21.6. UPLC-DAD-QTOF : calcd for C10H10O (M, H+), 146.0810; found, 
147.0811. 
1-(4-Bromophenyl)prop-2-en-1-one (14b) 
Prepared according to the general procedure starting from 1-(4-
bromophenyl)ethan-1-one. The title compound was obtained as a 
yellow oil. Yield: 1.1 g, 5.1 mmol, 51%. 1H NMR (300 MHz, CDCl3) 
δ 7.79 (d, J = 8.5 Hz, 2H), 7.60 (d, J = 8.6 Hz, 2H), 7.10 (dd, J = 17.1, 10.5 Hz, 1H), 6.43 
(dd, J = 17.1, 1.6 Hz, 1H), 5.93 (dd, J = 10.6, 1.6 Hz, 1H).13C NMR (75 MHz, CDCl3) δ = 
                                                 
126 Reproduced from: Guo, S. H.; Xing, S. Z.; Mao, S.; Gao, Y. R.; Chen, W. L.; Wang, Y. Q. Tetrahedron 
lett. 2014, 23, 6718–6720. 
 EXPERIMENTAL SECTION 165 
 Asymmetric α-Functionalization of Barbituric Acids via Brønsted Base Catalysis  
189.9, 135.8, 131.7, 131.6, 130.5, 130.0, 128.0, 125.8, 98.2. UPLC-DAD-QTOF : calcd for 
C9H7BrO (M, H+), 209.9680; found, 209.9781. 
1-Phenylprop-2-en-1-one (14c) 
Prepared according to the general procedure starting from acetophenone. 
The title compound was obtained as a yellow oil. Yield: 765.9 mg, 5.8 
mmol, 58%. 1H NMR (300 MHz, CDCl3) δ 8.00 – 7.84 (m, 2H), 7.61 – 
7.37 (m, 3H), 7.21 – 7.04 (m, 1H), 6.42 (dt, J = 17.1, 1.8 Hz, 1H), 5.93 – 5.83 (m, 1H).13C 
NMR (75 MHz, CDCl3) δ 191.0, 137.4, 133.2, 132.5, 130.2, 128.8, 128.8, 128.4. UPLC-
DAD-QTOF : calcd for C9H8O (M, H+), 132.0575; found, 132.0508. 
1-(o-Tolyl)prop-2-en-1-one (14d) 
Prepared according to the general procedure starting from 1-(o-tolyl)ethan-1-
one. The title compound was obtained as a yellow oil. Yield: 838.3 mg, 5.7 
mmol, 57%. 1H NMR (300 MHz, CDCl3) δ 7.48 – 7.42 (m, 1H), 7.42 – 7.28 
(m, 1H), 7.29 – 7.17 (m, 2H), 6.87 – 6.71 (m, 1H), 6.21 – 6.08 (m, 1H), 6.03 – 5.91 (m, 1H), 
2.42 (d, J = 1.6 Hz, 3H).13C NMR (75 MHz, CDCl3) δ 196.6, 138.1, 137.5, 136.7, 131.6, 
131.3, 130.9, 128.6, 125.6, 20.5. UPLC-DAD-QTOF : calcd for C10H10O (M, H+), 146.0810; 
found, 147.0807. 
1-(m-Tolyl)prop-2-en-1-one(14e) 
Prepared according to the general procedure starting from 1-(m-tolyl)ethan-
1-one. The title compound was obtained as a yellow oil. Yield: 818 mg, 5.6 
mmol, 56%. 1H NMR (300 MHz, CDCl3) δ 7.84 – 7.67 (m, 2H), 7.36 (dd, J 
= 4.4, 2.6 Hz, 2H), 7.15 (ddd, J = 17.1, 10.5, 1.3 Hz, 1H), 6.43 (dd, J = 17.1, 
1.6 Hz, 1H), 5.94 – 5.83 (m, 1H), 2.40 (s, 3H).13C NMR (75 MHz, CDCl3) δ 191.0, 138.4, 
137.3, 133.7, 132.5, 129.8, 129.2, 128.4, 125.8, 21.3. UPLC-DAD-QTOF: calcd for C10H10O 
(M, H+), 146.0810; found, 147.0804. 
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5.3.6. Catalytic reactions of barbituric acid derivatives with vinyl aryl 
ketones 14. 
 
 
5.3.6.1. General procedure 
To a mixture of the corresponding barbituric acid or equivalent (0.2 mmol, 1 equiv.) and 
vinyl aryl ketone 14 (0.6 mmol, 3 equiv.) in CH2Cl2 (1 mL), was added the catalyst (10 mol 
%) and the resulting mixture was stirred at room temperature for 20 – 24 h. Then the 
mixture was quenched with HCl 0.1 M and the organic layer was washed with water (0.7 
mL), dried over anhydrous MgSO4, filtered, and the solvent was evaporated under reduced 
pressure. The crude material was purified by flash column chromatography on silica gel 
(eluent hexane: ethyl acetate, 3:1). 
5.3.6.2.  Screening of donor barbituric substrates (Scheme 1) 
 
R X Donor/adduct Catalyst Yield (%) ee (%) 
H O 9/15 
C4 63 0 
C6 64 0 
H S 12Aa/18 
C4 67 0 
C6 69 0 
PhCH2 O 10/16 
C4 70 0 
C6 74 0 
PhCH2 S 11/17 
C4 75 0 
C6 79 0 
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(R)-1,5-Dimethyl-5-(3-oxo-3-(p-tolyl)propyl)pyrimidine-2,4,6(1H,3H,5H)-trione (15) 
Prepared according to the general procedure starting from 
1,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione 9 and 1-(p-
tolyl)prop-2-en-1-one 14a. The title compound was obtained 
as a white oil. Data for the product obtained with catalyst C10 
and 13 as donor at 0ºC: Yield: 41 mg, 0.14 mmol, 71 %. 
[α]D23=   ̶  54.32 (c= 0.29, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.89 (s, 1H), 7.77 (d, J = 
8.2 Hz, 2H), 7.22 (d, J = 7.9 Hz, 2H), 3.28 (d, J = 1.0 Hz, 3H), 2.93 (dt, J = 10.0, 7.5 Hz, 
2H), 2.40 (d, J = 11.1 Hz, 5H), 1.58 (s, 3H).13C NMR (75 MHz, CDCl3) δ 198.0, 172.5, 
171.8, 150.0, 144.1, 133.8, 129.3, 128.1, 50.7, 33.4, 32.4, 28.1, 24.3, 21.6. UPLC-DAD-
QTOF: calcd for C16H18N2O4 (M, H+), 303.1345; found, 303.1353. 
Rac-1-Benzyl-3,5-dimethyl-5-(3-oxo-3-(p-tolyl)propyl)pyrimidine-2,4,6(1H,3H,5H)-
trione (16)  
Prepared according to the general procedure starting from 1-
benzyl-3,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (10) 
and 1-(p-tolyl)prop-2-en-1-one (14a). The title compound 
was obtained as a white oil. Data for the product obtained 
with catalyst C4: Yield: 58.8 mg, 0.15 mmol, 74%.1H NMR 
(300 MHz, CDCl3) δ 7.69 – 7.48 (m, 2H), 7.52 – 7.22 (m, 7H), 5.11 (s, 2H), 3.35 (s, 3H), 
2.97 – 2.67 (m, 2H), 2.43 (s, 5H), 1.61 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 198.2, 171.8, 
171.7, 150.9, 138.4, 136.4, 134.0, 128.8, 128.7, 128.6, 128.4, 127.9, 125.2, 50.7, 45.2, 33.5, 
33.2, 28.8, 24.4, 21.3. UPLC-DAD-QTOF : calcd for C23H25N2O4 (M, H+), 393.1814; found, 
393.1818. 
Rac-1-benzyl-3,5-dimethyl-5-(3-oxo-3-(p-tolyl)propyl)-2-thioxodihydropyrimidine-
4,6(1H,5H)-dione(17)  
Prepared according to the general procedure starting from 
1-benzyl-3,5-dimethyl-2-thioxodihydropyrimidine-
4,6(1H,5H)-dione (11) and 1-(p-tolyl)prop-2-en-1-one 
(14a). The title compound was obtained as a white oil. Data 
for the product obtained with catalyst C4: Yield: 64.4 mg, 
0.15 mmol, 72%. 1H NMR (300 MHz, CDCl3) δ 7.70 – 7.58 
(m, 2H), 7.48 – 7.16 (m, 7H), 5.81 – 5.56 (m, 2H), 3.73 (s, 3H), 3.02 – 2.71 (m, 2H), 2.49 
– 2.39 (m, 5H), 1.63 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 198.3, 180.2, 170.3, 170.3, 
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138.4, 136.4, 136.1, 134.0, 128.4, 128.4, 128.2, 127.6, 125.2, 51.6, 50.8, 36.0, 33.3, 32.8, 
23.5, 21.3. UPLC-DAD-QTOF: calcd for C23H25N2O3S (M, H
+), 409.1592; found, 
405.1586. 
Rac-1,5-Dimethyl-5-(3-oxo-3-(p-tolyl)propyl)-2-thioxodihydropyrimidine-
4,6(1H,5H)-dione (18)  
Prepared according to the general procedure starting from 1-
(p-tolyl)prop-2-en-1-one and 1-(p-tolyl)prop-2-en-1-one 
12Aa and 1-(p-tolyl)prop-2-en-1-one 14a. The title 
compound was obtained as a white oil. Data for the product 
obtained with catalyst C4: Yield: 45 mg, 0.15 mmol, 74%. 1H NMR (300 MHz, CDCl3) δ 
9.19 (s, 1H), 7.83 (d, J = 8.3 Hz, 2H), 7.32 – 7.24 (m, 2H), 3.67 (s, 3H), 2.99 (dt, J = 9.2, 7.4 
Hz, 2H), 2.51 – 2.42 (m, 5H), 1.64 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 198.2, 178.6, 171.3, 
169.2, 144.7, 134.3, 129.7, 129.7, 128.6, 51.9, 34.6, 33.7, 32.8, 24.4, 22.1. UPLC-DAD-
QTOF: calcd for C16H18N2O3S (M, H+), 319.1116; found, 319.1116. 
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5.3.6.3.  Catalyst screening for the reaction of 13Aa with 14a[a] 
 
[a] Reactions carried out at room temperature using 0.2 mmol of 13Aa, 0.6 mmol 
of enone 14a and 10 mol % catalyst in 0.2 mL of CH2Cl2. Reaction time 16 h. [b] ee 
determined by chiral HPLC [c] Reaction carried out at 0 °C. 
  
170 CHAPTER 5  
 
5.3.6.4. Data for the reaction of templates 13 with enones 14 
 
The same general procedure described in section 5.3.6 (pag. 166) was employed using 
catalyst C10 and the specified temperature and time  
(R)-2-(Benzylthio)-1,5-dimethyl-5-(3-oxo-3-(p-tolyl)propyl)pyrimidine-4,6(1H,5H)-
dione (19)  
Prepared according to the general procedure starting 
from 2-(benzylthio)-1,5-dimethylpyrimidine-
4,6(1H,5H)-dione 13Aa and 1-(p-tolyl)prop-2-en-1-
one 14a. The title compound was obtained as a white 
oil. Yield: 55 mg, 0.15 mmol, 72%. [α]D23=   ̶  67.7° 
(c= 0.23, 96 % ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.44 
– 7.20 (m, 7H), 4.47 (d, J = 2.0 Hz, 2H), 3.35 (s, 3H), 3.11 – 2.98 (m, 1H), 2.92 – 2.80 (m, 
1H), 2.47 – 2.28 (m, 5H), 1.54 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 198.5, 179.5, 174.0, 
173.3, 144.4, 134.9, 134.4, 129.8, 129.6, 129.3, 129.2, 128.9, 128.5, 128.4, 53.5, 37.8, 34.0, 
32.9, 30.4, 22.6, 22.0 UPLC-DAD-QTOF: calcd for C23H24N2O3S (M, H
+), 409.1586; 
found, 409.1589. 
(R)-2-(Benzylthio)-5-(3-(4-bromophenyl)-3-oxopropyl)-1,5-dimethylpyrimidine-
4,6(1H,5H)-dione (20) 
Prepared according to the general procedure starting from 
2-(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione 
13Aa and 1-(4-bromophenyl)prop-2-en-1-one 14b. The 
title compound was obtained as a white oil. Yield: 59 mg, 
0.13 mmol, 63%. [α]D23 =  ̶  63.2° (c= 0.34, 95 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) 
δ 7.81 (d, J = 8.6 Hz, 2H), 7.62 (d, J = 8.6 Hz, 2H), 7.47 – 7.27 (m, 5H), 4.50 (s, 2H), 3.38 
(s, 3H), 3.13 – 2.98 (m, 1H), 2.93 – 2.79 (m, 1H), 2.38 (td, J = 6.3, 3.0 Hz, 2H), 1.57 (s, 
3H).13C NMR (75 MHz, CDCl3) δ 197.6, 179.0, 173.5, 172.9, 135.2, 134.5, 131.9, 129.6, 
129.4, 128.8, 128.4, 128.1, 53.1, 37.4, 33.8, 31.8, 30.0, 22.9. UPLC-DAD-QTOF: calcd for 
C22H21BrN2O3S (M, H+), 473.0535; found, 473.0529. 
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(R)-2-(Benzylthio)-1,5-dimethyl-5-(3-oxo-3-phenylpropyl)pyrimidine-4,6(1H,5H)-
dione (21)  
Prepared according to the general procedure starting from 2-
(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione 
13Aa and 1-phenylprop-2-en-1-one 14c. The title compound 
was obtained as a white oil. Yield: 48 mg, 0.12 mmol, 61%. 
[α]D23=  ̶  64.3° (c= 0.27, 92 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.95 (dd, J = 
8.4, 1.4 Hz, 2H), 7.69 – 7.25 (m, 8H), 4.50 (s, 2H), 3.38 (d, J = 2.9 Hz, 3H), 3.10 (ddd, J = 
17.1, 9.1, 6.4 Hz, 1H), 2.93 (td, J = 9.1, 6.8 Hz, 1H), 2.47 – 2.32 (m, 2H), 1.57 (s, 3H).13C 
NMR (75 MHz, CDCl3) δ 198.5, 179.1, 173.6, 172.9, 136.5, 134.5, 133.2, 129.4, 128.8, 
128.6, 128.1, 128.0, 53.1, 37.4, 33.7, 32.2, 30.0, 22.3. UPLC-DAD-QTOF: calcd for 
C22H22N2O3S (M, H
+), 395.1429; found, 395.1433. 
(R)-2-(Benzylthio)-1,5-dimethyl-5-(3-oxo-3-(o-tolyl)propyl)pyrimidine-4,6(1H,5H) 
(22) 
Prepared according to the general procedure starting from 2-
(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione 
(13Aa) and 1-(o-tolyl)prop-2-en-1-one (14d). The title 
compound was obtained as a white oil. Yield: 58 mg, 14 mmol, 
72%. [α]D23=   ̶  70.3° (c= 0.28, 85 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J 
= 6.9 Hz, 1H), 7.51 – 7.18 (m, 8H), 4.51 (s, 2H), 3.38 (s, 3H), 2.99 (dd, J = 9.2, 5.9 Hz, 1H), 
2.91 – 2.78 (m, 1H), 2.50 (s, 3H), 2.36 (dt, J = 9.0, 5.9 Hz, 2H), 1.56 (s, 3H).13C NMR (75 
MHz, CDCl3) δ 197.5, 174.2, 168.8, 168.0, 133.3, 132.5, 129.6, 127.1, 126.5, 124.5,  124.0, 
123.7, 23.2, 120.8, 48.2, 32.5, 31.5, 27.4, 25.1, 17.6, 16.4. UPLC-DAD-QTOF: calcd for 
C23H24N2O3S (M, H+),409.1586; found, 409.1587. 
(R)-2-(Benzylthio)-1,5-dimethyl-5-(3-oxo-3-(m-tolyl)propyl)pyrimidine-4,6(1H,5H)-
dione (23)  
Prepared according to the general procedure starting from 
2-(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione 
(13Aa) and 1-(m-tolyl)prop-2-en-1-one (14e). The title 
compound was obtained as a white oil. Yield: 50 mg, 0.12 
mmol, 62%. [α]D23=  ̶  69.2° (c= 0.24, 96 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.74 
(d, J = 9.0 Hz, 2H), 7.54 – 7.17 (m, 7H), 4.50 (d, J = 3.0 Hz, 2H), 3.38 (s, 3H), 3.09 (ddd, J 
= 17.0, 9.0, 6.2 Hz, 1H), 3.02 – 2.80 (m, 1H), 2.44 (s, 3H), 2.43 – 2.24 (m, 2H), 1.57 (s, 
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3H).13C NMR (75 MHz, CDCl3) δ 198.7, 179.1, 173.6, 172.8, 138.3, 136.6, 134.5, 133.9, 
129.4, 128.8, 128.5, 128.4, 128.0, 125.2, 53.1, 37.4, 33.7, 32.3, 30.0, 22.2, 21.3. UPLC-
DAD-QTOF: calcd for C23H25N2O3S (M, H+), 409.1586; found, 409.1587. 
(R)-2-(Benzylthio)-5-(3-(4-bromophenyl)-3-oxopropyl)-5-ethyl-1-methylpyrimidine-
4,6(1H,5H)-dione (24)  
Prepared according to the general procedure starting from 2-
(benzylthio)-5-ethyl-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Ba) and 1-(4-bromophenyl)prop-2-en-1-one (14b). The 
title compound was obtained as a white oil. Yield: 69 mg, 0.14, 
71%. [α]D23=  ̶  64.2° (c= 0.42, 97 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.79 (d, J 
= 8.6 Hz, 2H), 7.60 (d, J = 8.5 Hz, 2H), 7.49 – 7.21 (m, 5H), 4.51 (t, J = 5.8 Hz, 2H), 3.39 
(s, 3H), 3.11 – 2.95 (m, 1H), 2.95 – 2.72 (m, 1H), 2.41 (t, J = 7.6 Hz, 2H), 2.02 (dd, J = 7.5, 
1.6 Hz, 2H), 0.89 (t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 197.7, 178.3, 173.4, 
173.1, 135.2, 134.4, 131.8, 129.6, 129.4, 128.8, 128.2, 128.1, 127.7, 127.5, 121.3, 110.4, 
58.4, 37.4, 34.0, 33.0, 9.26. UPLC-DAD-QTOF: calcd for C23H23BrN2O3S (M, H+), 
487.0691; found, 487.0698. 
(S)-5-Benzyl-2-(benzylthio)-1-methyl-5-(3-oxo-3-(m-tolyl)propyl)pyrimidine-
4,6(1H,5H)-dione (25) 
Prepared according to the general procedure starting 
from 5-benzyl-2-(benzylthio)-1-methylpyrimidine-
4,6(1H,5H)-dione (13Ca) and 1-(m-tolyl)prop-2-en-1-
one (14e). The title compound was obtained as a white 
oil. Yield: 80 mg, 0.15 mmol, 75%. [α]D22=   ̶  71.2° (c= 0.22, 94 % ee, CH2Cl2). 1H NMR 
(300 MHz, CDCl3) δ 7.82 – 7.70 (m, 2H), 7.44 – 7.16 (m, 10H), 7.14 – 7.04 (m, 2H), 4.27 
(d, J = 3.4 Hz, 2H), 3.29 – 3.03 (m, 6H), 2.88 – 2.77 (m, 1H), 2.64 (ddd, J = 9.6, 5.6, 2.9 
Hz, 2H), 2.44 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 198.9, 177.7, 173.6, 172.6, 138.3, 
136.5, 134.5, 134.3, 133.8, 129.4, 129.4, 128.7, 128.5, 128.4, 128.1, 128.0, 127.5, 125.3, 
59.9, 48.2, 37.3, 34.4, 31.3, 29.6, 21.3. UPLC-DAD-QTOF: calcd for C29H28N2O3S (M, 
H+), 485.1899; found, 485.1901. 
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(S)-5-Allyl-2-(benzylthio)-1-methyl-5-(3-oxo-3-phenylpropyl)pyrimidine-4,6(1H,5H)-
dione (26) 
Prepared according to the general procedure starting from 5-
allyl-2-(benzylthio)-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Fa) and 1-phenylprop-2-en-1-one (14c). The title compound 
was obtained as a white oil. Yield: 54 mg, 0.13 mmol, 65%. 
[α]D23=  ̶  62.8° (c= 0.25, 92 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.01 – 7.89 (m, 
2H), 7.64 – 7.53 (m, 1H), 7.52 – 7.29 (m, 7H), 5.64 (dddd, J = 17.0, 10.1, 7.9, 6.8 Hz, 1H), 
5.20 – 5.04 (m, 2H), 4.58 – 4.41 (m, 2H), 3.37 (s, 3H), 3.15 – 3.02 (m, 1H), 2.91 – 2.78 (m, 
1H), 2.78 – 2.63 (m, 2H), 2.50 – 2.42 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 198.6, 177.8, 
173.6, 172.7, 136.5, 134.6, 133.1, 131.1, 129.4, 128.8, 128.7, 128.5, 128.0, 120.2, 58.0, 
43.6, 37.4, 34.0, 31.1, 29.8. UPLC-DAD-QTOF: calcd for C24H24N2O3S (M, H
+), 
421.1586; found, 421.1593. 
(R)-2-(Benzylthio)-1-(3,5-bis(trifluoromethyl)phenyl)-5-methyl-5-(3-oxo-3-
phenylpropyl)pyrimidine-4,6(1H,5H)-dione (27)  
Prepared according to the general procedure starting from 2-
(benzylthio)-1-(3,5-bis(trifluoromethyl)phenyl)-5-
methylpyrimidine-4,6(1H,5H)-dione (13Ae) and 1-
phenylprop-2-en-1-one (14c). The title compound was 
obtained as a white oil. Yield: 77 mg, 0.13 mmol, 65%. 
[α]D23=  ̶  63.02° (c= 1.4, 90 % ee, CH2Cl2). 1H NMR (300 
MHz, CDCl3) δ 8.16 (s, 1H), 8.07 – 7.92 (m, 3H), 7.71 (s, 1H), 7.68 – 7.57 (m, 1H), 7.50 
(dd, J = 8.3, 6.9 Hz, 2H), 7.38 – 7.24 (m, 4H), 4.44 (t, J = 6.9 Hz, 2H), 3.32 (dt, J = 17.4, 
6.2 Hz, 1H), 3.17 – 3.00 (m, 1H), 2.62 (dt, J = 13.8, 6.4 Hz, 1H), 2.53 – 2.40 (m, 1H), 1.68 
(s, 3H). 13C NMR (75 MHz, CDCl3) δ 199.5, 178.6, 173.1, 171.4, 136.3, 136.2, 133.9, 
133.5, 130.8, 130.1, 130.0, 129.4, 128.8, 128.7, 128.1, 128.0, 124.3, 124.3, 124.2, 53.2, 
38.2, 33.1, 32.2, 22.5. UPLC-DAD-QTOF: calcd for C29H22F6N2O3S (M, H
+), 593.1334; 
found, 593.1337. 
(R)-1-Benzyl-2-(benzylthio)-5-(3-(4-bromophenyl)-3-oxopropyl)-5-
methylpyrimidine-4,6(1H,5H)-dione (28)  
Prepared according to the general procedure starting from 1-
benzyl-2-(benzylthio)-5-methylpyrimidine-4,6(1H,5H)-
dione (13Ab) and 1-(4-bromophenyl)prop-2-en-1-one (14b). 
The title compound was obtained as a white oil. Yield: 74 mg, 
0.13 mmol, 67%. [α]D22=  ̶  70.02° (c = 0.22, 90 % ee, 
CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.76 (d, J = 8.6 Hz, 
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2H), 7.61 (d, J = 8.6 Hz, 2H), 7.47 – 7.20 (m, 8H), 5.23 – 4.99 (m, 2H), 4.49 (s, 2H), 3.07 
– 2.74 (m, 2H), 2.50 – 2.30 (m, 2H), 1.59 (s, 3H).13C NMR (75 MHz, CDCl3) δ 197.4, 
178.8, 173.7, 172.4, 134.88, 131.9, 129.4, 128.8, 128.3, 128.1, 128.1, 127.5, 53.3, 47.1, 
37.8, 33.7, 31.7, 22.9. UPLC-DAD-QTOF: calcd for C28H25BrN2O3S (M, H
+), 549.0848; 
found, 549.0855. 
(R)-2-(Benzylthio)-5-(3-(4-bromophenyl)-3-oxopropyl)-5-methyl-1-pentylpyrimidine-
4,6(1H,5H)-dione(29)  
Prepared according to the general procedure starting from 2-
(benzylthio)-5-methyl-1-pentylpyrimidine-4,6(1H,5H)-dione 
(13Ac) and 1-(4-bromophenyl)prop-2-en-1-one (14b). The 
title compound was obtained as a white oil. Yield: 78 mg, 0.15 
mmol, 73%. [α]D22=  ̶  73.13 °( c= 0.23, 92 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
7.80 (d, J = 8.6 Hz, 2H), 7.61 (d, J = 8.5 Hz, 2H), 7.45 – 7.26 (m, 4H), 4.48 (s, 2H), 3.93 – 
3.75 (m, 2H), 3.11 – 2.94 (m, 1H), 2.94 – 2.75 (m, 1H), 2.44 – 2.28 (m, 2H), 1.75 – 1.59 
(m, 3H), 1.60 – 1.51 (m, 3H), 1.33 (dd, J = 6.9, 3.5 Hz, 5H), 0.97 – 0.84 (m, 3H).13C NMR 
(300 MHz, CDCl3) δ 198.7, 180.2, 174.5, 173.6, 136.4, 135.6, 133.0, 130.7, 130.6, 130.0, 
129.5, 129.2, 54.2, 45.4, 38.6, 34.9, 32.7, 29.9, 29.1, 24.0, 23.3, 15.0. UPLC-DAD-QTOF: 
calcd for C26H30N2O3SBr (M, H
+), 529.1161; found, 529.1165. 
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5.3.6.5. C10-catalyzed reaction of 13Aa with acrolein 
 
To a mixture of 13Aa (52.4 mg, 0.2 mmol, 1equiv.) and acrolein (0.02 mL, 0.3 mmol, 1.5 
equiv.) in CH2Cl2 (1 mL), catalyst C10 (10 mol %) was added and the resulting mixture 
was stirred at 0 °C for 24 h. Then the reaction mixture was concentrated in the rotary 
evaporator, the residue was dissolved in dioxane/ HCl 6M (0.5ml/ 0.5mL), and the resulting 
mixture was stirred at room temperature for 6 h. Then, it was quenched with an aqueous 
solution of NaHCO3 (1 mL), diluted with water (1 mL) and the mixture extracted with 
EtOAc (3 x 3 mL). The organic layer was dried over MgSO4 and solvents were evaporated 
under reduced pressure. The crude material was purified by flash column chromatography 
on silica gel (eluting with hexane/ ethyl acetate, 1/1) to give aldehyde 30 as a colorless oil. 
Yield: 17.3 mg, 0.082 mmol, 41%. 1H NMR (300 MHz, CDCl3) δ 9.66 (s, 1H), 8.92 (s, 
1H), 3.27 (s, 3H), 2.48 – 2.33 (m, 2H), 2.31 – 2.28 (m, 2H), 1.56 (s, 3H). 13C NMR (300 
MHz, CDCl3) δ 200.0, 172.3, 171.5, 149.8, 50.5, 39.1, 30.0, 28.1, 24.5. MS (ESI, m/z): 
calcd for C9H12N2O4Na (M, +Na), 235.0695; found, 235.0683.  
The enantiomeric purity of this material was determined by chiral HPLC analysis 
after derivatisation into the corresponding dimethyl acetal, as follow: 
Derivatization of 30 onto the corresponding dimethyl acetal: To a solution of 
aldehyde 30 (31.6 mg, 0.15 mmol, 1 equiv.) in MeOH (0.6 mL) at ̶ 40 °C trimethyl 
orthoformate (0.03 mL, 0.15 mmol, 1 equiv.) and p-toluensulfonic acid (5 mg, 20 mol %) 
were added. The resulting mixture was allowed to reach the room temperature and stirred 
for 4 h at that temperature. Water (3 mL) was added to the reaction flask and the resulting 
mixture was extracted with EtOAc (3 x 3 mL). The combined organic phases were dried 
over MgSO4, filtered and evaporated under reduced pressure. Thus, obtained product was 
essentially pure (yellow oil) and submitted to HPLC analysis. Yield: 38.7 mg, 0.15 mmol, 
> 99%. [α]D22 = – 3.6º  (c = 0.1, 92 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) 3.28 (s, 
3H), 3.22 (d, J = 1.8 Hz, 6H), 2.09 (t, J = 7.8 Hz, 2H), 1.58 – 1.50 (m, 5H). 13C NMR (300 
MHz, CDCl3) δ = 173.1, 172.1, 150.3, 103.8, 53.0, 52.9, 51.4, 33.1, 28.6, 28.4, 26.4. MS 
(ESI, m/z): calcd for C11H18N2O5Na (M, Na+), 281.1113; found, 281.1118. 
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5.3.7. Catalytic reactions with vinyl ketone 31b 
5.3.7.1. General procedure 
 
To a suspension of the corresponding barbituric acid derivative 9-12 (0.2 mmol, 1 equiv.) 
and 4-methyl-4-((trimethylsilyl)oxy)pent-1-en-3-one 31b ( 110 mg, 0.6 mmol, 3 equiv.) in 
CH2Cl2 (1 mL), was added catalyst C10 or C11 (10 mol %) and the reaction was stirred at 
rt for 16 h. Then the mixture was quenched with HCl 0.1 M and the organic layer was 
washed with water (0.7 mL). The organic layer was dried over anhydrous MgSO4, filtered, 
and the solvent was evaporated under reduced pressure. The crude material was dissolved 
in dioxane/ HCl 6 M (0.5 ml/0.5 mL), and the resulting mixture was stirred for 6 h (until 
consumption of the silyl ether compound). The mixture was quenched with an aqueous 
solution of NaHCO3, diluted with water and extracted with EtOAc (3 x 3 mL). The 
combined organic layers were dried over MgSO4, filtered, and the solvents were evaporated 
under reduced pressure. The crude material was purified by flash column chromatography 
on silica gel. 
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5.3.7.2. Screening of donor barbiturates 
 
R X Donor Catalyst Adduct Yield (%) ee (%) 
H O 9 
C2 
32Aa 
62 0 
C4 61 0 
C6 61 0 
H S 12Aa 
C2 
32Aa 
67 0 
C4 64 0 
C6 69 0 
PhCH2 O 10 
C2 
33 
72 0 
C4 60 0 
C6 68 0 
PhCH2 S 11 
C2 
34 
63 0 
C4 73 0 
C6 74 0 
 
1-Benzyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-3,5-dimethylpyrimidine-
2,4,6(1H,3H,5H)-trione (33) 
Prepared according to the general procedure section 5.3.7.1 page 
176 starting from 1-benzyl-3,5-dimethylpyrimidine-
2,4,6(1H,3H,5H)-trione (10). The crude material was purified by 
flash column chromatography on silica gel (eluent with hexane: 
ethyl acetate, 4:1) to give the title compound as a white oil. Yield: 
48.9 mg, 0.14 mmol, 68%.1H NMR (300 MHz, CDCl3) δ 7.55 – 
7.24 (m, 5H), 5.20 – 4.98 (m, 2H), 3.34 (s, 3H), 2.54 – 2.41 (m, 2H), 2.32 (d, J = 6.9 Hz, 
2H), 1.56 (s, 3H), 1.29 (d, J = 1.7 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 213.4, 172.1, 
172.0, 151.3, 136.7, 129.3, 129.0, 128.4, 51.0, 45.7, 32.7, 31.0, 30.1, 29.3, 28.7, 26.8, 25.2. 
UPLC-DAD-QTOF: calcd for C19H24N2O5 (M, H
+), 360.1685; found, 360.1682. 
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1-benzyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-3,5-dimethyl-2-
thioxodihydropyrimidine-4,6(1H,5H)-dione (34) 
Prepared according to the general procedure starting from 1-benzyl-
3,5-dimethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (11). 
The title compound was obtained as a white oil. The crude material 
was purified by flash column chromatography on silica gel (eluent 
with hexane: ethyl acetate, 4:1) to give the title compound as a white 
oil. Yield: 52.7 mg, 0.15 mmol, 74%.1H NMR (300 MHz, CDCl3) 
δ 7.48 – 7.22 (m, 5H), 5.79 – 5.54 (m, 2H), 3.71 (s, 3H), 2.64 – 2.40 (m, 2H), 2.40 – 2.25 
(m, 2H), 1.58 (s, 3H), 1.32 (d, J = 3.9 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ = 213.0, 
180.1, 170.1, 136.0, 128.4, 128.2, 127.7, 51.4, 50.8, 36.0, 31.7, 30.5, 26.4, 24.1. UPLC-
DAD-QTOF: calcd for C19H24N2O4S (M, H
+), 376.1457; found, 376.1456. 
5.3.7.3. General procedure for the reaction of templates 13 with enone 31b 
 
To a suspension of the corresponding barbituric acid derivative 13 (0.2 mmol, 1 equiv.) and 
4-methyl-4-((trimethylsilyl)oxy)pent-1-en-3-one 31b ( 110 mg, 0.6 mmol, 3 equiv.) in 
CH2Cl2 (1 mL), was added catalyst C10 or C11 (10 mol %) and the reaction was stirred at 
rt for 16 h. Then the mixture was quenched with HCl 0.1 M and the organic layer was 
washed with water (0.7 mL). The organic layer was dried over anhydrous MgSO4, filtered, 
and the solvent was evaporated under reduced pressure. The crude material was dissolved 
in dioxane/ HCl 6 M (0.5 ml/0.5 mL), and the resulting mixture was stirred for 6 h (until 
consumption of the silyl ether compound). The mixture was quenched with an aqueous 
solution of NaHCO3, diluted with water and extracted with EtOAc (3 x 3 mL). The 
combined organic layers were dried over MgSO4, filtered, and the solvents were evaporated 
under reduced pressure. The crude material was purified by flash column chromatography 
on silica gel. 
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(R)-5-(4-Hydroxy-4-methyl-3-oxopentyl)-1,5-dimethylpyrimidine-2,4,6(1H,3H,5H) 
(32Aa)  
Prepared according to the general procedure starting from 2-
(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione (13Aa). 
The crude material was purified by flash column chromatography 
on silica gel (elutent with hexane: ethyl acetate, 1:1) to give the 
title compound as colourless oil. Yield: 43 mg, 0.16 mmol, 82%. [α]D23= +0.76° (c= 0.97, 
90 % ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 3.26 (s, 3H), 2.56 (q, J = 7.5, 7.1 Hz, 
2H), 2.28 (t, J = 7.3 Hz, 2H), 1.54 (s, 3H), 1.51 (s, 3H), 1.31 (s, 3H).13C NMR (75 MHz, 
CDCl3) δ 214.5, 173.5, 172.7, 151.0, 51.6, 32.6, 31.8, 29.2, 27.5, 25.9. UPLC-DAD-QTOF: 
calcd for C12H19N2O5 (M, H
+), 271.1294; found, 271.1301. 
(R)-1-Benzyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-5-methylpyrimidine-
2,4,6(1H,3H,5H)-trione (32Ab) 
Prepared according to the general procedure starting from 1-benzyl-
2-(benzylthio)-5-methylpyrimidine-4,6(1H,5H)-dione (13Ab). The 
crude material was purified by flash column chromatography on 
silica gel (eluent with hexane: ethyl acetate, 1:1) to give the title 
compound as a colorless oil. Yield: 47.2 mg, 0.12 mmol, 61%. 
[α]D23=  ̶ 3.8° (c= 0.73, 87% ee, CH2Cl2). 1H NMR (300 MHz, 
CDCl3) δ 8.94 (s, 1H), 7.47 – 7.38 (m, 2H), 7.38 – 7.26 (m, 3H), 5.14 – 4.93 (m, 2H), 2.56 
– 2.38 (m, 2H), 2.29 (d, J = 7.0 Hz, 2H), 1.55 (s, 3H), 1.26 (s, 6H).13C NMR (75 MHz, 
CDCl3) δ 214.2, 173.2, 172.8, 150.9, 137.1, 129.9, 129.8, 129.7, 129.2, 51.6, 45.7, 32.9, 
31.7, 27.4, 27.3, 25.7. UPLC-DAD-QTOF: calcd for C18H22N2O5Na (M, Na
+), 369.1426; 
found, 369.1433. 
(R)-1-Pentyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-5-methylpyrimidine-
2,4,6(1H,3H,5H)-trione (32Ac) 
Prepared according to the general procedure starting from 2-
(benzylthio)-5-methyl-1-pentylpyrimidine-4,6(1H,5H)-dione 
(13Ac). The crude material was purified by flash column 
chromatography on silica gel (eluent with hexane: ethyl acetate, 1:1) 
to give the title compound as a colorless oil. Yield: 42 mg, 0.13 
mmol, 63%. [α]D23=   ̶ 0.21° (c= 0.45, 87% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 4.09 
– 3.94 (m, 1H), 3.85 – 3.76 (m, 1H), 2.65 – 2.49 (m, 1H), 2.25 (t, J = 7.4 Hz, 2H), 1.53 (s, 
3H), 1.41 – 1.25 (m, 6H), 1.19 (d, J = 6.1 Hz, 8H), 0.88 (t, J = 6.9 Hz, 2H).13C NMR (75 
MHz, CDCl3) δ  213.3, 172.5, 172.3, 150.1, 64.4, 50.6, 41.6, 31.5, 30.9, 28.9, 27.6, 26.4, 
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25.3, 24.9, 22.3, 14.0. UPLC-DAD-QTOF:  calcd for C16H26N2O5Na (M, Na
+), 349.1739; 
found, 349.1739. 
(R)-5-(4-hydroxy-4-methyl-3-oxopentyl)-5-methyl-1-phenylpyrimidine-
2,4,6(1H,3H,5H)-trione (32Ad) 
Prepared according to the general procedure starting from 2-
(benzylthio)-5-methyl-1-phenylpyrimidine-4,6(1H,5H)-dione 
(13Ad). The crude material was purified by flash column 
chromatography on silica gel (eluent with hexane: ethyl acetate, 
1:1) to give the title compound as a colorless oil. Yield: 42 mg, 
0.12 mmol, 62%. [α]D23=  ̶ 0.21° (c= 0.45, 90% ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 9.22 (brs, 1H), 7.38 (m, 2H), 7.28 (m, 3H), 5.00 (m, 2H), 3.45 
(s, 1H), 2.43 (m, 2H), 2.29 (m, 2H), 1.50 (s, 3H), 1.22 (s, 6H). 13C NMR (75 MHz, CDCl3) 
δ UPLC-DAD-QTOF : calcd for C18H22N2O5Na , 369.1426; found, 369.1433. 
(R)-5-Ethyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-1-methylpyrimidine-
2,4,6(1H,3H,5H)-trione (32Ba)  
Prepared according to the general procedure starting from 2-
(benzylthio)-5-ethyl-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Ba). The crude material was purified by flash column 
chromatography on silica gel (eluent with hexane: ethyl acetate, 
2:1) to give the title compound as a yellow oil. Yield: 40 mg, 1.14 
mmol, 71%. [α]D23=  ̶ 2.8 °(c= 1, 94 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.58 (s, 
1H), 3.29 (s, 3H), 2.63 – 2.51 (m, 2H), 2.28 (t, J = 7.2 Hz, 2H), 2.01 (q, J = 7.4 Hz, 2H), 
1.32 (d, J = 1.0 Hz, 6H), 0.86 (t, J = 7.4 Hz, 3H).13C NMR (300 MHz, CDCl3) δ 213.7, 
172.4, 171.5, 150.2, 77.0, 56.3, 33.8, 31.5, 31.3, 28.3, 26.9, 9.7. UPLC-DAD-QTOF: calcd 
for C13H21N2O5 (M, H
+), 285.1450; found, 285.1451. 
(S)-5-Benzyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-1-methylpyrimidine-
2,4,6(1H,3H,5H) (32Ca)  
Prepared according to the general procedure starting from 5-
benzyl-2-(benzylthio)-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Ca). The crude material was diluted with 0.2 mL of water and 
0.3 mL of acetone and oxone (92 mg, 0.3 mmol, 1.5 equiv.) in 0.1 
mL of water was added and the reaction mixture was stirred 24 h 
at room temperature. The crude material was purified by flash column chromatography on 
silica gel (eluent with hexane: ethyl acetate, 2:1) to give the title compound as a white solid. 
M.p: 227 – 230 °C. Yield: 48 mg, 0.14 mmol, 70%. [α]D22=  ̶ 1.72° ( c= 0.84, 92% ee, 
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CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 8.10 (s, 1H), 7.33 – 7.25 (m, 3H), 7.08 – 7.03 (m, 
2H), 3.27 (s, 2H), 3.09 (s, 3H), 2.70 – 2.43 (m, 4H), 1.38 (s, 6H).13C NMR (75 MHz, 
CDCl3) δ 213.4, 171.8, 170.8, 149.2, 134.2, 129.5, 129.2, 129.1, 128.6, 57.9, 47.4, 31.8, 
31.7, 31.5, 28.0, 26.9. UPLC-DAD-QTOF: calcd for C18H23N2O5 (M, H
+), 347.1607; 
found, 347.1606. 
(S)-5-(4-Hydroxy-4-methyl-3-oxopentyl)-5-isobutyl-1-methylpyrimidine-
2,4,6(1H,3H,5H)-trione (32Da) 
Prepared according to the general procedure starting from 2-
(benzylthio)-5-isobutyl-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Da). The crude material was purified by flash column 
chromatography on silica gel (eluent with hexane: ethyl acetate, 
3:1) to give the title compound as a yellow oil. Yield: 42 mg, 0.14 
mmol, 68%. [α]D22=  ̶ 1.25° (c= 0.27, 93 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.43 
(s, 1H), 3.34 – 3.23 (m, 3H), 2.66 – 2.41 (m, 2H), 2.23 (t, J = 7.3 Hz, 2H), 1.95 (d, J = 6.6 
Hz, 2H), 1.62 – 1.56 (m, 1H), 1.31 (s, 6H), 0.80 (dd, J = 12.2, 6.6 Hz, 6H).13C NMR (75 
MHz, CDCl3) δ 213.3, 172.5, 171.6, 150.1, 54.6, 47.7, 34.2, 30.9, 30.1, 28.4, 27.0, 25.8, 
23.8, 23.5, 1.4.  UPLC-DAD-QTOF : calcd for C15H25N2O5 (M, H
+), 313.1763; found, 
313.1769. 
(S)-5-Allyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-1-methylpyrimidine-
2,4,6(1H,3H,5H)-trione(32Fa)  
Prepared according to the general procedure starting from 5-allyl-
2-(benzylthio)-1-methylpyrimidine-4,6(1H,5H)-dione (13Fa). 
The crude material was purified by flash column chromatography 
on silica gel (eluent with hexane: ethyl acetate, 2:1) to give the 
title compound as a colourless oil. Yield: 42 mg, 0.14 mmol, 72%. 
[α]D23=  ̶ 4.84° (c= 0.75, 92 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.65 (s, 1H), 
5.63 – 5.46 (m, 1H), 5.16 – 5.06 (m, 2H), 3.23 (s, 3H), 2.66 – 2.49 (m, 4H), 2.34 – 2.26 (m, 
2H), 1.30 (s, 6H).13C NMR (75 MHz, CDCl3) δ 213.6, 171.9, 170.99, 150.1, 130.4, 121.7, 
56.0, 44.5, 31.3, 31.2, 28.2, 26.8. UPLC-DAD-QTOF: calcd for C14H21N2O5 (M, H
+), 
297.1450; found, 297.1455. 
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5.3.8. Synthesis of heteroaryl vinylsulfone 35127 
 
Step 1: 1-Phenyl-1H-tetrazole-5-thiol (10.7 g, 60 mmol, 1 equiv.) was placed in a 500 ml 
flask equipped with a magnetic stirring bar and 1,2-dichloroethane (250 ml) followed by 
K2CO3 (20.1 g, 150 mmol, 2.5 equiv.) were added. The suspension was stirred and heated 
under reflux during 2 days. After cooling to room temperature, 200 ml of water were added 
and the mixture was extracted with CH2Cl2 (2 x 100 ml). The organic layers were 
combined, washed with water (200 ml) ad brine (200 ml), dried over MgSO4, filters and 
concentrated under reduced pressure to afford 13.9 g (58.2 mmol, 97%) of 5-(2-
chloroethylthio)-1-phenyl-1H-tetrazole as a pale yellow solid that was used in the next step 
without further purification. All data were consistent with those previously reported. 1H 
NMR (300 MHz, CDCl3), δ 7.72 (brs, 5H), 3.90 (t, J = 6.9 Hz, 2H), 3.67 (t, J = 6.9 Hz, 
2H). 
Step 2: The crude compound (4.8 g, 20 mmol, 1 equiv.) was placed in a 500 ml 
flask equipped with a magnetic stirring bar and dissolved in CH2Cl2 (50 ml). A solution of 
m-chloroperbenzoic acid (17.2 g, 100 mmol, 5 equiv.) in CH2Cl2 (200 ml) was added and 
the reaction mixture was stirred at room temperature for 3 days, whereupon it was filtered. 
The filtrate was transferred into a separatory funnel, washed with 150 ml of a NaHSO3 
solution 40% w/v, a sat. aq. NaHCO3 solution (2 x 150 ml) and brine (150 ml). The organic 
phase was dried over MgSO4, filtered and concentrated under vacuum. The obtained crude 
was dissolved in THF (100 mL) in a 250 mL flask equipped with a magnetic bar and 
triethylamine (4.1 mL, 30 mmol, 1.5 equiv.) was added dropwise. The clear solution turned 
to a clouded suspension which was stirred for 30 min. Solid triethylamine chloride was 
filtered and the solvent removed under reduced pressure. The residue was purified by flash 
column chromatography (hexane: EtOAc, 4: 1) to afford 4.53 g (19.2 mmol, 96%) of vinyl 
sulfone 35 as a white solid. All data were consistent with those previously reported. 1H 
NMR (300 MHz, CDCl3), δ 7.72 – 7.57 (m, 5H), 7.14 (dd, J = 10.0, 16.5 Hz, 1H), 6.67 (d, 
J = 16.5, 1H), 6.49 (d, J = 10 Hz, 1H). 
                                                 
127 Rodrigo, E.; Morales, S.; Duce, S.; García Ruano, J. L. Chem. Commun. 2011, 47, 11267–11269. 
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5.3.9. Addition of 2-benzylthio-4,6-dioxopyrimidines to heteroaryl vinyl 
sufone 35 
 
To a mixture of 2-(benzylthio)-1,5-dimethyldihydropyrimidine-4,6(1H,5H)-dione 13Aa 
(52.8 mg, 0.2 mmol, 1 equiv.) and heteroaryl vinyl sulfone 35 ( 56.7 mg, 0.24 mmol, 1.2 
equiv.) in CH2Cl2 (0.2 mL), was added the catalyst C10 (10 mol %) and the resulting 
mixture was stirred at room temperature for 16 h. Then the mixture was washed with water 
(0.4 mL), dried over anhydrous MgSO4, filtered, and the solvent was evaporated under 
reduced pressure. The crude material was purified by flash column chromatography on 
silica gel (eluent hexane: ethyl acetate, 1:1) to afford the 2-(benzylthio)-1,5-dimethyl-5-(2-
((1-phenyl-1H-tetrazol-5-yl)sulfonyl)ethyl)dihydropyrimidine-4,6(1H,5H)-dione 36 as a 
yellow foam, 65 mg, 0.13 mmol, 65% yield. 1H NMR (300 MHz, CDCl3) δ 7.82 – 7.53 (m, 
5H), 7.52 – 7.28 (m, 4H), 4.48 (d, J = 1.7 Hz, 2H), 3.99 – 3.69 (m, 2H), 3.30 (s, 3H), 2.61 
(ddd, J = 10.2, 9.0, 5.8 Hz, 2H), 1.54 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 178.14, 173.53, 
173.03, 153.31, 134.66, 133.37, 131.79, 130.59, 130.43, 130.00, 129.81, 129.46, 129.30, 
128.56, 125.63, 121.61, 52.60, 52.44, 37.95, 31.30, 30.46, 27.92, 25.96. UPLC-DAD-
QTOF: C22H24N6O4S2 [M+H]
+ calcd.:500.1300, found: 500.1702. 
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5.3.10. α-Amination reaction of 2-benzylthio-4,6-dioxopyrimidines 
 
To a mixture of 2-(benzylthio)-1,5-dimethyldihydropyrimidine-4,6(1H,5H)-dione 13Aa 
(52.8 mg, 0.2 mmol, 1 equiv.) and commercially available di-tert-butyl (E)-diazene-1,2-
dicarboxylate (55.2 mg, 0.24 mmol, 1.2 equiv.) in CH2Cl2 (0.2 mL), was added the catalyst 
C10 (10 mol %) and the resulting mixture was stirred at room temperature for 16 h. Then 
the mixture was evaporated under reduced pressure. The crude material was purified by 
flash column chromatography on silica gel (eluent hexane: ethyl acetate, 2:1) to afford di-
tert-butyl 1-((2-(benzylthio)-1,5-dimethyl-4,6-dioxohexahydropyrimidin-5-
yl)methyl)hydrazine-1,2-dicarboxylate 37 as a yellow foam, 71.1 mg, 0.14 mmol, 68% 
yield. 1H NMR (300 MHz, CDCl3) δ 7.32 (t, J = 1.8 Hz, 3H), 7.29 – 7.28 (m, 1H), 7.20 (s, 
1H), 4.40 (d, J = 2.2 Hz, 3H), 3.25 (s, 4H), 1.40 (s, 18H), 1.15 (d, J = 6.1 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 178.43, 173.10, 172.89, 170.15, 154.54, 129.38, 128.86, 128.43, 
128.19, 128.09, 127.69, 82.73, 64.37, 54.29, 52.80, 37.44, 31.62, 29.97, 28.06, 27.22, 
25.32, 23.28.UPLC-DAD-QTOF: C23H34N4O6S [M+H]
+ calcd.: 494.2199, found: 
494.2274. 
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5.3.11. Catalytic reactions of barbituric acid derivatives with allyl 
bromides 38 and 39. 
5.3.11.1. Synthesis of 2-(bromomethyl)acrylates 38 and 39 
 
Step 1: A solution of formaldehyde (30% aqueous, 2.5 mL, 30 mmol, 1.0 equiv.) and tert-
butyl or ethyl acrylate (90 mmol, 3.0 equiv.) in 200 mL of a mixture of 1,4-dioxane water 
(1:1, v/v) was stirred at room temperature over night. Then DABCO (10 g, 90 mmol, 3 
equiv.) was added and the mixture was stirred until the starting acrylate disappeared 
(monitored by TLC). The reaction mixture was then partitioned with ether (100 mL) and 
water (80 ml). The organic phase was washed with brine, dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to give tert-butyl 2-
(hydroxymethyl)acrylateas and the ethyl 2-(hydroxymethyl)acrylate, respectively, as a 
yellow oil. 
Step 2: The material obtained in the previous step (5 mmol, 1 equiv.), was dissolved 
in ether (5 mL) and cooled down in an ice/salt bath to – 30 °C. A solution of PBr3 (1.24 
mL, 2.5 mmol, 0.5 equiv.) in ether (7 mL) and added dropwise over a period of 5 min to 
the chilled reaction mixture, and the mixture was allowed to stir at 0 °C for 3 h. The reaction 
flask was cooled to – 10 °C, and H2O (5 mL) was added slowly with stirring. The mixture 
was then diluted with hexane (15 mL) and washed with H2O (20 mL). The organic layer 
was separated, dried, filtered, and the solvent evaporated to afford an oil product wich was 
purified by flash column chromatography (eluent hexane ethyl acetate, 10:1). Physical and 
spectroscopic data of that obtained products 38128 and 39129 were identical to those reported 
in the literature. Compound 38, yield: 599 mg, 18.6 mmol, 62%;1H NMR (300 MHz, 
CDCl3) δ 6.27 (d, J = 1.0, 0.8 Hz, 1H), 5.85 (q, J = 1.1 Hz, 1H), 4.35 (d, J = 1.1 Hz, 2H), 
4.27 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H). Compound 39, yield: 545 mg, 18.9 mmol, 
63%; 1H NMR (300 MHz, CDCl3) δ 6.25 (d, J = 1.0 Hz, 1H), 5.88 (q, J = 0.9 Hz, 1H), 4.17 
(d, J = 0.9 Hz, 2H), 1.55 (s, 9H). 
                                                 
128 Reproduced from: Pautigny, C.; Séverine Jeulin, T.; Ayad, Z.; Zhang, J.; Genêt, V.; Vidal, R. Adv. Synth. 
Catal. 2008, 350, 2525–2532. 
129 Reproduced from: Rüping, F.; Maison, C.H. K., W. ARKIVOC, 2015, (ii), 93–108. 
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5.3.11.2. Screening of bases for the reaction of 13Aa with 39 using 
catalyst C10 
 
 
5.3.11.3. General procedure and data of adducts 
 
To a mixture of the corresponding template 13 (0.2 mmol, 1.0 equiv.) and allylic bromide 
38 or 39 (0.20 mmol, 1.0 equiv.) in CH2Cl2 (1.0 mL), catalyst C10 (10 mol %) and K2CO3 
(28 mg, 0.2 mmol, 1.0 equiv.) were added and the reaction was stirred at 0 °C for 16 h. 
Then the mixture was quenched with HCl 1 M and extracted with CH2Cl2 (3 x 2 mL). The 
organic layer was washed with water (3 x 2 mL), dried over MgSO4 , filtered,  and solvent 
was evaporated under reduced pressure. The crude material was purified by flash column 
chromatography on silica gel (eluent hexane/ ethyl acetate, 4:1). 
  
Base Conversion (%, overnight) Yield (%) ee (%) 
K2CO3 100 63 99 
K3PO4 100 61 97 
Cs2CO3 100 65 77 
Et3N 100 71 10 
DMAP 100 68 24 
Without base 0 -- -- 
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(R)-2-((2-(Benzylthio)-1,5-dimethyl-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-5-
yl)methyl)acrylate (40) 
Prepared according to the general procedure starting from 2-
(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione 
(13Aa) and ethyl 2-(bromomethyl)acrylate (38). The title 
compound was obtained as a yellow oil. Yield: 45.6 mg, 0.12 
mmol, 62%. [α]D23= +81.25 ° (c = 0.24, 48 % ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 7.41 – 7.34 (m, 5H), 6.25 (s, 1H), 5.55 (s, 1H), 4.47 (d, J = 1.5 
Hz, 2H), 4.17 (dd, J = 7, 1Hz, 2 H), 3.31 (s, 3H), 3.01 (dd, J = 13, 1 Hz, 1 H), 2.79 (dd, J 
= 13,1 Hz, 1H), 1.52 (s, 3H), 1.30 (t, J = 7 Hz, 3H).13C NMR (75 MHz, CDCl3) δ 178.8, 
173.3, 173.2, 166.6, 135.3, 134.8, 129.7, 129.3, 129.1, 128.2, 125.6, 61.3, 53.8, 44.6, 41.6, 
37.6, 30.2, 21.2, 14.3. MS (ESI, m/z): calcd for C19H22N2O4S (M, H
+), 375.1300; found, 
375.1400. 
tert-Butyl (R)-2-((2-(benzylthio)-1,5-dimethyl-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-
5-yl)methyl)acrylate (41Aa) 
Prepared according to the general procedure starting from 2-
(benzylthio)-1,5-dimethylpyrimidine-4,6(1H,5H)-dione 
(13Aa) and tert-butyl 2-(bromomethyl)acrylate (39). The title 
compound was obtained as a yellow oil. Yield: 50.7 mg, 0.13 
mmol, 63%. [α]D22= +45.47° (c = 0.17, 99 % ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 7.50 – 7.25 (m, 5H), 6.17 (d, J = 1.3 Hz, 1H), 5.50 (d, J = 1.2 
Hz, 1H), 4.48 (s, 2H), 3.31 (s, 3H), 2.98 (dd, J = 13.5, 0.9 Hz, 1H), 2.71 (dd, J = 13.6, 0.9 
Hz, 1H), 1.52 (s, 3H), 1.48 (s, 9H).13C NMR (75 MHz, CDCl3) δ 179.5, 173.7, 166.3, 136.9, 
135.3, 130.2, 129.5, 129.3, 129.1, 128.7, 81.9, 67.8, 54.3, 42.4, 38.0, 30.7, 30.4, 28.6, 28.6, 
21.3. MS (ESI, m/z): calcd for C21H26N2O4S (M, H
+), 403.1613; found, 143.1614. 
tert-Butyl (R)-2-((1-benzyl-2-(benzylthio)-5-methyl-4,6-dioxo-1,4,5,6-
tetrahydropyrimidin-5-yl)methyl)acrylate (41Ab) 
Prepared according to the general procedure starting from 1-
benzyl-2-(benzylthio)-5-methylpyrimidine-4,6(1H,5H)-dione 
(13Ab) and tert-butyl 2-(bromomethyl)acrylate (39). The title 
compound was obtained as a yellow oil. Yield: 65.1 mg, 0.14 
mmol, 68%. [α]D22= +36.45° (c= 0.27, 90 % ee, CH2Cl2).  1H 
NMR (300 MHz, CDCl3) δ 7.49 – 7.19 (m, 12H), 6.13 (d, J = 
1.1 Hz, 1H), 5.40 (q, J = 1.0 Hz, 1H), 5.18 (d, J = 16.1 Hz, 1H), 4.90 (d, J = 16.1 Hz, 1H), 
4.53 – 4.38 (m, 2H), 3.01 (dd, J = 13.9, 1.0 Hz, 1H), 2.82 (dd, J = 13.9, 1.0 Hz, 1H), 1.54 
(s, 3H), 1.50 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 179.51, 174.47, 173.51, 166.77, 137.43, 
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136.14, 135.64, 130.54, 129.86, 129.74, 129.15, 129.04, 128.76, 82.26, 54.82, 48.27, 41.78, 
38.71, 29.03, 28.96, 22.66.MS (ESI, m/z): calcd for C27H30N2O4S (M, H
+), 479.1926; 
found, 479.18263. 
tert-Butyl (R)-2-((2-(benzylthio)-1-pentyl-5-methyl-4,6-dioxo-1,4,5,6-
tetrahydropyrimidin-5-yl)methyl)acrylate(41Ac) 
Prepared according to the general procedure starting from 1-
benzyl-2-(pentylthio)-5-methylpyrimidine-4,6(1H,5H)-dione 
(13Ac) and tert-butyl 2-(bromomethyl)acrylate (39). The title 
compound was obtained as colorless oil. Yield: 68.6 mg, 0.15 
mmol, 73%. [α]D22= +77.65° (c = 0.25, 98 % ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 7.51 – 7.22 (m, 5H), 6.15 (d, J = 1.2 Hz, 1H), 5.43 (d, J = 1.1 
Hz, 1H), 4.47 (s, 2H), 3.91 – 3.63 (m, 2H), 2.97 (dd, J = 13.9, 1.0 Hz, 1H), 2.77 (dd, J = 
13.9, 1.0 Hz, 1H), 1.67 – 1.61 (m, 3H), 1.50 (d, J = 5.5 Hz, 12H), 1.32 (ddd, J = 9.3, 7.7, 
5.5 Hz, 3H), 0.90 (t, J = 6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 179.42, 173.73, 173.10, 
166.25, 137.16, 135.32, 130.18, 129.50, 128.66, 128.58, 81.80, 54.13, 45.14, 41.59, 38.01, 
29.50, 28.61, 28.52, 22.80, 22.27, 14.56. MS (ESI, m/z): calcd for C25H34N2O4S (M, H
+), 
459.2239; found, 459.2240. 
tert-Butyl (R)-2-((2-(benzylthio)-5-ethyl-1-methyl-4,6-dioxo-1,4,5,6-
tetrahydropyrimidin-5-yl)methyl)acrylatetert-butyl (41Ba) 
Prepared according to the general procedure from 2-
(benzylthio)-5-ethyl-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Ba) and tert-butyl 2-(bromomethyl)acrylate (39). The title 
compound was obtained as a yellow oil. Yield: 54.1 mg, 0.13 
mmol, 67%. [α]D22=  ̶ 55.63°(c = 0.19, 96 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
7.49 – 7.24 (m, 5H), 6.12 (d, J = 1.3 Hz, 1H), 5.49 (d, J = 1.2 Hz, 1H), 4.47 (s, 2H), 3.33 
(s, 3H), 3.04 – 2.77 (m, 2H), 2.09 (q, J = 7.4 Hz, 2H), 1.47 (s, 10H), 0.83 (t, J = 7.3 Hz, 
3H).13C NMR (75 MHz, CDCl3) 
13C NMR (75 MHz, CDCl3) δ 178.6, 174.2, 173.4, 166.4, 
137.3, 135.3, 130.1, 129.5, 128.9, 128.7, 81.8, 59.9, 42.1, 38.0, 31.6, 30.5, 28.6, 10.3.MS 
(ESI, m/z): calcd for C22H28N2O4S (M, H
+), 417.1770; found, 417.1774. 
  
 EXPERIMENTAL SECTION 189 
 Asymmetric α-Functionalization of Barbituric Acids via Brønsted Base Catalysis  
tert-Butyl (R)-2-((5-benzyl-2-(benzylthio)-1-methyl-4,6-dioxo-1,4,5,6-
tetrahydropyrimidin-5-yl)methyl)acrylate (41Ca) 
Prepared according to the general procedure starting from 5-
benzyl-2-(benzylthio)-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Ca) and tert-butyl 2-(bromomethyl)acrylate (39). The title 
compound was obtained as a yellow oil. Yield: 60.2 mg, 0.13 
mmol, 63%. [α]D22= +70.30° (c= 0.20, 86 % ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3)
 δ 7.43 – 7.01 (m, 10H), 6.11 (d, J = 1.0 Hz, 1H), 5.43 (d, J = 1.1 
Hz, 1H), 4.28 (d, J = 1.9 Hz, 2H), 3.44 – 3.20 (m, 2H), 3.13 (d, J = 9.5 Hz, 5H), 1.48 (s, 
9H). 13C NMR (75 MHz, CDCl3) δ 178.4, 174.6, 173.4, 166.9, 138.2, 136.3, 135.7, 130.9, 
130.5, 129.9, 129.2, 129.0, 128.3, 128.3, 82.19, 61.1, 46.9, 41.4, 38.3, 30.7, 29.0.MS (ESI, 
m/z): calcd for C27H30N2O4S (M, H
+), 479.1926; found, 479.19263. 
tert-Butyl (R)-2-((5-allyl-2-(benzylthio)-1-methyl-4,6-dioxo-1,4,5,6-
tetrahydropyrimidin-5-yl)methyl)acrylate (41Fa) 
Prepared according to the general procedure starting from 5-
allyl-2-(benzylthio)-1-methylpyrimidine-4,6(1H,5H)-dione 
(13Fa) and tert-butyl 2-(bromomethyl)acrylate (39). The title 
compound was obtained as a yellow oil. Yield: 54.8 mg, 0.13 
mmol, 65%. [α]D22= +69.68° (c= 0.25, 92 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
7.44 – 7.27 (m, 4H), 6.14 (s, 1H), 5.72 – 5.54 (m, 1H), 5.49 (d, J = 1.2 Hz, 1H), 5.19 – 5.00 
(m, 2H), 4.46 (s, 2H), 3.31 (s, 3H), 3.02 – 2.83 (m, 2H), 2.81 – 2.66 (m, 2H), 1.47 (s, 
9H).13C NMR (75 MHz, CDCl3) δ 178.0, 174.3, 172.9, 166.3, 137.2, 135.3, 132.5, 130.5, 
130.1, 129.5, 128.9, 128.8, 128.7, 120.6, 81.8, 59.1, 42.3, 41.6, 38.0, 30.47, 28.6. MS (ESI, 
m/z): calcd for C23H18N2O4S (M, H
+), 429.1770; found, 429.1870. 
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5.3.12. Elaborations of Adducts 
5.3.12.1. . Synthesis of carboxylic acid 42 
 
Adduct 32Aa (54 mg, 0.2 mmol, 1 equiv.) was dissolved in 2 mL of methanol, and to this 
solution a suspension of sodium periodate (200 mg, 1.0 mmol, 5 equiv.) in water (1.0 mL) 
was added. The reaction mixture was stirred at room temperature, until disappearance of 
starting material as monitored by TLC (6 h). Then the solvent was evaporated under 
reduced pressure. The residue was partitioned between water (3 mL) and EtOAc (6 mL) 
and the aqueous phase was extracted with EtOAc (3 x 6 mL). The combined organic phases 
were dried over MgSO4, filtered, and the solvent was evaporated under reduced pressure, 
to afford essentially pure (R)-3-(1,5-dimethyl-2,4,6-trioxohexahydropyrimidin-5-
yl)propanoic acid 42. Yellow oil. Yield: 43.3 mg, 0.19 mmol, 97%. [α]D22= +2.1° (c= 0.18, 
CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 9.52 (s, 1H), 3.30 (s, 3H), 2.49 – 2.24 (m, 4H), 
1.56 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 177.6, 173.0, 172.6, 150.6, 50.8, 32.8, 30.2, 
28.5, 25.8. UPLC-DAD-QTOF: calcd for C9H13N2O2 (M, H
+), 229.0824; found, 229.0822. 
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5.3.12.2. Conversion of 45Aa into alkenes 56-58 
 
Step 1: BH3.THF complex (1 M in THF, 0.4 mL, 0.4 mmol, 2 equiv.) was added to a 
solution of adduct 32Aa (54 mg, 0.2 mmol, 1 equiv.) in dry THF (0.8 mL) at 0 °C and the 
resulting solution was stirred at the same temperature until the starting material disappeared 
(6 h). MeOH (0.4 mL) was added and the resulting mixture was stirred at room temperature 
for 30 min. The solvents were evaporated under reduced pressure and the residue thus 
obtained was dissolved in MeOH (0.4 mL) and a suspension of sodium periodate (107 mg, 
1 mmol, 5 equiv.) in water (0.5 mL) was added to the solution at room temperature. The 
reaction mixture was stirred at the same temperature for 1.5 h and solvents were evaporated 
under reduced pressure. Water 3 mL was added to the crude product and the resulting 
mixture was extracted with EtOAc (3 X 3 mL). The combined organic phases were dried 
over MgSO4, filtered, and the solvent was evaporated under reduced pressure, affording the 
aldehyde 30 as essentially pure compound. Yellow oil. Yield: 41.3 mg, 0.18 mmol, 88%. 
[α]D23= +0.84° (c = 0.34, 94 % ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 9.66 (s, 1H), 
8.92 (s, 1H), 3.27 (s, 3H), 2.49 – 2.41 (m, 2H), 2.30 (dd, J = 7.7, 6.3 Hz, 2H), 1.56 (s, 
3H).13C NMR (75 MHz, CDCl3) δ 200.0, 172.3, 171.5, 149.8, 50.5, 39.1, 30.0, 28.1, 24.5. 
UPLC-DAD-QTOF: calcd for C9H12N2O4Na (M, +Na), 235.0695; found, 235.0683.  
Step 2: 
(Method A) Synthesis of (R)-5-(but-3-en-1-yl)-1,5-dimethylpyrimidine-
2,4,6(1H,3H,5H)-trione 43130 
Methyltriphenylphosphonium bromide (142.8 mg, 0.4 mmol, 2 equiv.) was dissolved in 
THF (0.5 mL). Then t-BuOK (67.2 mg, 0.6 mmol, 3 equiv.) was added and the yellow 
suspension was stirred at 0 °C for 45 min. To this suspension a solution of the aldehyde 
(30) (42 mg, 0.2 mmol, 1 equiv.) in THF (0.3 mL) was added dropwise and the resulting 
mixture was stirred at room temperature for 6 h. Then, the solvents were evaporated under 
reduced pressure. The crude was purified by flash column chromatography on silica gel 
(eluent hexane: ethyl acetate, 4:1) to give the title compound as a white oil. Yield: 26 mg, 
1.14 mmol, 72%. [α]D23= +1.34 °(c = 0.88, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.93 
                                                 
130 Yang, N. Y.; Li, Z. L.; Ye, L.; Tan, B.; Liu, X. Y. Chem. Commun. 2016, 52, 9052–9055. 
192 CHAPTER 5  
 
(s, 1H), 5.77 – 5.62 (m, 1H), 5.05 – 4.92 (m, 2H), 3.30 (s, 3H), 2.16 (dd, J = 8.2, 1.2 Hz, 
2H), 2.08 – 1.97 (m, 2H), 1.58 (s, 4H).13C NMR (75 MHz, CDCl3) δ 172.7, 171.5, 149.5, 
136.4, 116.1, 51.1, 37.9, 29.9, 29.7, 25.1. UPLC-DAD-QTOF: calcd for C10H13N2O3 (M, 
H+), 209.0926; found, 209.0949. 
(Method B) Synthesis of (R,E)-1,5-dimethyl-5-(5-oxohex-3-en-1-yl)pyrimidine-
2,4,6(1H,3H,5H)-trione 44 
1-(Triphenylphosphoranylidene)-2-propanone (127.3 mg, 0.4 mmol, 2 equiv.) was 
dissolved in THF (0.5 mL). Then t-BuOK (33.6 mg, 0.6 mmol, 3 equiv.) was added and 
the yellow suspension was stirred at 0 °C for 45 min. To this suspension a solution of 
aldehyde 30 (42 mg, 0.2mmol, 1 equiv.) in THF (0.3 mL) was added dropwise and the 
resulting mixture was stirred at room temperature for 6 h. After reaction completion the 
solvents were evaporated under reduced pressure. The crude material was purified by flash 
column chromatography on silica gel (eluent with hexane: ethyl acetate 4:1) to give the title 
compound as a single diastereomer as a white oil. Yield: 55.7 mg, 0.14 mmol, 69%. [α]D23= 
+0.87°(c = 0.47, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 8.37 (s, 1H), 6.68 (d, J = 16.0 Hz, 
1H), 6.05 (d, J = 16.2 Hz, 1H), 3.31 (s, 3H), 2.28 – 2.12 (m, 7H), 1.60 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 198.7, 173.0, 172.0, 150.2, 145.7, 132.6, 51.9, 36.9, 29.0, 28.8, 27.8, 
26.2. UPLC-DAD-QTOF: calcd for C12H17N2O4 (M, H
+), 253.1188; found, 253.1197. 
(Method C) Synthesis of (R,E)-5-(4-bromobut-3-en-1-yl)-1,5-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione131 45 
To a solution of bromomethyl triphenylphosphonium bromide (95.8 mg, 0.22 mmol, 1.1 
equiv.) in anhydrous THF (1 mL), at – 78 °C, t-BuOK (26.6 mg, 0.22 mmol, 1.1 equiv.) 
was added. After stirring the mixture for 1 h at – 78 °C, a solution of aldehyde 30 (42 mg, 
0.2 mmol, 1 equiv.) in anhydrous THF (0.2 mL) was added dropwise and the reaction 
mixture was stirred for a further 1 h at – 78 °C. The reaction was then warmed to room 
temperature over 1 h. The solvents were evaporated under reduced pressure, the residue 
was purified by flash column chromatography on silica gel (eluent hexane/ethyl acetate 
2:1) to give the title compound as a mixture of diastereomers (dr 17:3 ) as a white oil. Yield: 
34.4 mg, 0.14 mmol, 68%. [α]D23= +1.34 ° (c = 0.52, CH2Cl2). 1H NMR (300 MHz, CDCl3) 
δ 8.07 (s, 1H), 6.19 (d, J = 6.9 Hz, 1H), 6.07 – 5.93 (m, 1H), 3.32 (s, 3H), 2.24 – 2.19 (m, 
4H), 1.59 (s, 4H).13C NMR (75 MHz, CDCl3) δ 173.1, 172.2, 150.2, 133.3, 110.1, 51.7, 
37.2, 28.8, 26.8, 26.2. UPLC-DAD-QTOF: calcd for C9H13N2O2 (M, H
+), 287.0031; found, 
207.0034.  
                                                 
131 Tofi, M.; Georgiou, T.; Montagnon, T.; Vassilikogiannakis, G. Org. Lett. 2005, 15, 3347–3350. 
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5.3.12.3. Conversion of 32Aa into ketone 15 (chemical correlation to 19) 
 
p-Tolylmagnesium bromide (5 M in THF, 1 mmol, 5 equiv.) was added to a solution of 
32Aa (54 mg, 0.2 mmol, 1 equiv.) in dry THF (1 mL) at 0 oC and the resulting solution was 
stirred at the same temperature until the reaction was finished (monitored by TLC). Then a 
saturated aqueous solution of NH4Cl (2 mL) was added at 0 
oC and the resulting mixture 
was extracted with CH2Cl2 (3  3 mL). The solvents were evaporated under reduced 
pressure and the residue thus obtained was dissolved in MeOH (1 mL). A suspension of 
NaIO4 (214 mg, 1 mmol, 5 equiv.) in water (0.4 mL) was added to the solution at room 
temperature and the resulting mixture was stirred at the same temperature for 1 h. Then 
solvents were evaporated under reduced pressure, water (2 mL) was added to the residue 
and the resulting mixture was extracted with CH2Cl2 (3  3 mL). The combined organic 
phases were dried over MgSO4, filtered and evaporated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (eluting with 
hexane/ethyl acetate, 3:1) to give ketone 15 as a white oil. Yield: 32 mg, 0.12 mmol, 53%. 
[α]D24= –58.70° (c= 0.27, CH2Cl2, 90 % ee). 1H NMR (300 MHz, CDCl3) δ 8.89 (s, 1H), 
7.77 (d, J = 9 Hz, 2H), 7.22 (d, J = 9 Hz, 2H), 3.28 (s, 3H), 2.97 – 2.80 (m, 2H), 2.44 – 
2.38 – 2.35 (m, 5H), 1.58 (s, 3H). 13C NMR (300 MHz, CDCl3) δ 198.0, 172.5, 171.8, 
150.0, 144.2, 133.8, 129.26, 128.1, 50.7, 33.4, 32.4, 28.1, 24.3, 21.6. MS (ESI, m/z): calcd 
for C16H18N2O4 (M, H
+), 303.1345; found, 303.1353. 
On the other hand, adduct 19 (60.6 mg, 0.2 mmol, 1 equiv.) was dissolved in 
dioxane/6 M HCl (0.5 ml/ 0.5 mL), and the resulting mixture was stirred at r.t. for 6 h. Then 
the mixture was quenched with an aqueous solution of NaHCO3 (2 mL), diluted with water 
(2 mL) and extracted with EtOAc (3  4 mL). The combined organic layers were dried over 
MgSO4, filtered, and the solvents were evaporated under reduced pressure. The crude 
material was purified by flash column chromatography on silica gel (eluting with 
hexane/ethyl acetate 3:1) to give ketone 15 as a white oil. Yied 45 mg, 0.14 mmol, 70%. 
[α]D23= – 54.32° (c= 0.29, CH2Cl2). 
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5.3.12.4. Conversion of adduct 41Fa into spiranic compounds 46 and 47 
 
Step 1: To a solution of 41Fa (85.7 mg, 0.2 mmol, 1 equiv.) in CH2Cl2 (8 mL) was added  
Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-
imidazolidinylidene](benzylidene)(tricyclohexylphosphine)ruthenium(II) (2nd generation 
Grubbs Catalyst) (6.4 mg, 5 mol %) and the reaction was stirred a reflux for 24 h. The 
resulting mixture was directly submitted to a flash column chromatography on silica gel 
(eluent hexane: ethyl acetate, 8:1) to give the title compound 46 as a red oil. Yield: 63.1 
mg, 0.16 mmol, 78%. [α]D22= +5.07° (c= 0.16, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
7.50 – 7.31 (m, 4H), 6.61 (d, J = 2.4 Hz, 1H), 4.50 (s, 2H), 3.38 (s, 3H), 3.34 – 3.02 (m, 
4H), 1.49 (s, 9H).13C NMR (75 MHz, CDCl3) δ 178.6, 173.7, 173.5, 163.7, 139.6, 135.2, 
134.2, 130.1, 129.6, 128.8, 81.5, 58.2, 43.9, 41.7, 38.1, 30.9, 28.8, 28.6. UPLC-DAD-
QTOF: calcd for C21H24N2O4S (M
+), 400.1457; found, 400.1455. 
Step 2: To a solution of spiranic compound 46 (40.1 mg, 0.1 mmol, 1 equiv.) in a 
mixture of dioxane/ H2O (3:1, 0.4 mL) was added HCl 6 M (3 drops). The reaction was 
stirred at room temperature for 1 h. Then the mixture was directly submitted to a column 
chromatography on silica gel (eluent hexane: ethyl acetate, 2:1) to give the title compound 
47 as a red oil. Yield: 17.9 mg, 0.06 mmol, 61%. [α]D22= +3.05° (c= 0.07, CH2Cl2).1H NMR 
(300 MHz, CDCl3) δ 6.65 – 6.57 (m, 1H), 3.33 (s, 3H), 3.21 (s, 4H), 1.50 (s, 9H). 13C NMR 
(75 MHz, CDCl3) δ 172.3, 170.9, 162.7, 149.5, 138.2, 134.3, 81.1, 54.5, 44.9, 43.3, 28.5, 
28.1.UPLC-DAD-QTOF: calcd for C14H18N2O5 (M
+), 294.1216; found, 294.1214. 
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5.3.12.5. N-Alkylation of adduct 43 
 
To a solution of adduct 43 (54 mg, 0.2 mmol, 1 equiv.) in DMF (0.4 mL) was added DIPEA 
(44 µL, 0.26 mmol, 1.3 equiv.) and after stirring for 5 minutes at room temperature benzyl 
or allyl bromide was added (0.26 mmol, 1.3 equiv.). The resulting solution was stirred at 
the same temperature until disappearance of starting material as monitored by 1H NMR. 
Water (1 mL) was added and the resulting mixture was extracted with EtOAc (3 x 1 mL). 
The combined organic layers were washed with brine (10 x 3 mL), dried over MgSO4, 
filtered, and the solvent was evaporated under reduced pressure. The crude material was 
purified by flash column chromatography on silica gel (eluent hexane: ethyl acetate, 6:1) 
(R)-1-Benzyl-5-(but-3-en-1-yl)-3,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (48) 
Prepared according to the general procedure using benzyl bromide. 
Colorless oil. Yield: 42.6 mg, 0.14 mmol, 71%. [α]D23= +1.23° (c = 
0.23, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.53 – 7.23 (m, 5H), 
5.70 – 5.45 (m, 1H), 5.08 (d, J = 1.4 Hz, 2H), 4.84 – 4.67 (m, 2H), 
3.30 (s, 3H), 2.18 – 2.09 (m, 2H), 1.94 – 1.81 (m, 2H), 1.54 (s, 3H).13C 
NMR (75 MHz, CDCl3) δ 172.8, 172.7, 151.6, 137.2, 129.8, 129.2, 
128.7, 116.5, 51.8, 45.8, 39.4, 30.5, 29.3, 26.0. UPLC-DAD-QTOF: calcd for C17H20N2O3 
(M, H+), 301.1474; found, 301.1476. 
(R)-1-Allyl-5-(but-3-en-1-yl)-3,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (49) 
Prepared according to the general procedure using allyl bromide. 
Colorless oil. Yield: 31.5 mg, 0.13 mmol, 63%. [α]D23= +0.87° (c= 
0.27, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 5.87 (dd, J = 17.1, 10.2 
Hz, 1H), 5.75 – 5.58 (m, 1H), 5.39 – 5.19 (m, 2H), 5.04 – 4.83 (m, 
2H), 4.50 (dd, J = 6.1, 1.3 Hz, 2H), 3.31 (d, J = 0.7 Hz, 3H), 2.16 (dd, 
J = 9.2, 6.5 Hz, 2H), 2.05 – 1.88 (m, 2H), 1.55 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 172.9, 
172.33, 151.3, 137.3, 132.0, 119.6, 116.6, 51.8, 44.7, 39.2, 30.6, 29.3, 26.2.UPLC-DAD-
QTOF:  calcd for C13H18N2O3 (M, H
+), 251.1317; found, 251.1319. 
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5.3.12.6. Arylation of adduct 43132 
 
A slurry of adduct 43 (42 mg, 0.2 mmol, 1 equiv.), phenylboronic acid (73.0 mg, 
0.6 mmol, 3 equiv.), anhydrous Cu(OAc)2 (72.6 mg, 0.4 mmol, 2 equiv.), and triethylamine 
(80 µL, 0.6 mmol, 3 equiv.) in ethylene chloride (0.2 mL) was stirred a reflux for 24 h. 
Then the mixture was directly submitted to a flash column chromatography on silica gel 
(eluent hexane: ethyl acetate, 8:1) to give the title compound as a yellow oil. Yield: 38.9 
mg, 0.14 mmol, 68%. [α]D22= +0.34° (c= 0.12, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
7.58 – 7.43 (m, 3H), 7.21 – 7.17 (m, 2H), 5.86 – 5.65 (m, 1H), 5.12 – 4.97 (m, 2H), 3.37 
(s, 3H), 2.30 – 2.21 (m, 2H), 2.17 – 2.07 (m, 2H), 1.66 (s, 3H).13C NMR (75 MHz, CDCl3) 
δ 172.1, 171.9, 150.8, 136.7, 134.5, 129.4, 129.1, 128.2, 116.1, 51.5, 38.5, 30.1, 28.7, 25.6. 
UPLC-DAD-QTOF: calcd for C16H18N2O3 (M, H
+), 286.1317; found, 286.1315. 
  
                                                 
132 Addapted from: Chan, D. M. T.; Monaco, K. L.; Wang, R. P.; Winters, M. P. Tetrahedron Lett. 1998, 39, 
2933–2936. 
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5.3.12.7. X-ray analysis: ORTEP diagrams of compounds 25 and 32Ad 
 
Molecule A 
 
Molecule B 
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5.3.13. Representative NMR spectra 
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5.3.14. HPLC chromatograms 
Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 50:50, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 90:10, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 50:50, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IC 0.5 mL/min, hexano:isopropanol 95:5, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 50:50, λ = 210 nm  
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Chiralpack IB 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
 
 
 
 
 
 
 
  
1
7
.0
4
4
2
3
.7
9
9
A
U
0.00
0.10
0.20
0.30
0.40
0.50
Minutes
10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00
1
6
.7
5
8
2
3
.3
8
3
A
U
0.00
0.20
0.40
0.60
0.80
1.00
Minutes
10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00
 Retention Time % Area 
1 17.044 50.50 
2 23.799 49.50 
 Retention Time % Area 
1 16.758 95.83 
2 23.383 4.17 
288 CHAPTER 5  
 
HPLC analyses of aldehyde 30 were carried out after derivatization of 30 onto the 
corresponding dimethyl acetal. 
Chiralpack IB 0.5 mL/min, hexano:isopropanol 80:20, λ= 210 nm  
 
 
a) Obtained from the conjugate addition to acrolein and derivatization (Section 
5.3.6.5 p. 175) 
 
 
b) Obtained from the oxidative scission of adduct 32Aa and derivatization (Section 
5.3.12.3, p 191) 
 
 
Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IB 0.5 mL/min, hexano:isopropanol 90:10, λ = 210 nm  
 
 
 
 
 
  
2
0
.0
3
0
2
3
.6
6
6
A
U
0.00
0.20
0.40
0.60
0.80
1.00
Minutes
12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00
17
.0
49
18
.8
42
A
U
0.00
0.20
0.40
0.60
0.80
Minutes
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
 Retention Time % Area 
1 20.030 51.17 
2 23.666 48.83 
 Retention Time % Area 
1 17.049 93.48 
2 18.842 6.52 
292 CHAPTER 5  
 
Chiralpak IA, 80:20 Hexano:i-PrOH, 0.5 mL/min, λ=210 nm 
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack IA 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpack ADH 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpak IC, 50:50 Hexano:iPrOH, 1.0 mL/min, λ=210 nm 
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Chiralpack IC 0.5 mL/min, hexano:isopropanol 80:20, λ = 210 nm  
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Chiralpak IA, 80:20 Hexano:i-PrOH, 0.5 mL/min, λ=210 nm 
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Chiralpak IA, 80:20 Hexano:i-PrOH, 0.5 mL/min, λ=210 nm 
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Chiralpak IC, 80:20 Hexano:i-PrOH, 0.5 mL/min, λ=210 nm 
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Chiralpak IC, 80:20 Hexano:i-PrOH, 0.5 mL/min, λ=210 nm 
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Chiralpak IC, 80:20 Hexano:i-PrOH, 0.5 mL/min, λ=210 nm 
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Chiralpak IA, 90:10 Hexano:i-PrOH, 1.0 mL/min, λ=210 nm 
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Chiralpak IC, 90:10 Hexano:EtOH, 1.0 mL/min, λ=210 nm 
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5.4. Experimental section of Chapter 4 
5.4.1. Synthesis of (E)-N-(2-nitrophenyl)-4-phenylbut-3-enamide 51 
 
Step 1: Preparation of allyl carboxylic acid: 133 
Phenylacetaldehyde (5.80 ml, 50.0 mmol, 1.0 equiv.) was added to a mixture of malonic 
acid (5.7 g, 55.0 mmol, 1.1 equiv.) and N-methylmorpholine (5.6 g, 55.0 mmol, 1.1. equiv.). 
The reaction mixture was heated at 95 oC for 16 h. Then, the mixture was cooled to room 
temperature, and 11 % H2SO4 (25.0 mL) was added with continuous stirring for 30 min. 
The mixture was extracted with CH2Cl2 (2 x 20 mL), washed with H2O, dried over MgSO4, 
filtered, and concentrated under reduced pressure. The crude was purified via silica gel 
chromatography (Hexane: EtOAc 60: 40) to obtain the acid as a yellow oil (2.9 g, 42.5 
mmol, 85%). 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.18 (m, 5H), 6.61 – 6.48 (m, 1H), 6.32 
(dt, J = 15.9, 7.1 Hz, 1H), 3.33 (dd, J = 7.1, 1.4 Hz, 2H). 
Step 2: Preparation of 51 
To a solution of allyl carboxylic acid (3.6 g, 20 mmol, 1 equiv.) SOCl2 is added (3 mL, 40 
mmol, 2 equiv.) at 0 °C and stirred at room temperature under nitrogen for 16 h. After 
completion the SOCl2 was evaporated under reduced pressure and the residue was 
dissolved in pyridine (5.2 g., 66 mmol, 3.3 equiv.) and o-nitrophenyl amine (2.4 g, 20 
mmol, 1 equiv.) was added dropwise at 0 °C. After completion, the reaction was diluted in 
DCM (20 mL) and acidified with HCl 1 M, the aqueous phase was then extracted with 
dichloromethane (3 x 150 mL), dried over MgSO4 and concentrated under reduced 
pressure. The crude was purified via silica gel chromatography (Hexane: EtOAc, 3:1) to 
obtain 51 as a yellow oil (6.9 g, 10.6 mmol, 53%). 1H NMR (300 MHz, CDCl3) δ 10.60 
(brs, 1H), 8.83 (dd, J = 8.6, 1.3 Hz, 1H), 8.23 (dd, J = 8.5, 1.6 Hz, 1H), 7.67 (ddd, J = 8.7, 
7.3, 1.6 Hz, 1H), 7.54 – 7.43 (m, 2H), 7.43 – 7.24 (m, 3H), 7.20 (ddd, J = 8.6, 7.3, 1.4 Hz, 
1H), 6.73 (dt, J = 15.7, 1.3 Hz, 1H), 6.41 (dt, J = 15.7, 7.4 Hz, 1H), 3.45 (dd, J = 7.4, 1.3 
Hz, 2H).13C NMR (75 MHz, CDCl3) δ 164.8, 135.3, 135.1, 134.84, 134.7, 134.6, 129.8, 
                                                 
133 Zhang, S. J.; Hu, W. X. Synth. Commun. 2010, 40, 3093–3100. 
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129.5, 126.2, 114.9, 114.9, 114.8, 114.7, 114.7, 56.2. UPLC-DAD-QTOF: C16H14N2O3 
[M+H]+ calcd.: 282.1004, found: 282.1107. 
5.4.1.1. Synthesis of iminoamides 56 and 57 
 
Step 1:134  
A protected amino acid (997 mg, 5.7 mmol, 1 equiv.) and nitroaniline (780 mg, 5.7 mmol, 
1 equiv.) were dissolved in dry pyridine (30 mL). The clear yellow solution was cooled to 
– 15 °C and recently distilled phosphorus oxychloride (0.6 mL, 6.3 mmol, 1.1 equiv.) was 
added dropwise with vigorous stirring. During the addition, the reaction mixture coloured 
deeply red and became turbid in the course of 5 to 20 minutes. The colour of the suspension 
slowly changed to brown and the reaction was complete after 30 minutes (monitored by 
TLC). The reaction mixture was then quenched with crushed ice water (100 mL) and 
extracted into EtOAc (once 50 mL and three times 30 mL). After drying on Na2SO4 filtered 
and evaporated in vacuo. The residue was co-evaporated successively with hexane and 
diethyl ether. The solid was recristalizated with a mixture of ether and hexane (1:1). The 
resulting yellow foam was used in the next step without further purification. 
  
                                                 
134 Rijkers, D. T. S.; Adams, H.; Hemker, C.; Tesser, G. I. Tetrahedron, 1995, 51, 11235–11250. 
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Tert-butyl (2-((2-nitrophenyl)amino)-2-oxoethyl)carbamate 52 
The title compound was prepared from o-nitroaniline. The product was 
purified by recrystallization as a yellow foam. Yield: 1.14 g, 3.5 mmol, 
61%. 1H NMR (300 MHz, CDCl3) δ 11.02 (brs, 1H), 8.84 (dd, J = 8.6, 1.3 
Hz, 1H), 8.25 (dd, J = 8.5, 1.6 Hz, 1H), 7.69 (ddd, J = 8.7, 7.2, 1.6 Hz, 
1H), 7.26 – 7.10 (m, 1H), 5.19 (brs, 1H), 4.05 (d, J = 6.1 Hz, 2H), 1.57 (s, 3H), 1.53 (s, 
6H).13C NMR (75 MHz, CDCl3) δ 169.6, 136.6, 134.9, 127.0, 126.5, 124.2, 122.7, 81.8, 
46.4, 28.9.UPLC-DAD-QTOF: C13H17N3O5 [M+H]
+ calcd.: 295.1168, found: 295.1274. 
tert-butyl (2-((4-nitrophenyl)amino)-2-oxoethyl)carbamate 53 
The title compound was prepared from p-nitroaniline. The product 
was purified by recrystallization as a yellow foam. Yield: 1.27 g, 3.9 
mmol, 69 %. All data were consistent with those previously 
reported.27 
Step 2: 
To a solution of carbamate (3 mmol, 880 mg, 1 equiv.) in CH2Cl2 (12 mL) trifluoroacetic 
acid (4.5 mL) was added at 0 °C and then warmed to room temperature during 30 min. The 
reaction was monitored by TLC and when the reactant was disappeared the reaction was 
evaporated in vacuo, washed with a mixture of ether and pentane (1:1) and finally was dried 
in vacuo. The resulting yellow salt was used in the next step without further purification. 
2-((2-nitrophenyl)amino)-2-oxoethan-1-aminium 2,2,2-trifluoroacetate 54 
The title compound was prepared from tert-butyl (2-((2-
nitrophenyl)amino)-2-oxoethyl)carbamate. Yield: 3 mmol, 929 mg, > 
99%. 1H NMR (300 MHz, D2O) δ 8.15 – 7.93 (m, 1H), 7.84 – 7.59 (m, 
2H), 7.41 (ddd, J = 8.6, 6.6, 2.3 Hz, 1H), 4.03 (s, 3H).13C NMR (75 
MHz, D2O) δ 166.4, 135.1, 129.6, 127.1, 126.4, 125.6, 41.2. UPLC-
DAD-QTOF: C10H10F3N3O5 [M+H]
+ calcd.: 309.0573, found: 
309.0574. 
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2-((4-nitrophenyl)amino)-2-oxoethan-1-aminium 2,2,2-trifluoroacetate 55 
The title compound was prepared from tert-butyl (2-((4-
nitrophenyl)amino)-2-oxoethyl)carbamate. Yield: 3 mmol, 929 
mg, > 99%. 1H NMR (300 MHz, D2O) δ 8.15 (d, J = 9.2 Hz, 2H), 
7.61 (d, J = 9.2 Hz, 2H), 3.97 (s, 2H). 13C NMR (75 MHz, D2O) δ 
165.8, 143.7, 142.9, 127.4, 125.1, 120.1, 114.4, 41.2. UPLC-
DAD-QTOF: C10H10F3N3O5 [M+H]
+ calcd.: 309.0573, found: 
309.1526. 
Step 3:135 
To a suspension of the trifluoroacetic salt (927 mg, 3 mmol, 1 equiv.) in CH2Cl2 (11 mL) 
benzophenone imine (0.5 mL, 3 mmol, 1 equiv.) and Na2 CO3 anhydrous (630 mg, 7.5 
mmol, 2.5 equiv.) was added. The reaction was stirred at room temperature for 24 h. Then 
the reaction was filtered to remove the salt that was formed and then evaporated to dryness 
in vacuo. The crude was purificated by recrystallization in ether: hexane (1:1).The solid 
was diluted in DCM (10 mL) and washed with a saturated aqueous sodium bicarbonate 
solution (3 x 10 mL) and dried in vacuo. 
2-((diphenylmethylene)amino)-N-(2-nitrophenyl)acetamide 56 
The title compound was prepared from 2-((2-nitrophenyl)amino)-
2-oxoethan-1-aminium 2,2,2-trifluoroacetate. The product was 
purified as a yellow foam. Yield: 606 mg, 2.3 mmol, 78 %. 1H 
NMR (300 MHz, CDCl3) δ 12.16 (brs, 1H), 9.09 – 8.75 (m, 1H), 
8.29 (dd, J = 8.5, 1.7 Hz, 1H), 8.03 – 7.79 (m, 2H), 7.79 – 7.64 (m, 
1H), 7.64 – 7.37 (m, 6H), 7.37 – 7.06 (m, 3H), 4.17 (s, 2H).13C NMR (75 MHz, CDCl3) δ 
172.3, 171.6, 139.4, 138.1, 137.4, 136.7, 135.5, 132.1, 130.2, 130.1, 129.9, 129.5, 128.2, 
126.9, 124.5, 123.5, 58.6. UPLC-DAD-QTOF: C21H17N3O3 [M+H]
+ calcd.: 359.1270, 
found: 359.1274. 
  
                                                 
135  Abaskharon, R. M.; Brown, S. P.; Zhang, W.; Chen, J.; Smith, A. B.; Gai, F. Chemical Physics Letters, 
2017, 683, 193–198. 
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2-((diphenylmethylene)amino)-N-(4-nitrophenyl)acetamide 57 
The title compound was prepared from 2-((4-
nitrophenyl)amino)-2-oxoethan-1-aminium 2,2,2-
trifluoroacetate. The product was purified as a yellow foam. 
Yield: 883 mg, 2.5 mmol, 82 %. 1H NMR (300 MHz, CDCl3) 
δ 9.78 (brs, 1H), 8.43 – 8.15 (m, 2H), 7.96 – 7.81 (m, 2H), 
7.71 (dd, J = 8.2, 1.5 Hz, 2H), 7.61 – 7.39 (m, 5H), 7.39 – 7.08 
(m, 3H), 4.13 (s, 2H). 13C NMR (75 MHz, CDCl3) δ 171.9, 170.0, 144.3, 144.0, 139.0, 
136.5, 131.9, 130.1, 129.8, 129.2, 127.8, 125.9, 119.8, 57.4. UPLC-DAD-QTOF: 
C21H17N3O3 [M+H]
+ calcd.: 359.1270, found: 359.1372. 
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5.4.1.2. Synthesis of iminoester 5828 
 
To a suspension of glycine methyl ester hydrochloride (1.4 g, 11 mmol, 1 equiv.) in CH2Cl2 
(40 mL) benzophenone imine (1.8 mL, 11 mmol, 1 equiv.) was added. The reaction was 
stirred at room temperature for 24 h. Then the reaction was filtered to remove the salt that 
was formed and then evaporated to dryness in vacuo. The crude was purificated by 
recrystallization in ether: hexane (1:1).The solid was diluted in DCM (10 mL) and washed 
with a saturated aqueous sodium bicarbonate solution (3 x 10 mL) and dried in vacuo to 
afford the methyl 2-((diphenylmethylene)amino)acetate as a white oil 2.8 g, 11 mmol, > 
99% yield. All data were consistent with those previously reported. 1H NMR (300 MHz, 
CDCl3) δ 7.74 – 7.61 (m, 2H), 7.56 – 7.42 (m, 4H), 7.43 – 7.29 (m, 3H), 7.25 – 7.14 (m, 
1H), 4.25 (s, 2H), 3.77 (s, 3H). 
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5.4.2. Aldol reaction of 56 with phenylpropanal 
 
To a mixture of the 2-((diphenylmethylene)amino)-N-(2-nitrophenyl)acetamide 56 (71.8, 
0.2 mmol, 1 equiv.) and 3-phenylpropanal (80.4 mg, 0.6 mmol, 3 equiv.) in CH2Cl2 (0.2 
mL), was added the catalyst C17 (20 mol %) and the resulting mixture was stirred at room 
temperature for 48 h. After that time, two products were formed, the desired product 60/61 
and the cycled product 61. Then, the solvent was evaporated under reduced pressure and 
the residue was purified by flash column chromatography on silica gel (hexane: EtOAc, 
10:1) to afford the adduct 59 and 60 and the cycled product 61 as a yellow oil.  
(2R,3S)-2-((diphenylmethylene)amino)-3-hydroxy-N-(2-nitrophenyl)-5-
phenylpentanamide 59 
The product was purified as a yellow oil. Yield: 74 mg, 0.15 
mmol, 72 %. [α]D22=  ̶ 64.17 °( c= 0.08, 80 % ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 11.43 (s, 1H), 8.32 (dd, J = 8.7, 1.5 
Hz, 1H), 8.05 – 7.77 (m, 1H), 7.42 (dd, J = 7.1, 1.9 Hz, 2H), 7.37 
– 7.20 (m, 3H), 7.15 (dd, J = 4.0, 2.3 Hz, 2H), 7.09 – 6.73 (m, 14H), 4.00 – 3.86 (m, 1H), 
3.58 (dd, J = 10.4, 6.9 Hz, 1H), 3.23 (d, J = 10.3 Hz, 1H), 2.76 – 2.53 (m, 2H), 2.09 (dp, J 
= 10.2, 3.2 Hz, 1H), 1.99 – 1.80 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 172.45, 171.98, 
144.63, 143.22, 142.31, 136.23, 129.75, 129.58, 129.19, 129.05, 129.01, 128.82, 128.69, 
128.31, 128.02, 127.66, 126.57, 126.32, 125.86, 123.97, 122.40, 79.34, 67.21, 37.49, 
33.23.UPLC-DAD-QTOF: C30H27N3O4 [M+H]
+ calcd.: 493.2002, found: 493.20176. 
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(4S,5R)-N-(2-nitrophenyl)-5-phenethyl-2,2-diphenyloxazolidine-4-carboxamide 61 
The product was purified as a yellow oil. Yield: 0.1 mg, 0.02 
mmol, 10%. [α]D22=  ̶+ 13.73 °( c = 0.1, CH2Cl2). 1H NMR (300 
MHz, CDCl3) δ 11.77 (brs, 1H), 8.66 (dd, J = 8.5, 1.3 Hz, 1H), 8.22 
(dd, J = 8.4, 1.6 Hz, 1H), 7.95 – 7.84 (m, 1H), 7.84 – 7.69 (m, 2H), 
7.69 – 7.52 (m, 3H), 7.49 (dd, J = 4.4, 2.1 Hz, 2H), 7.31 – 6.91 (m, 
9H), 4.34 – 4.23 (m, 1H), 3.91 (dd, J = 10.4, 7.0 Hz, 1H), 3.57 (d, J = 10.5 Hz, 1H), 3.15 – 
3.03 (m, 1H), 2.95 (ddd, J = 13.8, 9.9, 6.4 Hz, 1H), 2.42 (ddd, J = 10.2, 6.7, 3.2 Hz, 1H), 
2.33 – 2.12 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 172.0, 144.6, 143.2, 142.3, 136.2, 129.8, 
129.6, 129.2, 129.1, 129.0, 128.8, 128.7, 128.3, 128.0, 127.7, 126.6, 126.3, 125.9, 124.0, 
122.4, 99.8, 79.3, 67.2, 37.5, 33.2. UPLC-DAD-QTOF: C30H27N3O4 [M+H]
+ calcd.: 
493.2002, found: 493.2003. 
5.4.2.1. Reduction reaction to afford 63 
 
To a crude aldol reaction obtained in the previous step after 48 h, methanol (0.4 mL), 
NaBH3CN (32 mg, 0.5 mmol, 2.5 equiv.) and AcOH (24 µL, 0.4 mmol, 2 equiv.) were 
added and it stirred for 3 h. The solvents were evaporated, the residue was redissolved in 
dichloromethane, washed with a saturated NaHCO3 solution, dried over MgSO4 and 
evaporated under reduced pressure. The crude was purified by column chromatography 
(Hx/EtOAc 90/10) to afford the reduced adduct 62 as a yellow foam in 86% of yield. 1H 
NMR (300 MHz, CDCl3) δ 11.77 (s, 1H), 8.72 (d, J = 8.5 Hz, 1H), 8.20 (d, J = 10.0 Hz, 
1H), 7.60 (t, J = 8.6 Hz, 1H), 7.52 – 7.45 (m, 2H), 7.46 – 7.31 (m, 4H), 7.31 – 7.05 (m, 
9H)., 4.91 (s, 12H), 4.07 (m, 1H), 3.32 (d, J = 3.9 Hz, 1H), 2.86 (m, 1H), 2.67 (m, 1H), 
1.88 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 173.6 , 143.0 , 142.4 , 141.4 , 137.1 , 135.7 , 
134.0 , 129.0 , 128.8 , 128.7 , 128.6 , 127.8 , 127.6 , 127.4 , 126.2 , 125.9 , 123.7 , 122.2 , 
72.1 , 66.8 , 65.0 , 35.4 , 32.4. UPLC-DAD-QTOF: C30H30N3O4 [M+H]
+ calcd.: 495.2158, 
found: 495.2267. 
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5.4.3. X-ray analysis: ORTEP diagram of compound 56 
 
Molecule A 
 
Molecule B 
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5.4.4. Representative NMR spectra 
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5.4.5. HPLC chromatograms 
5.4.5.1. Aldol reaction  
Chiralpak IC, 90:10 Hexano: EtOH, 0.5 mL/min, λ=210 nm 
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ABSTRACT: The catalytic asymmetric α-functionaliza-
tion of prochiral barbituric acids, a subtype of pseudosym-
metric 1,3-diamides, to yield the corresponding 5,5-
disubstituted (quaternary) derivatives remains essentially
unsolved. In this study 2-alkylthio-4,6-dioxopirimidines are
designed as key 1,3-diamide surrogates that perform
exceedingly in amine-squaramide catalyzed C−C bond
forming reactions with vinyl ketones or Morita−Baylis−
Hillmann-type allyl bromides as electrophiles. Mild acid
hydrolysis of adducts aﬀords barbituric acid derivatives
with an in-ring quaternary carbon in unprecedented
enantioselectivity, oﬀering valuable materials for biological
evaluations.
Barbituric acids and derivatives are very interesting 1,3-diamide scaﬀolds for the development of therapeutic
agents and functional materials.1 Several approaches for the
asymmetric synthesis of chiral barbiturates in which chirality
resides outside of the ring (I, R1 = R2) are reported.2 In
contrast, the enantioselective synthesis of chiral barbiturates
with in-ring chirality remains unsolved (Figure 1a). The groups
of Brunner3 and Trost,4 independently, described palladium-
catalyzed asymmetric allylic alkylation reactions of I (R1 = H,
R2 = Me, R3 = alkyl) with allyl acetates or carbonates to
proceed with enantioselectivities from poor to modest. Lam’s
group has described the Rh(III)-catalyzed oxidative annulations
of cyclic 1,3-dicarbonyl compounds with alkynes,5 including a
single example involving nonsymmetric barbiturates I (R1 = H,
R2 = Me, R3 = Ph) that yields the corresponding spiroindene
adduct in 11% ee. It is thus not surprising that, among the
thousands of 5,5-disubstituted barbiturates synthesized and
selected for clinical trials, the great majority are racemic,6 even
though pharmacological proﬁle may be conﬁguration-depend-
ent.7 Here we describe a catalytic highly enantioselective route
to barbiturates with an in-ring all-carbon quaternary stereo-
center for the ﬁrst time. For this realization 2-alkylthio-4,6-
dioxopyrimidines III are designed as key barbituric acid
equivalents that perform exceedingly under bifunctional
Brønsted base/H-bond activation (Figure 1c).
Chiral organobase catalysis is recognized as one of the
operationally simplest approach for the enantioselective
functionalization of acidic CH pro-nucleophiles.8 Recently,
while our work was in progress, Rawal and co-workers reported
the enantioselective conjugate addition of symmetrically N,N′-
disubstituted barbituric acids to prochiral nitroalkenes triggered
by a bifunctional amine-thiosquaramide organocatalyst.2d
Whereas N,N′-disubstituted barbituric acids thus seems to be
suitable for a mild Brønsted base deprotonation,9 the
asymmetric organocatalytic C(5)-functionalization of prochiral
barbiturates of general structure II (R1 ≠ R2, Figure 1b) has not
yet been realized. A major problem concerns the pseudosym-
metrical structure of the 1,3-diamide moiety (Figure 1b) which
makes enantioface discrimination complicated,10 a situation
that would be critical during generation of a quaternary
stereocenter.11 For example (Scheme 1), at the outset of our
investigation barbiturates 1 and 2, as well as their thio-
Received: August 29, 2017
Published: October 12, 2017
Figure 1. Asymmetric α-functionalization of 1,3-diamides toward
barbituric acid derivatives with an in-ring stereogenic carbon.
Scheme 1. Initial Experiments with (Thio)Barbiturates 1−4
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analogues 3/4Aa, were treated with vinyl ketone 6a in the
presence of 10 mol % catalyst C1 (Figure 2) to give,
respectively, adducts 7−10 as essentially racemic material
(<20% ee at best).12 Reaction reversibility (retro-Michael
process)2d,9 as a cause of the low enantiocontrol could be
discarded as no crossover products were detected when adducts
7 and 8 were admixed with vinyl ketone 6b in the presence of a
base catalyst.12 We then questioned whether 2-benzylthio-4,6-
dioxopyrimidines 5 (Figure 2), which as far as we know have
never been employed in asymmetric catalysis, could be used to
solve this problem, considering: (i) the ready conversion into
the target barbituric acids upon standard hydrolytic conditions,
(ii) the enhancement of structural dissymmetry as compared to
the nearly symmetric diamides 1−4, and (iii) the suitability
toward deprotonation (pseudoaromatic enolate would be
formed) promoted by a weak base.
The preparation of compounds 5 was aﬀorded in one
benzylation step from the easily available thiobarbiturates 4
(Figure 2).12,13 Initial assessment of the behavior of these
compounds in conjugate additions was gratifying as the
reaction of 5Aa with enone 6a under the catalytic conditions
of Scheme 1 aﬀorded adduct 11 with a promising 66% ee
(Table 1, entry 1). The enantioselectivity could not be
improved when other known catalysts, such as bifunctional
thiourea C214 or squaramides C315 and C416 (entries 2−4), or
modiﬁed analogues C5, C6 and C717 (entries 5−7) were
employed. Eventually, the sterically more congested catalysts
C8 and C9, which can be prepared easily through Grignard
technology, performed the best.12 Thus, catalyst C8 provided
product 11 with 80% ee at room temperature and a remarkable
96% ee by running the reaction at 0 °C (entries 8, 9). The silyl
analogue C9 provided similar selectivities, but slower reaction.
To the best of our knowledge, this realization constitutes the
ﬁrst catalytic asymmetric Michael reaction of α-branched 1,3-
diamides.18
As the results in Table 2 show, several aryl vinyl ketones with
electron donating (Me) or withdrawing (Br) substituents on
the aromatic ring were equally competent reaction partners,
apparently irrespective of the o-, m-, or p- substitution pattern
(compounds 11−15). Also, the method tolerates substrates 5
with a range of substituents at both the N(3) (methyl, pentyl,
benzyl, aryl) and the C(5) (methyl, ethyl, benzyl, allyl) position
of the heterocycle to give the respective adducts 11−21 in ee’s
generally above 90%. However, intrinsically less reactive
Michael acceptors, such as acrylates and, by extension, α,β-
unsaturated esters, were not competent reaction partners. In
the opposite direction, the more reactive but less sterically
demanding acrolein, upon reaction with 5Aa, led, after
hydrolysis, to adduct 22, but with a poor 48% ee. In order to
surmount these diﬃculties, we next examined the reactions
with α-silyloxy enone 23, an acrylate and acrolein equivalent
very easy to prepare from acetone.19 As before, initial
experiments using enone 23 in combination with (thio)-
barbiturates 1 and 4 provided the corresponding addition
adduct as essentially racemic material independently of the
catalyst employed.12 Gratifyingly, however, the reaction of 23
with various 2-benzylthio-4,6-dioxopyrimidines 5 proceeded
smoothly and with very high enantioselectivity (Table 3).
Adducts from these reactions were isolated after acidic
hydrolysis leading to barbituric acids 24. As data in the table
show, products 24 bearing linear/branched alkyl or allyl R1
Figure 2. Barbituric substrates and catalysts used in this study.
Table 1. Catalyst Screening for the Reaction of 5Aa with 6a
To Give 11a
entry catalyst yield (%) ee (%)
1 C1 67 66
2 C2 71 36
3 C3 60b n.d.
4 C4 69 32
5 C5 67 73
6 C6 59 54
7 C7 66 75
8 C8 72 80
9 C8c 60 96
10 C9 62 78
aReactions carried out at r.t. using 0.2 mmol of 5Aa, 0.6 mmol of
enone 6a and 10 mol % catalyst in 0.5 mL of CH2Cl2; yields of isolated
product after chromatography; ee determined by chiral HPLC.
bConversion. cReaction run at 0 °C.
Table 2. Scope of the Reaction of 2-Benzylthio-4,6-
dioxopyrimidines 5 with Aryl Vinyl Ketones 6a
entry R R1 R′′ product yield (%)b ee (%)c
1 Me Me 4-Me 11 72 96
2 Me Me 4-Br 12 63 95
3 Me Me H 13 61 92
4 Me Me 2-Me 14 72 85
5 Me Me 3-Me 15 62 96
6 Me Et 4-Br 16 71 97
7 Me Bn 3-Me 17d 75 94
8 Me Allyl H 18 65 92
9 Are Me H 19 65 90
10 Bn Me 4-Br 20 67 90
11 nPent Me 4-Br 21 73 92
aReactions carried out at 0.2 mmol scale in 0.5 mL of CH2Cl2.
bYields
of isolated product after chromatography. cee determined by chiral
HPLC. dX-ray. eAr: 3,5-(CF3)2C6H3.
Journal of the American Chemical Society Communication
DOI: 10.1021/jacs.7b09124
J. Am. Chem. Soc. 2017, 139, 15308−15311
15309
substituents are produced in good yields and enantioselectiv-
ities typically above 90%, with isopropyl being an exception
(entry 8). The absolute conﬁguration of adduct 24Ad was
established by single crystal X-ray structural analysis20 and that
of the remaining adducts by analogy and by assuming a uniform
reaction mechanism. To further illustrate the potential of
templates 5 to build-up quaternary barbiturates through
modiﬁcation at C(5), the alkylation reaction with allyl bromides
derived from Morita−Baylis−Hillmann adducts was examined.
It was found that the reaction of 5 with allyl bromides 25/26 in
the presence of 1 equiv of K2CO3 and 10 mol % catalyst C8
proceeded smoothly at 0 °C (Table 4).21 Curiously, these
reactions were sensitive to both the nature of the ester group
and the base employed. For example, while ethyl ester 25 led to
adduct 27Aa using K2CO3 as base with moderate enantiose-
lectivity (entry 1, 54% ee), the tert-butyl congener 25 aﬀorded
28Aa in a remarkable 99% ee under the same conditions (entry
2). Among the bases examined, K3PO4 provided a similar (97%
ee) selectivity, whereas Cs2CO3 led to a reduced 77% ee and
tertiary amines were completely ineﬀective in terms of
enantioselectivity.12 As data in Table 4 show, the allylic
alkylation with 25 resulted suitable for a variety of substrates 5,
aﬀording adducts 28 with short and long alkyl, allyl or aryl
groups installed at the C(5) and N(1) positions in generally
good yields and selectivities of 89% ee or higher.
Transformations in Scheme 2 give an idea of the versatility of
the present method for the preparation of 5,5-disubstituted
chiral barbituric acid derivatives. Thus oxidative ketol cleavage
in 24Aa furnished the acid 30 almost quantitatively, while
applying a reduction/1,2-diol cleavage sequence, aldehyde 22
was produced in 88% overall yield. Subsequent Wittig
oleﬁnation gave rise to elongated barbiturates 31−33.
Eventually, conversion of both 24Aa and 11 into the same
ketone 29 served to further corroborate the stereochemical
assignments. On the other hand, ring closing metathesis of
tethered diene 28Fa and subsequent hydrolysis of the resulting
adduct 34 provided spiranic barbiturate 35 as essentially
enantiopure compound. Finally, N-alkylation/arylation of imide
31 using standard protocols gave rise fully substituted
barbiturates 36, 37 and 38, which are products otherwise
diﬃcult to obtain in enantioenriched form.
On the other hand, according to recent proposals for this
type of catalysis where the squaramide is doubly H-bonded to
the nuclephilic component (enolate) and the protonated
Table 3. Scope of Nucleophiles for the Reaction with
Acrylate Equivalent 23a
entry R1 R product yield (%) ee (%)
1 Me Me 24Aa 82 90
2 Me Bn 24Ab 61 81(87)b
3 Me nPent 24Ac 63 83(87)b
4 Me Ph 24Adc 62 90
5 Et Me 24Ba 71 94
6 Bn Me 24Ca 70 92
7 iBu Me 24Da 68 93
8 iPr Me 24Ea − −
9 Allyl Me 24Fa 72 92
aReactions carried out at 0.2 mmol scale in 0.5 mL of CH2Cl2.
bReactions run at room temperature using 10 mol % C9. cX-ray.
Table 4. Allylic Alkylation with MBH Bromides 25/26a
entry R1 R product yield (%) ee (%)
1 Me Me 27Aa 62 54
2 Me Me 28Aa 63 99
3 Me Bn 28Ab 61 90
4 Me nPent 28Ac 73 99
5 Et Me 28Ba 67 96
6 Bn Me 28Ca 63 86
7 Allyl Me 28Fa 65 92
aReactions carried out using 0.2 mmol of 5 and 1 equiv of each
bromide 25/26 and K2CO3 in 0.5 mL of CH2Cl2.
Scheme 2. Elaboration of Adducts
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quinuclidine activates the electrophile,22 model A could be
invoked, which would correctly explain the observed stereo-
chemistry.
In summary, we report here the ﬁrst highly enantioselective
construction of chiral barbiturates with an in-ring quaternary
stereogenic center, based on the catalytic α-functionalization of
2-alkylthio 4,6-dioxopyrimidines as key barbituric acid equiv-
alents. Squaramide-tertiary amine bifunctional catalysts are able
to trigger the reaction of these templates with Michael
acceptors eﬃciently, being the highest selectivities attained
with the new bulky catalyst C8. While extension of this
approach (i.e., using diﬀerent acceptors) can be foreseen,
chemical elaboration of adducts provides a route to structurally
diverse, quaternary barbituric acid derivatives hitherto inacces-
sible in optically active form.
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Lett. 2005, 7, 1967−1969 For pioneering work:. (c) Okino, T.;
Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2003, 125, 12672−12673.
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